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ABSTRACT 
 The objective of this dissertation is to understand the functions  of Escherichia coli 
YqjA and YghB, which are members of the conserved DedA/Tvp38 membrane protein 
family. YqjA and YghB are inner membrane (IM) proteins with multiple predicted 
membrane–spanning domain, sharing 62% amino acid identity and partly overlapping 
functions. Simultaneous in-frame deletions of these two genes in a strain named BC202 
results in various phenotypes including cell division defects, temperature sensitivity, and 
sensitivity to drugs and alkaline pH. The cell division defect of BC202 is due to the 
inefficient secretion of periplasmic amidases by the twin arginine transport (Tat) pathway 
into the periplasm and drug sensitivity is due to the inefficient function of various drug 
efflux pumps. Both these phenotypes are related to the loss of proton motive force (PMF) 
in BC202. Overexpression of MdfA, a Na+-K+/H+ antiporter or growth in acidic media has 
the ability to rescue all the phenotypes of BC202. In addition, the ∆yqjA mutant (but not 
the ∆yghB mutant) is alkaline sensitive and overexpression of yqjA can restore growth at 
alkaline pH only when more than 100mM of sodium or potassium ions is present in the 
growth medium. Osmotic pressure augments the YqjA mediated growth at alkaline pH. 
Furthermore, charged amino acids are also essential for YqjA and YghB function that were 
previously shown important for various secondary transporters. Additionally, yqjA 
expression is higher at alkaline pH and increased expression of yqjA also required 
sodium/potassium salts above pH 9.0. The transcriptional regulator CpxR is required for 
the expression of yqjA at alkaline pH in the presence of Na+/K+. Based on these results, we 
suggest YqjA and YghB are osmosensing proton-dependent transporters required for E. 
coli drug resistance and alkaline pH tolerance
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CHAPTER 1 
GENERAL INTRODUCTION 
 
1.1  The structure and composition of Gram-negative bacteria cell envelope 
  Bacteria are the oldest form of the living organism, as ancestors of present bacteria 
appeared on earth approximately four billion years ago. Over the extraordinary period of 
time, the random mutations, shifting environments and natural selection gave rise to two 
different cell wall structures in bacteria; the Gram negative and Gram positive cell envelope 
varieties. The designation of Gram positive and Gram negative bacteria are based on the 
different reaction of the cell envelope toward Gram staining due to their structural and 
chemical composition. The cell envelope offers bacteria their shape, provide a site for 
energy generation used for growth and division, and promotes pathogenesis and confers 
evasion from host immune responses. Importantly, the cell envelope continues to be a well-
known target in the search for novel drugs to Figureht the rise in multidrug resistance 
(Kleanthous and Armitage 2015). A key feature of Gram-negative bacteria like Escherichia 
coli is their cell envelope as shown in Figure. 1.1. The Gram-negative cell envelope is 
formed by three layers; the outer membrane (OM), the periplasm which contains the 
peptidoglycan layer, and the inner membrane (IM). 
 The outer membrane (OM): The Gram-negative bacteria can be distinguished from 
Gram-positive bacteria due to the presence of the outer membrane. It is an asymmetric lipid 
bilayer with an inner leaflet made of phospholipids and outer leaflet composed of 
lipopolysaccharide (LPS). LPS is an amphipathic molecule, made up of lipid A, a core 
oligosaccharide and an O-antigen polysaccharide. It is responsible for the endotoxic shock 
linked with the septicemia (Raetz and Whitfield 2002; Nikaido 2003). LPS blocks the 
diffusion of numerous hydrophobic molecules, which can simply diffuse across 
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phospholipid bilayers (Nikaido 2003). LPS assembly on the OM occurs through the Lpt 
(lipopolysaccharide transport) pathway (Okuda, Sherman et al. 2016). The hydrophobicity 
of LPS makes it very challenging to treat Gram-negative pathogens as most of the known 
drugs are relatively hydrophobic in nature (Okuda, Sherman et al. 2016). Apart from lipids, 
OM also contains two distinct types of protein namely lipoproteins and β-barrel proteins. 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Structure and composition of the E. coli cell envelope. The outer membrane 
(OM) is an asymmetric bilayer with phospholipids (PL) on the inner leaflet and 
lipopolysaccharide (LPS) on the outer leaflet. It also contains lipoproteins anchored to the 
inner leaflet and β-barrel protein (porins). The periplasm is an aqueous cellular 
compartment sandwiched between OM and IM and contains a thin peptidoglycan layer. 
The inner membrane (IM) is made of phospholipids on both inner and outer leaflet. This 
Figure was replicated with authorization from Nature Publishing Group with slight 
modifications: Nature Reviews Microbiology (Ruiz, Kahne et al. 2009). 
 
  The lipoproteins are assembled by Lol (localization of lipoproteins) pathway to the 
OM (Silhavy, Kahne et al. 2010). Lipoproteins possess N-terminal lipid moieties which 
help them in associating with the inner leaflet of OM.  There are around 100 OM 
lipoproteins present in E. coli, however,  the functions of most of them are still unknown 
(Miyadai, Tanaka-Masuda et al. 2004). The β-barrel proteins which (also known as outer 
membrane proteins (OMPs)) are also part of OM usually forms channels and are essential 
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for nutrient uptake but may also be enzymes. The β-barrel channels only permit the 
diffusion of  small hydrophilic molecules through it but not larger molecules (Silhavy, 
Kahne et al. 2010). The OMPs are gathered to the OM by the Bam (β- barrel assembly 
machinery) complex (Ruiz, Kahne et al. 2006). The OM also serves as a protective barrier 
shielding Gram negative bacteria from various toxic chemicals and therefore it is an 
essential organelle (Ruiz, Kahne et al. 2006; Silhavy, Kahne et al. 2010). The Mla 
(maintenance of lipid asymmetry) is an ABC transport system that helps in conserving the 
OM lipid asymmetry. There are at least six different Mla proteins present in all the 
compartments of cell envelope and that assist retrograde transport of phospholipid from 
OM to the inner membrane. The Mla pathway is thought to be a bacterial intermembrane 
phospholipid trafficking system (Malinverni and Silhavy 2009; Sutterlin, Shi et al. 2016). 
 The Periplasm : The periplasm is the aqueous compartment sandwiched between 
the outer membrane and inner membrane (Ruiz, Kahne et al. 2006). It is an extremely 
viscous layer of the cell envelope packed densely with soluble proteins and the 
peptidoglycan layer. The periplasm occupies around 40% of the total cell volume of Gram-
negative bacteria. The peptidoglycan layer consists of repeating units of N-acetyl 
glucosamine and N-acetyl muramic acid and crosslinked pentapeptide side chains that 
contribute to the cell shape and blocking cell lysis that can occur as a result of the high 
turgor pressure in the cytoplasm (Vollmer, Blanot et al. 2008; Silhavy, Kahne et al. 2010). 
Moreover, it is covalently linked to the outer membrane by Braun’s lipoprotein (Ruiz, 
Kahne et al. 2006). The periplasm represents an evolutionary ancestor of the lysosomes of 
eukaryotic cells due to the presence of degrading enzymes like alkaline phosphatase or 
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RNAse (De Duve and Wattiaux 1966). Additionally, it has an oxidizing environment and 
lacks the presence of any energy source such as ATP. 
 The inner membrane (IM):  The inner membrane or the cytoplasmic membrane 
borders the cytoplasm and is essential for cell integrity. It consists of both proteins and 
phospholipids. The content of phospholipids varies between bacterial species; for example 
in E. coli phosphatidylethanolamine (PE) is 70-80%, phosphatidylglycerol (PG) is 15-20% 
and cardiolipin (CL) is 5% or less (Kanemasa, Akamatsu et al. 1967). There are two 
predominant forms of IM proteins; integral inner membrane proteins and lipoproteins. 
Integral IM proteins possess α-helical transmembrane domains that are inserted 
perpendicular to the plane of the membrane, and lipoproteins are attached to the outer 
leaflet of the IM by lipid modification of an amino terminal cysteine residue (Tokuda and 
Matsuyama 2004; du Plessis, Nouwen et al. 2011). The IM is a semipermeable barrier that 
assists in the transport of molecules into and out of the cell. The IM serves as a site for 
many cellular processes like ATP synthesis, protein translocation, and lipid biosynthesis. 
Some IM proteins act as sensors of certain chemicals, stresses or physical stimuli and help 
in transducing the signal to the cytoplasm (Ruiz, Kahne et al. 2009). Approximately 25-
30% of the genes in the sequenced genomes are predicted to encode integral IM proteins 
(Daley, Rapp et al. 2005); however, to date only  relatively few structures of IM proteins 
are present in the Protein Data Bank (PDB) because they are highly hydrophobic in nature 
and resistant to form 3D crystals for structural analysis (Engel and Gaub 2008; White 2009; 
Rose, Beran et al. 2011). 
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1.2 Genetics of the E. coli DedA/Tvp38 membrane protein family  
 There are eight genes (yqjA, yghB, yabI, yohD, dedA, yqaA, ydjX and ydjZ) in the 
E. coli genome that encode members of the DedA/Tvp38 protein family (Doerrler, Sikdar 
et al. 2013). Presently, YqjA and YghB are the best-characterized members of this protein 
family. A number of years ago, a unique E. coli mutant was isolated in the Doerrler 
laboratory named Lud135 (Thompkins, Chattopadhyay et al. 2008). It was found that 
Lud135 had mutations in two non-essential genes- a nonsense mutation (W92TGA) in yqjA 
and a missense mutation (G203D) in yghB. Thereafter, an E. coli strain (named BC202) 
with simultaneous deletion of yqjA and yghB was created in the parent strain W3110, which 
showed various phenotypes identical to Lud135 (Thompkins, Chattopadhyay et al. 2008). 
YqjA and YghB are proteins of 219 and 220 amino acids, respectively, and share 62% 
amino acid identity with each other. The other six proteins of the E. coli DedA family 
display 25 to 30% amino acid identity with each other and YqjA/YghB. BC202 exhibits 
numerous phenotypes that provide a tool to study the roles of the DedA protein family. The 
distinguishing phenotypes of BC202 (∆yqjA ∆yghB) and ∆yqjA are described as follows: 
 The cell division defect: Bacterial cells divide into two identical daughter cells 
through a process of binary fission (Haeusser and Margolin 2016). The process of cell 
splitting (cytokinesis) occurs through a complex cooperating network of cytoplasmic, 
periplasmic and membrane bound cell division proteins that get recruited to the division 
site. If the process of cytokinesis is inactivated through any means, the bacterial cells grow 
as cylindrical rods and bacterial chromosomes continue to replicate and segregate, resulting 
in filamentous cells with numerous nucleoids (Haeusser and Margolin 2016). BC202 
displays a cell division defect phenotype with distinctive cell chaining at all growth 
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temperatures. An exponential phase culture of BC202 growing at 30⁰C consists of a 
heterogeneous mixture of cells bearing wild-type shape as well as cells with membrane 
bulges and irregular shapes unlike parent W3110 when seen under the microscope (Figure 
1.2, A) (Thompkins, Chattopadhyay et al. 2008). Our lab has demonstrated that the 
inefficient export of amidase (AmiA and AmiC) into the periplasm by the twin-arginine 
transport (TAT) pathway is responsible for the cell division defect of BC202 (Sikdar and 
Doerrler 2010). The twin-arginine translocation (Tat) protein export system is a PMF 
dependent protein export pathway present in the cytoplasmic membranes of most bacteria 
and archaea and helps in transporting fully folded proteins to the periplasm (Palmer and 
Berks 2012; Berks 2015). 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. The cell division defect and temperature sensitivity of BC202. (A) The wild 
type W3110 cells divide normally but BC202 displays a cell division defect under similar 
growth conditions. (B) BC202 grows at 30⁰C but not at 42⁰C while wild type W3110 grow 
fine at all temperatures (not shown). This Figure was modified and replicated with 
authorization from American Society for Microbiology: Journal of Bacteriology 
(Thompkins, Chattopadhyay et al. 2008). 
  
 Temperature sensitivity: BC202 shows similar growth as wild type W3110 at 30⁰C 
but fails to grow at a temperature above 42⁰C (Figure 1.2, B) (Thompkins, Chattopadhyay 
et al. 2008). The temperature sensitivity of BC202 is a phenotype independent of cell 
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division. The exact reason behind the temperature sensitive phenotype still remains 
unclear. 
 Altered membrane phospholipid composition: Membrane lipid homeostasis is very 
critical for the bacterial cell physiology. Many bacteria have the ability to change their 
membrane phospholipids that help them to survive in various environmental conditions. 
The phospholipids used in the biosynthesis of the membranes components often get 
recycled and they are essential for the stability of the cell envelope in the dividing cells 
(Zhang and Rock 2008). However, BC202 exhibits an altered membrane phospholipid 
composition with increased amounts of acidic phospholipids PG and CL and reduced 
amount of zwitterionic phospholipid PE at all growth temperature (Thompkins, 
Chattopadhyay et al. 2008). The cause behind and the significances of the altered 
membrane composition in BC202 remain unclear. 
 Activation of envelope stress response pathways: Envelope stress responses (ESRs) 
pathways in Gram-negative bacteria have mainly been defined in relation to their role in 
the biogenesis and maintenance of the bacterial envelope. Moreover, the ESRs also control 
resistance to antimicrobial agents through proteolysis of unfolded proteins, changes in 
proton motive force (PMF), and the expression of multidrug resistant genes (Guest and 
Raivio 2016). Six different stress response systems are characterized in E. coli- σ32 (RpoH) 
cytoplasmic stress pathway, σE (RpoE) periplasmic stress response pathway and the Cpx, 
Psp, Rcs and Bae extracytoplasmic stress response pathways. These stress response 
systems allow bacteria to survive in hostile environmental conditions like extreme 
temperature, pH, and osmolarity. Out of these stress response pathways, extracytoplasmic 
stress response pathways- Cpx, Psp, Rcs and Bae are highly activated in BC202 at 
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permissive growth condition supporting the role of YqjA and YghB in envelope 
maintenance (Sikdar, Simmons et al. 2013). 
 Loss of membrane potential (ψ): The proton motive force (PMF) in E. coli is 
composed of two components- the transmembrane electrical potential difference, ∆ψ (ψin - 
ψout), with ψin (electrical potential inside) more negative than ψout (electrical potential 
outside), and the transmembrane pH difference, ∆pH (pHin - pHout) with pHin (intracellular 
pH) being more alkaline than pHout (extracellular pH) under standard growth conditions. 
BC202 exhibits a significant loss of membrane potential as compared to wild type W3110 
strain suggesting the requirement of YqjA and YghB for PMF homeostasis as shown in 
Figure 1.3 (Sikdar, Simmons et al. 2013). 
 
Figure 1.3. The membrane potential (Δψ) measurement of W3110 and BC202 using JC-1 
red/green dye based assay. (A-C) Fluorescent red-green overlay images of (A) W3110, (B) 
BC202 and (C) W3110 treated with Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) 
acted as control. The changes in Δψ are presented as the green (530 nm)/red (590 nm) ratio. 
Increase in the green/red ratio indicates a decrease in membrane potential Δψ. This Figure 
was modified and replicated with authorization from American Society for Microbiology: 
Journal of Bacteriology (Sikdar, Simmons et al. 2013). 
  
 Drug sensitivity: Resistance to various antibiotic and biocides is often provided by 
various secondary membrane transporters, which utilize PMF as a source of energy. BC202 
was found to be sensitive to numerous antibiotics and biocides, which are effluxed in a 
9 
 
PMF-dependent manner (Kumar and Doerrler 2014). The details of the drug sensitivity 
phenotype are discussed later in this dissertation (Chapter 3). 
 Motility and biofilm formation defect: Motility in bacteria is generally connected 
with the flagella with certain exceptions. This feature helps them to escape adverse 
environments. BC202 is non-motile unlike the parent strain W3110 (unpublished data). 
Additionally, BC202 is also not able to form biofilms when compared to wild type W3110 
strain (unpublished data), a phenotype that might be due to loss of motility (Pratt and Kolter 
1998). 
 Alkaline pH sensitivity: Neutrophilic bacteria, like E. coli have the ability to 
survive in a wide range of pH between 5.5 and 9.0. However, the ∆yqjA mutant is sensitive 
to alkaline pH at 37⁰C (Kumar and Doerrler 2015). The specifics and cause of this 
phenotype are discussed in later part of this dissertation (Chapter 4). 
 The distinguishing phenotypes of BC202 (∆yqjA ∆yghB) and ∆yqjA are 
summarized in (Figure 1.4): 
 
 
 
  
  
   
 
 
 
              
 
 
 
 
Figure 1.4. The Summary of phenotypes of E. coli DedA family mutants.   
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Figure 1.5. A list of known suppressors of BC202 or ∆yqjA phenotypes.  
 The eight genes from E. coli are further functionally and evolutionary grouped into 
a complementing group (yqjA, yghB, yabI, and yohD) and non-complementing group 
(dedA, yqaA, ydjX, and ydjZ) depending on their ability to complement the cell division 
and temperature sensitivity phenotypes of DedA family mutant (Boughner and Doerrler 
2012). These results suggested that two groups of proteins have coevolved in E. coli. Our 
lab has pioneered in the characterization of the DedA/Tvp38 protein family using BC202 
as a primary mutant and discovered various suppressors (Figure 1.5) that helped in 
deciphering the functions of these proteins. Based on a series of publications from our lab, 
we have proposed that members of conserved DedA/Tvp38 protein family are likely to be 
a novel family of transporters (Thompkins, Chattopadhyay et al. 2008; Liang, Xu et al. 
2010; Sikdar and Doerrler 2010; Boughner and Doerrler 2012; Doerrler, Sikdar et al. 2013; 
Sikdar, Simmons et al. 2013; Kumar and Doerrler 2014; Kumar and Doerrler 2015). 
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1.3 The DedA/Tvp38 membrane protein family: E. coli and beyond 
 The DedA/Tvp38 protein family is an ancient and highly conserved family of inner 
membrane proteins, present in most sequenced genomes, including bacteria, archaea, and 
eukarya (Doerrler, Sikdar et al. 2013). The DedA family got its name from a 1987 
publication when a group of scientists titled specific DNA region found between the hisT 
and purF genes (downstream [of hisT ] E. coli DNA gene A) as DedA (Nonet, Marvel et 
al. 1987). Tvp38, a eukaryotic homolog of this family present in Saccharomyces cerevisiae, 
was isolated in proteomic analysis of Golgi subcompartments. Tvp38 was involved in a 
cooperative network that consists of late Golgi proteins and helps in the effective 
maintenance/function of the late Golgi/endosomal compartments (Inadome, Noda et al. 
2007). In general, the members of DedA/Tvp38 family have 4-6 predicted transmembrane 
domains and contain 200-250 amino acids. The DedA domain is highly conserved and 
includes both a cytoplasmic and a transmembrane region, as well as an amphipathic helix. 
All the proteins containing a DedA domain are assembled in NCBI Clusters of Orthologous 
groups (COG0586) (Doerrler, Sikdar et al. 2013). They do not show any similarity to 
known enzymes, channels, transporters or signaling proteins. In short, the function of this 
protein family remains obscure. However, a novel software AlignMe has shown that the 
bacterial DedA family proteins may share structural motifs with the LeuT protein 
superfamily based on the hydrophobicity profile (Khafizov, Staritzbichler et al. 2010). 
LeuT is a bacterial homolog of the neurotransmitter sodium symporter, and contain two 
sets of five transmembrane domains having a pseudo two-fold axis of symmetry along the 
plane of the membrane (Faham, Watanabe et al. 2008). 
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Thousands of prokaryotic homologs of DedA proteins are present in the NCBI protein 
database, and many bacteria have several members of this family in their genome (Figure 
1.6.) For example, there are eight predicted DedA homologs in the E. coli genome: yqjA, 
yghB, yohD, yabI, dedA, yqaA, ydjX, and ydjZ. Individually, each of these genes is 
nonessential as single knock-outs have been created and are present in the Keio collection 
(Baba, Ara et al. 2006). However, collectively the DedA family is essential in E. coli as a 
strain with all eight genes deleted is  non-viable and requires expression of a DedA family 
member in trans from a plasmid for survival (Boughner and Doerrler 2012). A multiple 
sequence alignment using ClustalW of DedA homologs is shown in Figure. 1.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Numbers of DedA family homologs in several bacterial species. This table lists 
the number of DedA family homologs present in sequenced genomes of representative 
eubacterial and archaeal species with (protein BLASTp E-value < 0.02) of E. coli YqjA, 
YghB, DedA,YohD, YabI, YdjZ, YdjX, and YqaA were included in the numbers of 
proteins displayed in the second column. As shown, various bacterial species contain 
multiple DedA homologs but some obligate intracellular pathogenic bacterial species like 
Chlamydia sp. do not have any significant DedA homologs.* The DedA family homologs 
have been shown to be collectively essential in E. coli (Boughner and Doerrler 2012). ** 
The single DedA homolog of B. burgdorferi has also been shown to be essential (Liang, 
Xu et al. 2010). 
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Figure 1.7. Multiple sequence alignments of DedA homologs using ClustalW 2.1. The 
multiple sequence alignment using eight DedA homologs of E. coli K-12 (protein name 
preceded by Ec_), BCG2664 of Mycobacterium bovis, BB0250 from Borrelia burgdorferi 
and HP1162 from Helicobacter pylori, are aligned with the help of ClustalW 2.1 
www.ebi.ac.uk/Tools/msa/clustalw2/). The boxed region signifies the DedA domain 
(COG0586) and predicted transmembrane domains are shown in green and the blue. The 
transmembrane regions are predicted using TMHMM software (Sonnhammer, von Heijne 
et al. 1998). The only conserved Glycine (G) amino acid is shown in bold and is either in 
or near the predicted amphipathic helix for all the aligned homologs. This Figure was 
modified and replicated with authorization from American Society for Microbiology: 
Journal of Bacteriology (Doerrler, Sikdar et al. 2012). 
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 The DedA family is also essential in Borrelia burgdorferi, the causative agent of 
Lyme disease, as deletion of its only gene (bb0250) of this organism results in death (Liang, 
Xu et al. 2010). Moreover, using hyper-saturated transposon mutagenesis coupled with 
high-throughput sequencing, an essential dedA genes in Caulobacter was discovered 
(CCNA_01607)(Christen, Abeliuk et al. 2011). In that study, the dedA genes are also 
reported essential in Caulobacter crescentus (Christen, Abeliuk et al. 2011). Apart from 
these, the occurrence of DedA homologs in various reduced genomes, including bacterial 
and archaeal species, extends support to the necessity of the DedA protein family for 
species survival (Doerrler, Sikdar et al. 2013). Recently, a phylogenetic study has evaluated 
three DedA homologs in cyanobacterium Synechocystis sp. PCC6803 named Slr0232, 
Slr0509 and Slr0305 (Keller and Schneider 2013; Keller, Schleppi et al. 2015). In that 
study, the invesitigators found that Slr0232 and Slr0509 are more closely related to E. coli 
YqjA and Slr0305 are more closely related to E. coli YdjX (Keller and Schneider 2013).  
 Although most of the studies about DedA family are done on prokaryotes, a bit of 
information is also available about DedA proteins from the eukaryotic organisms. Using 
Mos1 transposon mutagenesis, a DedA family member, Bus-19 (bacterially unswollen-19; 
having similarity with YdjX of E. coli) was found in a screen for Caenorhabditis elegans 
mutants which displayed altered the response to the bacterial pathogen Microbacterium 
nematophilum (Yook and Hodgkin 2007). The bacteria were no longer able to colonize the 
rectum of ∆bus-19 mutants, possibly due to loss of cell surface receptor in nematode (Yook 
and Hodgkin 2007). This study consistent with the idea that DedA family proteins may 
play a role in the function of the eukaryotic secretory pathway. Moreover, a membrane-
associated protein, Tvp38 (Tlg-2 compartment Vesicle protein of 38kD), was found in the 
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Tlg2-containing membrane by proteomic analysis of immunoisolated Golgi 
subcompartments of Saccharomyces cerevisiae (Inadome, Noda et al. 2007). Tvp38 
was involved in an interactive network that consists of the late Golgi/endosomal proteins. 
Apart from nematodes and yeast, DedA homologs are also present in the Mus musculus 
and Homo sapiens genomes. Tmem41A is a protein present in Mus musculus and Homo 
sapiens that shares a 25% amino acid similarity with E. coli YdjX (Doerrler, Sikdar et al. 
2013). 
 DedA proteins have been reported to play a role in the virulence of some species 
and may represent a possible drug target. A DedA homolog (BCG2664) from 
Mycobacterium bovis provides resistance to the antibiotic halicyclamine A when 
overexpressed in M. smegmatis (Arai, Liu et al. 2011). Furthermore, DedA proteins are 
also necessary for resistance to cationic peptides in both Salmonella enterica (Shi, Cromie 
et al. 2004) and Neisseria meningitidis (Tzeng, Ambrose et al. 2005). In Salmonella, YqjA 
provides resistance to protamine and cationic peptide magainin 2. Generally, covalent 
modifications of lipid A are required for resistance to cationic peptides (Zhou, Ribeiro et 
al. 2001), but the Salmonella ∆yqjA mutant displays wild-type lipid A profile. Therefore, 
the role of YqjA in providing resistance to cationic peptide remains unknown in Salmonella 
(Shi, Cromie et al. 2004). Likewise, Neisseria NMB1052 (dedA) mutant was found 
susceptible to polymyxin. For resistance to cationic peptides, Neisseria utilizes 
lipopolysaccharide modification, efflux pumps, and type IV secretion (Tzeng, Ambrose et 
al. 2005). Many Gram-negative pathogens use Type III secretion system to transfer effector 
proteins into the host cells. In Yersinia pestis, the DedA family gene ctgA (similar to E. 
coli YabI) was found to play a role in the secretion of Yops, as a mutant named CHI 1345 
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having insertion mutation in ctgA had compromised Yops secretion and attenuated 
virulence in mouse infection model (Houppert, Kwiatkowski et al. 2012). 
    This dissertation will mainly focus on the roles of YqjA and YghB in the drug 
resistance and alkaline pH tolerance in E. coli.  I provide evidence to support the hypothesis 
that these proteins function as proton dependent transporters. 
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CHAPTER 2 
PROTON DEPENDENT MULTIDRUG TRANSPORTERS AND ALKALINE pH 
HOMEOSTASIS IN BACTERIA 
 
2.1 Introduction 
 Bacterial cells possess a group of cytoplasmic membrane transport systems, which 
participate in the vital uptake of nutrients, efflux of toxic substances, energy generation, 
and maintenance of cellular homeostasis. In the past two decades, the advancement in 
cloning and sequencing technologies led to the identification of many such transport 
systems (Paulsen, Brown et al. 1996). Based on the direction of transport of substance, 
membrane transporters can be classified into three types: uniporter, symporter, and 
antiporters (Figure 2.1). A uniporter transports one kind of substance down its 
concentration gradient, for example, ion channels. For symporters, movement of one 
molecule down its concentration gradient allow the co-transport of another molecule 
against its concentration gradient in the same direction like in the case of lactose permease, 
which co-transports a proton and lactose. Finally, an antiporter allows the movement of 
one molecule down its concentration gradient and another molecule against its 
concentration gradient in the opposite direction such as MdfA which catalyzes Na+/H+ 
antiport. 
  
 
 
 
  
 
Figure 2.1. Three classes of transporter (Uniporter, symporter, Antiporter). 
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 The development of numerous antibiotics for controlling pathogenic organisms has 
been one of the most significant achievements in the past century. However, the extensive 
use of antibiotics has led to the rise of bacterial strains which can survive in the presence 
of multiple antibiotics (Putman, van Veen et al. 2000). This acquisition of multidrug 
resistance (MDR) has become a severe threat to  modern health care due to the increasing 
problem in attaining effective clinical treatments (Kumar, He et al. 2016). The resistance 
to antibiotics or other drugs may arise through various mechanisms, including enzymatic 
inactivation of antibiotics, target alteration, decreased membrane permeability, and drug 
metabolism (Figure 2.2) (Putman, van Veen et al. 2000; Higgins 2007). However, in most 
cases efflux systems provide resistance to the antibiotics or biocides (Van Bambeke, Balzi 
et al. 2000). Multidrug transporters play a major role in providing MDR by exporting a 
large number of structurally distinct compounds. The substrates for MDR transporters 
mainly consist of different types of antibiotics, biocides, dyes, detergents, cationic 
peptides, fatty acids and bile salts. The MDR transporters are of great clinical significance 
due to their multispecific nature that provides a severe hindrance to chemotherapy of 
infectious disease (Nishino and Yamaguchi 2001). 
Many species of bacteria have multiple MDR transporter genes in their genome (for 
example 39 putative genes are reported in E. coli) (Nishino and Yamaguchi 2001; Sulavik, 
Houseweart et al. 2001). As a group, they form a coordinated system of transporters with 
overlapping specificities, which provide a robust survival strategy (Tal and Schuldiner 
2009). Previously, it was believed that multispecificity of MDR transporters occurs by an 
indirect mechanism in which there is not a direct contact between the transporters and its 
substrate. However, recent studies including the recent crystal structures of MDR 
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transporters suggested the direct interaction of substrates to transporters and the broad 
substrate range is due to their multiple substrate binding capacities (Higgins 2007). 
Multidrug transporters have large hydrophobic binding pockets in their transmembrane 
region, mainly consisting of aromatic amino acids which help in nonspecific hydrophobic 
interactions, and also a few charged residues that interact with oppositely charged 
substrates (Zheleznova, Markham et al. 2000; Murakami, Nakashima et al. 2006). In 
certain cases, the binding pocket can also accommodate two different substrates at the same 
time (Lewinson and Bibi 2001). 
 
Figure 2.2. Mechanisms used by bacteria for drug resistance. They have numerous 
strategies to protect themselves from the toxic effect of antimicrobial compounds including 
(a) altering the drug target, (b) enzymatic degradation of drugs, (c) adjusting the cell 
membrane permeability, (d) use of multidrug efflux pump. In this Figure the antimicrobial 
agents are represented by yellow color and red color arrow show the direction of movement 
of drugs. This Figure was replicated with authorization from Hindawi Publishing 
Corporation (Kumar, Mukherjee et al. 2013). 
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2.2 Families of multidrug transporters 
MDR transporters are well categorized on the basis of sequence homology and are 
extensively documented (Saier and Paulsen 2001; Paulsen 2003). Depending on the 
structural difference and bioenergetics used, multidrug transporters can be classified into 
five superfamilies which are involved in the extrusion of toxic compounds to the outside 
of the cell (Figure 2.3) (Paulsen, Brown et al. 1996; Du, van Veen et al. 2015).   
 
Figure 2.3. The schematic representation of multidrug efflux transporters. Based on the 
phylogeny, bioenergetics used and transport mechanism, multidrug resistance transporters 
are classified into five superfamilies of efflux pumps. ABC transporters (left), MFS, SMR, 
RND and MATE families. This Figure is self-drawn based on idea of (Delmar, Su et al. 
2014).  
 
 Members of these families are highly conserved and are present in all the domains 
of life (Yen, Chen et al. 2010). The ATP-binding cassette (ABC) superfamilies have the 
distinct feature of containing the ATP-binding cassette (ABC), and utilize ATP hydrolysis 
as an energy source to pump the drug out of the cells. Example are human P-glycoprotein 
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and SAV1866 from S. aureus (Dawson and Locher 2007). Since they use ATP hydrolysis 
as their energy source, they are also called as “primary active transporters” (Murakami 
2008). All other multidrug transporters fall into the category of secondary transporters as 
they transport protons or sodium ions down their electrochemical gradients to extrude the 
drugs outside the cells (Putman, van Veen et al. 2000). The secondary transporters are 
further classified into four different groups: the major facilitator superfamily (MFS) 
(Griffith, Baker et al. 1992; Marger and Saier 1993; Yin, He et al. 2006), resistance 
nodulation cell division (RND) (Saier, Tam et al. 1994; Seeger, Schiefner et al. 2006), 
small multidrug resistance (SMR) (Paulsen, Skurray et al. 1996; Chen, Pornillos et al. 
2007), and multidrug and toxic compounds extrusion (MATE) families (Brown, Paulsen 
et al. 1999; Tanaka, Hipolito et al. 2013) as shown in (Figure 2.3). Generally, these 
transporters vary in size, with 400-450 amino acids in MFS family and MATE transporters, 
around 1000 amino acids in the RND transporters and approximately 100 amino acids in 
SMR family transporters (McKeegan, Borges-Walmsley et al. 2003). ABC transporters are 
less common in bacteria and provide resistance to specific drugs unlike the secondary 
multidrug transporter (Marquez 2005). The details of proton-dependent superfamilies are 
discussed as follows. 
 2.2.1 The major facilitator superfamily (MFS): The MFS is ancient, well 
characterized, universal, and the largest known superfamily of secondary transporters and 
passive solute transporters, comprising  more than 15000 sequenced members from all 
kingdoms of life (Hoglund, Nordstrom et al. 2011; Saier, Reddy et al. 2014; Yan 2015; 
Kumar, He et al. 2016). It was discovered by Henderson and coworkers (Henderson and 
Maiden 1990) but the term “major facilitator superfamily” was coined by Saier et al 
25 
 
(Marger and Saier 1993) in order to phylogenetically classify the solute permease and drug- 
resistance protein (Yan 2013; Yan 2015). The MFS participates in all types of transport 
including uniport, symport, and antiport of numerous substances (Marger and Saier 1993; 
Paulsen, Brown et al. 1996). Based on the transport process involved, the members of MFS 
were initially divided into five different clusters which take part in (a) drug resistance (b) 
sugar uptake (c) uptake of Krebs cycle intermediates (d) phosphate ester/phosphate 
antiport, and (e) oligosaccharide uptake (Marger and Saier 1993). Currently, this 
superfamily has more than 74 families in it, each of which are involved in transport of 
broad spectrum of substrates including monosaccharide, oligosaccharides, amino acids, 
lipids, organic ions, vitamins, enzyme cofactors, chromophores, and nucleobases (Saier 
and Paulsen 2001; Yen, Chen et al. 2010; Reddy, Shlykov et al. 2012).  
Most members of this superfamily have 12-14 transmembrane helices (TMH) and 
contain 400-600 amino acids (Law, Almqvist et al. 2008; Du, van Veen et al. 2015). In 
spite of low sequence similarity, dissimilar substrate specificities and coupling mechanism, 
these transporters share an extraordinary degree of structural similarity. The basic 
structural design involves two domains, each grouped into two pseudo symmetrical 6-TM 
bundles in the membrane plane and connected by a long cytoplasmic loop or two 
transmembrane helices (Sun, Zeng et al. 2012; Deng, Xu et al. 2014; Wisedchaisri, Park et 
al. 2014; Du, van Veen et al. 2015). The substrate binding pocket is mainly formed by the 
membrane-embedded cavity present in-between the two domains (Heng, Zhao et al. 2015). 
They also have a conserved hallmark sequence, DRXXRR, at identical positions on the N- 
and C- terminal part of the proteins (Law, Almqvist et al. 2008). Based on the sequencing 
studies, it was suggested that the C-terminal regions of these proteins participate mainly in 
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substrate recognition and the N- terminal halves are involved in proton translocation 
(Paulsen, Brown et al. 1996). These proteins operate by an alternating access mechanism, 
in which the substrate binding cavity is accessible from either sides of the membrane at 
some point in the transport cycle. A rocker-switch-type movement leads to conformational 
changes between inward open, occluded,  and outward open states during transport of 
substrate in exchange of protons. However, the types of transport coupling may vary 
between the family members. (Bapna, Federici et al. 2007; Schaedler and van Veen 2010; 
Du, van Veen et al. 2015). In E. coli, MdfA is one of the most studied and best characterized 
bacterial MFS family antiporter (Edgar and Bibi 1997; Sigal, Cohen-Karni et al. 2006). 
MdfA, a model for secondary MDR transport from MFS family and a known suppressor of 
BC202 
 
 MdfA is one of the suppressors of the BC202 phenotypes since overexpression of 
MdfA from a plasmid can rescue the cell division and temperature sensitivity phenotypes 
(Sikdar, Simmons et al. 2013). It also corrects the drug sensitivity of BC202 and partially 
corrects the alkaline pH sensitivity of ∆yqjA mutant (Kumar and Doerrler 2014))(Kumar 
and Doerrler 2015)). MdfA is a cytoplasmic membrane protein with 12 transmembrane 
helices (Figure 2.4 A) and containing 410 amino acids. MdfA was previously called Cmr 
because it was thought to be a chloramphenicol specific transporter (Nilsen, Bakke et al. 
1996; Edgar and Bibi 1997; Adler and Bibi 2002). However, overexpression of MdfA from 
a multicopy plasmid provides resistance to a wide range of structurally discrete compounds 
including neutral, zwitterionic, and lipophilic monovalent cations, such as 
chloramphenicol, ethidium bromide, tetraphenylphosphonium (TPP), benzalkonium 
chloride, some aminoglycosides, and fluoroquinolones in E. coli (Edgar and Bibi 1997; 
Bibi, Adler et al. 2001). Homologs of MdfA are found in many pathogenic bacteria 
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including Shigella flexineri (99% identity) (Jin, Yuan et al. 2002), and Salmonella 
typhimurium (90% identity) (Parkhill, Dougan et al. 2001).  
 
Figure 2.4. The secondary structure of MdfA and mechanism of drug/H+ transport by 
MdfA. (A) Based on hydropathy profile and gene fusion analysis MdfA has 12 
transmembrane helices in it. This part of the Figure is replicated with authorization from 
American society for microbiology: journal of Bacteriology (Adler and Bibi 2002). (B) 
The model shows the mechanism in which the transport of drug/H+ takes place. This part 
of the Figure is replicated with authorization from Elsevier: Molecular cell (Fluman, Ryan 
et al. 2012). 
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 Remarkably, MdfA is promiscuous not only in its substrate profile but also in the 
use of PMF components to drive electroneutral or electrogenic transport. The transport of 
cationic substrates is electroneutral in nature in which no net movement of charge occurs, 
whereas the neutral substrate is transported in an electrogenic manner resulting in net 
movement of electric charges (Lewinson, Adler et al. 2003). The electrogenic transport is 
governed by both transmembrane potential (∆ψ) and a transmembrane pH (∆pH) 
component of the PMF (∆µH), whereas electroneutral transport only requires ∆pH 
component (Bibi, Adler et al. 2001). The stoichiometry of drug/proton determines the 
electrogenic or electroneutral transport of drugs. Generally, MdfA has a stoichiometry of 
1: monovalent cationic drugs, signifying movement of one proton per antiport cycle. 
Because of this, the transport of divalent cationic drugs is energetically unfavorable by 
MdfA. However, providing an additional acidic residue either by random mutagenesis or 
by rational design in the predicted substrate binding pocket may allow MdfA to transport 
divalent cationic compounds as well (Tirosh, Sigal et al. 2012). 
  Biochemical and structural studies have shown the complexity of multidrug 
recognition and transport mechanism of MdfA. Mutational analysis suggested no 
irreplaceable acidic amino acid for the transport activity of MdfA (Sigal, Molshanski-Mor 
et al. 2006). Moreover, the amino acids cysteine (C21), glutamate (D26), glycine (39), 
valine (V54), and threonine (T56), alanine (A128, A147, and A191) and valine (V335) 
were proposed to form the drug binding site for MdfA and permit the recognition of various 
drugs (Edgar and Bibi 1997; Adler and Bibi 2004). The membrane-embedded negatively 
charged residues glutamic acid (E26) and aspartic acid (D34), and the positively charged 
arginine (R112) are proposed to participate in the transport function (Edgar and Bibi 1999; 
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Adler and Bibi 2004; Adler, Lewinson et al. 2004; Sigal, Cohen-Karni et al. 2006). 
 Recently, a model for MdfA transport activity was proposed in which aspartate 
(D34) is shown to be the proton binding site and it was suggested that substrate and protons 
compete for binding with each other but they bind at a different location within the protein 
during the transport cycle (Fluman, Ryan et al. 2012). The detailed mechanism of MdfA 
mediated drug/H+ transport, explaining the remarkable way of indirect competition, is 
shown in (Figure 2.4 B). In the first step, the proton is released from aspartate (D34) to the 
cytoplasm, which also requires the help of glutamate (E26). The drugs represented by (S) 
(Figure 2.4 B) cannot bind to the protein in the proton bound state, which is shown by 
dashed line. In the second step, the drug (S) bind to the protein upon deprotonation at a site 
other than D34. Once the drug is bound to the protein, there is a conformational switch that 
allows the drug bound pocket to open towards the periplasm. The drug is released in the 
periplasm. Thereafter, the release of the drug will allow a proton to bind D34 from the 
periplasmic side. The binding of proton again brings back MdfA to inward-facing 
conformation.  
 As an MFS protein, MdfA is expected to have the ‘rocker switch’-type mechanism 
that enables alternating access of the binding pocket to either side of the membrane. 
According to this model, the MdfA mediated drug transport cycle starts with the proton 
release from aspartate (D34) to the cytoplasm which also requires the help of glutamate 
(E26). The deprotonation of protein causes drugs to bind at a site other than D34. Once the 
drug is bound to the protein, there is a conformational switch that allows the drug bound 
pocket to open towards the periplasm. Next, the drug is released into the periplasm and 
release of drug allow proton to bind D34 from the periplasmic side. The binding of proton 
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again brings back MdfA to inward-facing conformation (Fluman, Ryan et al. 2012). MdfA 
forms a monomer in detergent solution and in proteoliposomes (Sigal, Lewinson et al. 
2007). The complementary gene fusion analysis showed that the C-terminal region of 
MdfA is not essential for the transport function (Adler and Bibi 2002). Three crystal 
structures of MdfA-ligand complexes are resolved all in inward facing conformation and 
has supported the previous biochemical evidence of importance of charged amino acids in 
transport cycle (Heng, Zhao et al. 2015). Apart from drug/proton transport, MdfA also 
catalyzes a low-affinity Na+-K+/H+ antiport activity and thus provides alkaline pH 
tolerance to E. coli (Lewinson, Padan et al. 2004). 
 2.2.2 The Resistance-Nodulation-Division (RND) Superfamily: Based on the 
sequence homology of functionally related membrane proteins, the RND protein 
superfamily was first described in 1994 (Saier, Tam et al. 1994). The unique designation 
of resistance/nodulation/division came from the identification of homologs involved in the 
nodulation of legumes by rhizobia (NolGHI) (Gottfert 1993), cell division protein (EnvD) 
(Klein, Henrich et al. 1991), and drug resistance. The RND superfamily can be further 
classified into seven protein families depending on their participation in the transport of 
transition metals, organic substances, drugs, and polypeptides (Tseng, Gratwick et al. 1999; 
Kim, Nies et al. 2011). These proteins are omnipresent in all the domains of life including 
bacteria, archaea, and eukaryotes (Tseng, Gratwick et al. 1999). Out of all MDR efflux 
pumps, the RND superfamily has the broadest range of antimicrobial substrates (Nikaido 
1998) and is present in most pathogenic bacteria including, Burkholderia pseudomallei, 
Escherichia coli O157:H7, Haemophilus influenzae, Neisseria gonorrhoeae, 
Pseudomonas aeruginosa, Salmonella typhimurium, and Vibrio cholerae (Helms, Vastrup 
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et al. 2002; Livermore 2003; Poole 2003). In Gram-negative bacteria, the efflux pumps 
belonging to the RND superfamily, such as AcrAB of E. coli and MexAB of Pseudomonas 
aeruginosa are the major players for providing multidrug resistance, since mutants lacking 
these genes are susceptible to most of the tested drugs (Kim, Nies et al. 2011). RND efflux 
pumps are a hindrance to the development of new potential antibiotics or drugs because of 
their specificity for a broad variety of substrates (Li, Zolli-Juran et al. 2004; Caughlan, 
Jones et al. 2012).  RND efflux pumps also play a major role in virulence of pathogenic 
bacteria by helping them in colonization, evading phagocytosis, and biofilm formation 
(Paulsen, Brown et al. 1996; Nikaido and Takatsuka 2009).  
RND proteins usually contain around 700-1300 amino acids, and their predicted 
structure consists of 12 transmembrane segments (TMS) with two large extracytoplasmic 
loops between TMS 1 and TMS 2, and TMS 7 and TMS 8 (Saier, Tam et al. 1994; Paulsen, 
Brown et al. 1996). Comparative sequence investigation have suggested that the N-terminal 
halves have sequence similarity with the C-terminal halves, indicating the tandem 
intragenic duplication of these transporters during evolution, similar to the MFS 
transporters (Saier, Tam et al. 1994; Paulsen, Brown et al. 1996). The RND family proteins 
are usually functional as a tripartite system (Figure 2.5) with the RND pump protein (AcrB) 
in the cytoplasmic membrane, a periplasmic adaptor protein of the MFP (membrane fusion 
protein) family (AcrA) (Zgurskaya and Nikaido 2000) and an outer membrane channel 
such as TolC of E. coli from the outer membrane factor (OMF) family (Fralick 1996) to 
extrude substrates out of cells (Nikaido 2011). Two different types of efflux occur through 
this tripartite system (i) transenvelope efflux and (ii) periplasmic efflux, using the proton 
gradient as an energy source (Figure 2.5). 
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Figure 2.5. Model of RND efflux pumps tripartite system. The RND efflux protein usually 
has an inner membrane RND protein, a membrane fusion protein, and an outer membrane 
protein to extrude the substrate from the cytoplasm. Transenvelope efflux allows the 
cytoplasmic substrates to get extruded directly to the external environment. Periplasmic 
efflux involves the removal of periplasmic substrates through RND protein and outer 
membrane protein with the help of membrane fusion protein. The Figure is replicated with 
authorization from ASM journal: Journal of Bacteriology (Kim, Nies et al. 2011). 
 
In transenvelope efflux, the substrate is directly effluxed to the external 
environment from the cytoplasm using an RND protein in the inner membrane and an outer 
membrane protein. However, in periplasmic efflux the substrate is extruded out from the 
periplasm (Kim, Nies et al. 2011). Recently, the crystal structure of all the three 
components of the RND efflux pump (AcrAB) were published detailing the mechanism of 
the assembly and transport process (Koronakis, Sharff et al. 2000; Murakami, Nakashima 
et al. 2002; Akama, Kanemaki et al. 2004; Akama, Matsuura et al. 2004). AcrA-AcrB-
TolC of E. coli and MexA-MexB-OprM of Pseudomonas aeruginosa are two best-
characterized examples of RND family proteins. 
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AcrAB-TolC multidrug efflux system from RND family 
 The E. coli AcrAB-TolC multidrug efflux pump is thought to be the best-studied 
efflux system and primarily responsible for the resistance to a wide variety of biocides and 
antibiotics. The acrAB operon contains two genes acrA and acrB which encode AcrA 
(member of MFP family) and AcrB (member of RND family) respectively (Ma, Cook et 
al. 1995) while the gene for TolC is present at a different position on the chromosome 
(Fralick 1996). All together they form a tripartite efflux system in which AcrB is at the 
cytoplasmic membrane, AcrA is periplasmic protein and TolC is a channel spanning the 
outer membrane. The schematic representation of the E. coli AcrAB-TolC efflux system is 
shown in Figure 2.6. Each component of the tripartite system is explained in details as 
follows. 
 
 
 
 
 
 
 
 
Figure 2.6. Schematic representation of E. coli AcrAB-TolC efflux system: Three 
components (i) AcrB are present in cytoplasmic membrane (ii) a periplasmic adapter 
protein AcrA and (iii) the outer membrane channel TolC. The Figure is replicated with 
authorization from Elsevier publisher: Current opinion in microbiology journal (Blair and 
Piddock 2009). 
 
 AcrB : the inner membrane component : AcrB is an inner membrane protein that 
utilizes proton motive force to extrude different substances including antibiotics like 
penicillin, cephalosporin, fluoroquinolones, macrolides, tetracycline and rifampicin, 
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cationic dyes such as acriflavine, crystal violet and ethidium bromide, and detergents such 
as Triton X-100, bile acids and organic solvents out of the cytoplasm  (Ma, Cook et al. 
1995; Yu, Aires et al. 2003; Nikaido and Takatsuka 2009). Crystallographic studies have 
shown that AcrB is a homotrimer complex of three identical protomers in the inner 
membrane, which form a “jellyfish” like shape as shown in Figure 2.7 (Murakami, 
Nakashima et al. 2002; Du, van Veen et al. 2015). Each protomer has 1049 amino acids 
and is divided into three domains (i) the transmembrane domain (TMD), (ii) periplasmic 
domain (PD), (iii) a TolC-docking domain in the periplasm (Figure 2.7) (Murakami, 
Nakashima et al. 2006; Tornroth-Horsefield, Gourdon et al. 2007; Nikaido 2011).  
 
 
 
 
 
 
 
 
 
 
Figure 2.7. The Structural arrangement of E. coli AcrAB-TolC efflux system: This system 
consists of the membrane fusion protein (MFP) AcrA and two membrane proteins: TolC, 
a channel in the outer membrane, and AcrB, a proton-dependent drug antiporter in the inner 
membrane. AcrB consists of the transmembrane domain, the porter (pore) domain, and the 
TolC docking domain. TolC is present on the outer membrane (OM) with its β-barrel 
domain and forms a long channel which tapers to a closed entrance at the proximal end in 
the periplasm by its α-helical domain. AcrA is separated into the membrane proximal 
domain, β-barrel domain, the lipoyl domain, and the α-helical hairpin. AcrA is linked with 
the inner membrane via an N-terminally attached lipid anchor. The Figure is replicated 
with authorization from Elsevier publisher: Chemistry and biology (Oswald and Pos 2011). 
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 In vivo site-directed disulfide crosslinking experiments showed that AcrB opens 
like a funnel into the TolC-docking domain (Tamura, Murakami et al. 2005), and loops 
from the TolC docking domain help in holding all three protomers together (Sennhauser, 
Amstutz et al. 2007). AcrB has 12 transmembrane helices out of which the 4th and 10th 
transmembrane domains have a triplet of charged amino acids, Asp 407, Asp 408, and Lys 
940, all of which are important for proton translocation and are located distally from the 
substrate binding site (Murakami, Nakashima et al. 2006; Su, Li et al. 2006; Seeger, von 
Ballmoos et al. 2009). The structure of AcrB is asymmetric in nature as each protomer are 
organized differently and various conformations of each monomer are necessary for the 
rotating mechanism (also called “peristaltic” transport mechanism) in which the substrates 
go through different modes of binding that include access, binding, and extrusion and back 
to access mode in the transport cycle as shown in (Figure 2.8) (Murakami, Nakashima et 
al. 2006; Sennhauser, Amstutz et al. 2007; Takatsuka and Nikaido 2009; Du, van Veen et 
al. 2015).  Recently, novel pyrano-pyridine based inhibitors of AcrB were developed 
having more powerful inhibition capacity than previously known inhibitors that will help 
in combating MDR gram-negative pathogens (Sjuts, Vargiu et al. 2016). 
 AcrA: The periplasmic component: AcrA is a periplasmic protein necessary for the 
transport activity of AcrAB-TolC tripartite system. It belongs to the membrane fusion 
protein family and is coexpressed with AcrB. AcrA is crucial for the multi-drug resistance 
phenotype along with AcrB (Ma, Cook et al. 1995; Paulsen, Brown et al. 1996).  AcrA is 
categorized as a lipoprotein based on sequence similarity and it is bound to the inner 
membrane through N-terminal lipid moiety (Ma, Cook et al. 1995). 
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Figure 2.8. Schematic representation of “peristaltic” transport mechanism of E. coli AcrB. 
The three protomers of AcrB adopt different conformations individually upon substrate 
binding, namely Loose (L), Tight (T) and Open (O). The top panel shows a cross section 
(two protomers of the AcrB/TolC trimers or AcrA hexamer). TolC is at the top and AcrA 
is contacting both AcrB and TolC. The middle panel is the view of AcrB trimer with respect 
to the periplasmic domain of the pump. The lower panel shows the movement of the 
substrate between the binding pockets in protomers. The various geometric representation 
like a triangle (low), rectangle (high), and circle (no) show the binding affinity for the 
substrates. In the first state of the cycle (from left to right), a monomer binds a substrate 
(acridine) in its transmembrane domain (L conformation), subsequently transports the 
substrate from the transmembrane domain to the hydrophobic binding pocket (conversion 
to T conformation) and finally releases the substrate in the funnel toward TolC (O 
conformation). Peristaltic transport of drugs through the AcrB tunnels and through TolC 
would account for a strict unidirectional movement towards the outside of the cell. The 
conversion from the T monomer to the O monomer conformation is suggested to be the 
major energy-requiring (proton motive force-dependent) step in this functional rotation 
cycle and requires the binding of a proton to the proton translocation site (D407, D408, and 
K940) from the periplasm. The release of a proton from the proton translocation site to the 
cytoplasm might occur during conversion from the O monomer to the L monomer (as 
depicted) or from the latter to the T monomer. AcrA is expected to participate in the 
transduction of the conformational changes from AcrB to TolC , which results in the 
movement of the proximal part of TolC and the facilitation of drug extrusion to the outside 
of the cell. The Figure is replicated with authorization from Elsevier publisher: Current 
opinion in Structural biology journal (Du, van Veen et al. 2015). 
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 The structure of AcrA has four domains (a) the C-terminal domain which is 
conserved in the membrane-fusion proteins (b) the β-barrel domain (c) the lipoyl domain, 
which is suggested to function as swinging arm and participating in carrying substrate to 
their destination and (d) a helical domain which interacts with TolC as shown in (Figure 
2.7)  (Johnson and Church 1999; Zgurskaya and Nikaido 1999; Mikolosko, Bobyk et al. 
2006; Ge, Yamada et al. 2009).  
 TolC: The outer membrane component: TolC is present in the OM and accountable 
for extrusion of hydrophobic and amphipathic drugs out of the cell. The crystallographic 
studies have shown that TolC is made of three identical protomers, consisting of 428 amino 
acids that form a “channel-tunnel like” structure. Each protomer consists of a β-barrel 
domain (channel domain) attached to the outer membrane and a helical domain (tunnel 
domain) projecting into the periplasm as shown in (Figure 2.9) (Koronakis, Li et al. 1997; 
Koronakis, Eswaran et al. 2004).  
 
 
 
 
 
 
 
 
Figure 2.9. The complete structure of TolC. The three protomers of TolC are colored in 
red, yellow and blue. The beta barrel representing the channel domain is at the top and α- 
helical structure showing the tunnel domain is at the bottom. The Figure is replicated with 
authorization from nature publishing group: nature with slight modifications (Koronakis, 
Sharff et al. 2000). 
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 Apart from AcrAB efflux pump, many other multidrug transporter including AcrEF 
(Kobayashi, Tsukagoshi et al. 2001), YhiUV (Nishino and Yamaguchi 2002), EmrAB 
(Borges-Walmsley, Beauchamp et al. 2003), MdtABC (Nagakubo, Nishino et al. 2002), 
and the MacAB (Kobayashi, Nishino et al. 2001) are dependent on TolC for expulsion of 
drugs outside the cell. TolC is also responsible for hemolysin secretion (Wandersman and 
Delepelaire 1990). 
 2.2.3 The small multidrug resistance (SMR) superfamily: Members of SMR 
superfamily are usually small integral membrane proteins having 100 to 140 amino acids 
and participate in the efflux of lipophilic cationic drugs and numerous quaternary 
ammonium compounds (QACs) (Paulsen, Skurray et al. 1996; Bay, Rommens et al. 2008). 
The well-known substrates for SMR are methyl viologen (MV), tetraphenylphosphonium 
(TPP), benzalkonium chloride, cetyltrimethylammonium bromide (CTAB), ethidium 
bromide, and acriflavine (Yerushalmi, Lebendiker et al. 1995; Chung and Saier 2001). 
Phylogenetic studies of the SMR family suggested that all the members of this superfamily 
are not drug transporters and they are further classified into three types: (i) small multidrug 
pumps (SMP), which provide multidrug resistance to bacteria as well as archaea (for 
example EmrE from E. coli), (ii) suppressor of GroEL mutation proteins (SUG) which 
depend on the ability to phenotypically suppress the mutation in groE (Greener, 
Govezensky et al. 1993), and (iii) the paired SMR (PSMR) which need coexpression of 
two separate SMR gene products providing resistance in the bacteria (for example YdgE 
and YdgF from E. coli) (Bay, Rommens et al. 2008).  
 Typically all classes of the SMR superfamily have four predicted transmembrane 
domains. Multiple sequence alignment and membrane topology studies have shown the 
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presence of conserved amino acid motifs in each of four predicted transmembrane domains 
(Figure 2.10). However, the knowledge of topology and orientation of these proteins are 
often the subject of controversial debate. Both uni-directional orientation and the bi-
directional concept of the dual topology of a homodimer have been proposed in the 
literature (Pornillos and Chang 2006; von Heijne 2006). EmrE is a model for studying the 
evolution and mechanism of SMR family (Schuldiner 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10. The representation of three classes of small multidrug resistance protein 
(SMR) topology. (A) E. coli EmrE belong to SMP class (B) SugE represent the SUG class 
(C) YdgE and (D)YdgF from E. coli belong to PSMR class. SMR protein consists of four 
transmembrane helices. The amino acids of each protein are depicted by circles. Site-
directed mutagenesis studies have suggested that the amino acids highlighted in red affect 
the drug resistance activity. The conserved motif for all SMR proteins is shown by blue 
color and conserved residue specific to SMP are shown by green, SUG is shown by yellow 
and PSMR is shown by violet. The Figure is replicated with authorization from Elsevier 
publication: Biochimica et Biophysica Acta with slight modifications (Bay, Rommens et 
al. 2008). 
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EmrE: model for studying mechanism of transport of SMR family 
 EmrE is a small (110 amino acids) SMR transporter that provides resistance to 
multiple hydrophobic positively charged drugs, including ethidium bromide, proflavine, 
methyl viologen, erythromycin and tetracycline in E. coli (Higgins 2007; Schuldiner 2009). 
EmrE forms the basis of a unique experimental model system to study the coupling 
mechanism of secondary transporter not only due to its small size and stability, but also 
because the detergent-solubilized proteins is able to show the antiport of a proton and 
substrate, replicating catalytic activity in the membrane (Schuldiner 2007). Based on 
hydropathy analysis, EmrE has four predicted transmembrane domains (Figure 2.10). 
Transport experiments have shown that the energy requisite for activity depends on the 
nature of the substrate. For example, monovalent cationic compounds like TPP+ are 
transported in an electrogenic manner whereas transport of divalent cations like methyl 
viologen (MV) are electroneutral in nature (Rotem and Schuldiner 2004).  
 Altogether, there are eight charged amino acids in EmrE, of which only glutamate 
(E14) is located in the transmembrane region and is highly conserved in hundreds of 
homologs in bacteria and archaea (Schuldiner 2009; Schuldiner 2014). Site-directed 
mutagenesis and pH dependent studies have shown that E14 is indispensable for both the 
substrate and proton binding, out of which only one can bind at one time (Schuldiner 2009).  
Moreover, biochemical and structural data have suggested that EmrE functions as a 
homodimer, but whether it functions as parallel or antiparallel dimers has been highly 
controversial (Schuldiner 2009). The parallel dimer is symmetric in nature in which both 
subunits are in the same orientation, whereas anti-parallel dimers are asymmetric having 
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both subunits in opposite membrane orientation (dual topology) (Figure 2.11)(Schuldiner 
2009) (Sanders 2015). 
 
 
 
 
 
 
 
 
 
Figure 2.11. The schematic representation of the topology of E. coli EmrE. Theoretically, 
two subunits of EmrE can either acquire a parallel or anti-parallel orientation. (A) A 
parallel orientation is when the N- and C-termini of both subunits in the dimer are on the 
same side of the membrane. (B) In contrast, for an anti-parallel orientation, the N- and C-
termini of each subunit are on opposite sides of the membrane and as a result, obtain a dual 
topology, where the dimers are a combination of both Cin and Cout. The Figure is drawn 
based on the idea from (Rapp, Granseth et al. 2006; Schuldiner 2007; Schuldiner 2009; 
Woodall, Yin et al. 2015). 
 
 The structural data from Cryo-EM , X-ray crystallography (Chen, Pornillos et al. 
2007; Lloris-Garcera, Slusky et al. 2013) and NMR dynamics experiment (Morrison, 
DeKoster et al. 2012), along with the biochemical evidence (Lloris-Garcera, Bianchi et al. 
2012) support the anti-parallel orientation of EmrE (Figure 2.12, b). Moreover, the 
membrane topology sequence determinants, arginine and lysine residues present in EmrE 
loops (K_R bias) further support the dual topology orientation (Rapp, Granseth et al. 2006). 
The anti-parallel dimer adopts the dual topology in a cotranslational manner by the 
ribosome and translocon (Woodall, Yin et al. 2015). On the other hand, there are various 
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biochemical data backing the parallel orientation including the design of functional EmrE 
constructs in which the monomers are associated with short polar loops making the 
constructs energetically unfavorable to cross the membrane (Steiner-Mordoch, Soskine et 
al. 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12. The model of single-site alternating access mechanism of EmrE transport. (A) 
EmrE translocates one cationic substrate in exchange for two protons. In this model, EmrE 
undergoes a cycle of alternatingly inward and outward facing binding pocket on one side 
of the membrane during the transport cycle. The change in conformation only takes place 
when either two protons or cationic substrate compete for binding to a single glutamate 
residue (E14).(B).The cartoon structure of conformational interconversion of anti-parallel 
EmrE in substrate bound form is shown. This Figure is replicated with authorization from 
Nature publishing group: Nature (Morrison, DeKoster et al. 2012). 
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 Additionally, crosslinking of amino acids present in opposite sides of the membrane in the 
anti-parallel model is possible without affecting the transport activity supporting the 
parallel orientation (Soskine, Mark et al. 2006). Furthermore, electron paramagnetic 
resonance (EPR) studies of spin-labelled EmrE in TM3 showed restricted constraint, 
further backing the parallel orientation concept (McHaourab, Mishra et al. 2008).  
 As far as the transport mechanism is concerned, the single site alternate access 
mechanism has been suggested for anti-parallel EmrE in which EmrE switches the inward 
and outward-facing conformations to transport the substrate across the membrane. In this 
transport process, the proton and substrate interact with a single binding site (E14) leading 
to a conformational change (Figure 2.12) (Morrison, DeKoster et al. 2012). E14 acts as the 
carrier for the two protons that are released into the cytoplasm to energetically initiate the 
EmrE antiport cycle (Schuldiner 2009). Moreover, the pH gradient across the E. coli 
membrane may help in altering the equilibrium of EmrE in support of an inward-open 
resting conformation important for substrate binding (Gayen, Leninger et al. 2016). 
 2.2.4 The Multidrug and Toxic Compound Extrusion (MATE) Family: The 
transporters of the MATE family help in the extrusion of cationic, lipophilic compounds 
and xenobiotics and provide multidrug resistance to pathogenic bacteria and cancer cells 
(Omote, Hiasa et al. 2006; Kuroda and Tsuchiya 2009). They are functionally flexible in 
using H+ or Na+ motive force for their transport activity (Jin, Nair et al. 2014). Around 900 
MATE transporters have been reported so far based on the amino acid similarity and 
classified into the NorM, DinF (DNA-damage-inducible protein F), and eukaryotic 
subfamilies (Brown, Paulsen et al. 1999; Lu 2015). Out of these subfamilies, NorM and 
DinF have the ability to utilize either the proton or sodium gradient to energize transport 
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while eukaryotic subfamilies are mainly proton-dependent transporters (Morita, Kataoka 
et al. 2000; Su, Chen et al. 2005; Masuda, Terada et al. 2006; Lu 2015). Typically, MATE 
family proteins have 400-700 amino acids and contain 12 predicted transmembrane 
domains. Biochemical and structural data have suggested that these transporters also follow 
a rocker- switch mechanism similar to the MFS transporters (Du, van Veen et al. 2015). 
 2.2.5 Coordination between the multidrug transporters: a strong tool for survival: 
Genomic studies have revealed that most bacteria have a vast number of drug transporter 
genes. Various methods have been employed to study the roles of these drug transporters. 
Sulavik et al created  knock out strains of various efflux pumps and studied the effect of 
35 different compounds including antibiotics, dyes, and detergents on these strains 
(Sulavik, Houseweart et al. 2001). In another study, overexpression of  a complete library 
of E. coli putative drug transporters from a plasmid showed that around 20 genes provide 
resistance to at least one of the 26 biocides tested (Nishino and Yamaguchi 2001). These 
studies supported the idea that deletion of efflux pumps other than AcrAB-TolC has 
minimal effect on the drug sensitivity in E. coli. The minimal effect of gene deletion of 
other transporters except AcrAB-TolC can be explained on the basis of overlapping 
function of one transporter to shield the loss of other transporters (Tal and Schuldiner 
2009). The model in (Figure 2.13) was proposed explaining the coordinated network of 
transporters with overlapping capacity in providing a strong survival strategy against toxic 
environments. . According to this model, there is a two stage functional organization of 
membrane transporters in which MFS (MdfA) and SMR (EmrE) like transporters 
associated with the cytoplasmic membrane transport the toxic substrates from the 
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cytoplasm to periplasm and AcrAB-TolC removes the toxic compounds from periplasm 
out of the cell (Tal and Schuldiner 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13 Model of functional co-ordination among AcrAB-TolC, EmrE, and MdfA in 
E. coli. The EmrE and MdfA are single component multidrug transporters present in the 
cytoplasmic membrane. These transporters remove their respective substrates from the 
cytoplasm into the periplasm. Thereafter, AcrAB-TolC captures those substrates and 
extrudes them out of the cells. This Figure is replicated with authorization from PNAS (Tal 
and Schuldiner 2009).   
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2.3 Alkaline pH homeostasis in E. coli 
The proton motive force (PMF) is an electrochemical gradient of protons across the 
cell membrane established by active proton pumping and moderated by secondary ion 
movement (Mitchell 1961; Krulwich, Sachs et al. 2011). Usually, the bacterial PMF has 
two components: a transmembrane electrical potential (∆ψ), which is negative inside as 
compared to outside and a transmembrane pH gradient (∆pH), which is usually alkaline 
inside relative to the outside (Rottenberg 1979; Kashket 1985). ∆ψ is generated by 
electrically unbalanced movement of ions across the membrane and defined as the potential 
difference across the membrane when measured with two identical electrodes (Rottenberg 
1979). ∆pH is the difference between the cytoplasmic pH (pHin) and outside pH of the 
environment (pHout) (Padan and Schuldiner 1987). The PMF of a bacterial cell is 
represented by the equation: PMF (mV) = ∆ψ – (2.303RT/F)*∆pH, where R is the gas 
constant, T is the absolute temperature, and F is the Faraday constant (Krulwich, Sachs et 
al. 2011). Primary proton pumps including the respiratory or other redox potential-driver 
pumps facilitate electrogenic transport of protons outward and help in generation of PMF 
across the membrane (Padan and Schuldiner 1987). Secondary transporter and rotary 
nanomachines like the ATP synthase and the flagellar motor can utilize the PMF to 
energize active transport and mechanical processes, ultimately contributing to the pH 
homeostasis of specific bacteria (Krulwich, Sachs et al. 2011). Additionally, the proton 
concentration across the cell membrane plays a crucial role in bioenergetics of the bacterial 
cell (Mitchell 1966).   
Bacteria are classified into three categories based on the pH requirement: 
acidophile, neutrophile and alkaliphiles. Acidophiles like Lactobacillus can grow in pH < 
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5, neutrophiles like Escherichia coli can survive at external pH values of 5.5-9.0 and 
alkaliphiles like Bacillus alcalophilus can live at pH 10-13.0 range. Depending on the 
demands of pH homeostasis, bacterial species can regulate the relative level of both PMF 
components (Krulwich, Sachs et al. 2011). The environmental pH partially controls the 
cytoplasmic pH, or intracellular pH, which ultimately affects protein stability, enzymatic 
functions, nucleic acid structure, and other important biological molecules (Slonczewski, 
Fujisawa et al. 2009). Therefore, pH homeostasis is essential for the existence of bacterial 
cells at unfavorable pHs. There have been extensive studies and reports about the acidic 
pH homeostasis of bacteria (Matin 1999; Foster 2004), but here I will mainly concentrate 
on describing the bacterial alkaline pH homeostasis which is an important aspect of many 
pathogen life styles. 
There are many natural habitats with elevated pH, including sea water, and bacteria 
are able to reside in such places. For instance, enteric bacteria inhabiting the human gut 
have to survive in pH > 10 in the pancreatic duct below the pylorus (Evans, Pye et al. 1988). 
Additionally, neutrophilic enterobacteria E. coli and Vibrio cholerae can survive in alkaline 
marine environments over a period of time, where they are a risk to public health (Hood 
and Ness 1982). The ability of bacteria to persist and grow at alkaline pH is of great 
importance for physiology, ecology, and pathogenesis, and also for remediation and 
industrial applications (Padan, Bibi et al. 2005). Although neutrophiles like E. coli can 
grow in a broad range of external pH, from 5.5 – 9.0, they have to retain their cytoplasmic 
pH to a narrow range of pH 7.4-7.8 for their survival (Krulwich, Sachs et al. 2011). At 
alkaline pH, alkaliphiles and neutrophiles have an inverted ∆pH (acid inside) which gets 
deducted from PMF resulting in constant cytoplasmic pH inside and only the ∆ψ 
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component of PMF plays the major role in the maintenance of cytoplasmic pH 
(Slonczewski, Fujisawa et al. 2009). Additionally, the surface-associated proton 
concentration as relative to cytoplasmic proton concentration could establish a ∆pH, which 
is chemiosmotically suitable than the bulk ∆pH during the growth at alkaline pH 
(Krulwich, Guffanti et al. 1990).  
 The ability to survive in alkaline environments is critical for many bacterial species.  
Studies aimed at understanding alkaline tolerance have applications in biotechnology, 
bioremediation and medicine (Horikoshi 1999; Margesin and Schinner 2001).  Alkaline 
tolerance is important for the ability of the microbiome and bacterial pathogens to adapt to 
the alkaline environment of the gut (Krulwich, Sachs et al. 2011), for the bioprecipitation 
of uranium under alkaline conditions by Deinococcus radiodurans (Kulkarni, Ballal et al. 
2013) and it is even relevant to the origin of life, which is believed to have occurred in 
alkaline hydrothermal vents (Martin, Baross et al. 2008).  
 Transcriptome and proteome analysis, along with genetic studies, suggested 
various adaptive mechanisms are employed by bacteria for alkaline pH homeostasis. These 
include: (a) upregulation of ATP synthase that brings in protons during ATP generation 
(Krulwich, Sachs et al. 2011) (b) metabolic switching for acid production (Stancik, Stancik 
et al. 2002), (c) increased synthesis of acidic metabolite by amino acid deaminases like 
TnaA tryptophanase (Blankenhorn, Phillips et al. 1999), (d) cell surface modifications such 
as increased synthesis of anionic phospholipids or specific neutral lipids that aid in 
cytoplasmic proton preservation (Clejan, Krulwich et al. 1986), and (e) increased 
expression and activity of monovalent cation/proton antiporters (Padan, Bibi et al. 2005). 
Amongst these strategies, cation/proton antiporters play a dominant role in the survival of 
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bacteria to challenges of alkaline pH tolerance, salt, temperature or osmolarity (Padan and 
Schuldiner 1994; Padan, Gerchman et al. 1999). The different strategies employed by E. 
coli on exposure to alkali challenge are shown in Figure 2.14. 
 
 
 
 
 
 
 
 
 
 
Figure 2.14. Mechanisms of alkaline pH adaptation by neutrophilic bacteria like E. coli. In 
order to survive alkaline environments, E. coli must maintain its cytoplasmic pH to a 
narrow range and therefore the genes such as TnaA (tryptophan deaminase), ATP synthase, 
Non-proton-pumping Cyd and Na+/H+ antiporters get highly activated and on the other 
hand, proton pumping Nuo proteins get down regulated mainly to keep the cytoplasmic pH 
in a range of 7.4 to 4.8.Cyd, cytochrome bd; NhaA, Na+/H+ antiporters; Nuo, NADH–
ubiquinone oxidoreductase; TnaA, tryptophan deaminase (also known as 
tryptophanase).The Figure was reproduced with the permission from nature publishing 
group: Nature review Microbiology (Krulwich, Sachs et al. 2011). 
 
Genomic studies have shown the existence of five to nine dissimilar genes encoding 
transporters that can act as cation/proton antiporters in most sequenced bacterial genomes 
(Krulwich, Hicks et al. 2009). To date, five cation/proton antiporters (NhaA, NhaB, ChaA, 
MdfA, and MdtM) have been reported to  play a role in alkaline pH tolerance in E. coli 
(Padan and Landau 2016). A comprehensive phylogenetic analysis of both eukaryotic and 
prokaryotic genomes have grouped the putative antiporter genes into three different 
monovalent cation proton antiporter superfamilies (CPA)(Chang, Lin et al. 2004). The 
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CPA1 family mainly consists of the eukaryotic sodium-hydrogen exchanger (NHE) Na+/H+ 
antiporters along with a few prokaryotic orthologs like Mj-NhaP1 (Chang, Lin et al. 2004). 
The CPA2 family includes NhaA as its prokaryotic member and also has orthologs in some 
eukaryotic genomes including the human genome. Lastly, the CPA3 family consists of  
Mrp-type antiporters from alkaliphilic Bacillus (Swartz, Ikewada et al. 2005). Mrp-type 
antiporters involves six to seven membrane proteins forming a hetero-oligomeric complex 
for its transport activity, unlike other cation/proton antiporters which only need one 
membrane protein for their activity (Morino, Suzuki et al. 2014).  
Na+ and H+ are the most predominant ions in the cell that has an important roles in 
cell physiology and bioenergetics. A balanced concentration of these ions is critical for 
protein functions inside the cell and any fluctuation in their concentration results in cell 
stress (Padan, Venturi et al. 2001). The Na+/H+ antiporters utilize these ions for regulation 
of the intracellular pH and also balance the Na+ ion content. These Na+/H+ antiporters were 
first discovered by Mitchell and his colleagues in 1974 (West and Mitchell 1974). They 
proposed that Na+/H+ antiporters have a vital role in maintaining a balanced concentration 
of Na+ and H+ ions in the cells. Since then, Na+/H+ antiporters have been identified in the 
membranes of most cells including microorganisms, plants and animals (Orlowski and 
Grinstein 2007; Fliegel 2008). Importantly, a number of these antiporters are also 
recognized as potential drug targets in humans (Karmazyn 2013).  The  Na+/H+ antiporters 
usually show the presence of a sensor and transducer region,  which helps them to sense 
the ion concentration and react and control activity through transducer regions to maintain 
homeostasis (Padan, Venturi et al. 2001). Multiple cation/proton antiporters are present in 
bacteria, which maintain the Na+ and H+ cycle, not all of them participate in the alkaline 
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pH homeostasis. The schematic representation of Na+ and H+ cycle and different 
cation/proton antiporter systems in E. coli is shown in Figure 2.15.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.15. Schematic representation of the Na+/H+ antiporters , the Na+ cycle, H+ and K+ 
translocating proteins in E. coli. The various transporters present in the cytoplasmic 
membrane playing a role in the balance of Na+, H+, and K+ ions are shown. A respiratory 
chain with Q denote ubiquinone pumps out the H+, ATP synthases (F0F1) utilizes H+ to 
generate ATP and bring H+ in the cytoplasm, the flagellar motor (MotAB) also bring in the 
H+ ions. Apart from these, H+/Solute symporter or Na+ /Solute symporter and cation/proton 
antiporters (NhaA, NhaB, MdfA, MdtM, and ChaA) make sure to keep the H+ and Na+ 
cycle balance. The Figure is self-drawn with certain modifications and ideas are taken from 
(Padan, Bibi et al. 2005). 
 
Each antiporter has distinct properties that including stoichiometry and rate, 
expression profile, affinity for substrate and transport mechanism and structure-functional 
relationship (Padan, Bibi et al. 2005). Usually, in alkaline environments (pH > 7.6), to 
maintain cytoplasmic pH around 7.6, protons should accumulate in the cytoplasm. 
Therefore, Na+/H+ antiporters should be electrogenic in nature rather than electroneutral 
allowing ∆ψ to drive the net accumulation of cytoplasmic proton concentration (Macnab 
and Castle 1987; Krulwich, Ito et al. 1998). For example, E. coli NhaA has a coupling 
stoichiometry of 2H+/Na+ and NhaB has a stoichiometry of 3H+/2Na+ (Taglicht, Padan et 
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al. 1993; Pinner, Padan et al. 1994). Some antiporters other than Na+/H+ antiporter may 
also help in maintaining alkaline tolerance by utilizing another substrate. For example, in  
Bacillus substilis an electroneutral Bs-MleN, a paralogue of the Na+/H+ antiporter Bs-
NhaC, catalyzes 2H+ - malate -2 / Na+ - lactate -1 transport and helps in net cytoplasmic 
accumulation of H+ (Wei, Guffanti et al. 2000). Moreover, multifunctional Bs-Tet(L) and 
Bs-Mrp antiporters utilize K+, along with PMF to catalyze Na+ (K+)/ H+ exchange (Cheng, 
Baldwin et al. 1996; Ito, Guffanti et al. 1999). Additionally, many bacteria also use K+/H+ 
antiporters for alkaline pH homeostasis as implicated in many studies (Plack and Rosen 
1980; Kakinuma and Igarashi 1995). Recently, MdtM was found to be a low-affinity 
antiporter that catalyzes an electrogenic exchange of Na+, K+, Rb+ or Li+ for H+  
(Holdsworth and Law 2013). Here, I will discuss the role of five different cation/proton 
antiporters (NhaA, NhaB, ChaA, MdfA, MdtM) in providing alkaline pH tolerance in E. 
coli as shown in Figure 2.16. 
 
Figure 2.16. Cation/proton antiporters in E. coli. NhaA, NhaB, ChaA, MdfA, MdtM are 
the cation/proton antiporters reported to play a role in alkaline pH tolerance. These 
antiporters have the ability to use different types of cations in exchange of proton for their 
activity at alkaline pH as shown. The Figure is self-drawn. 
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 2.3.1 NhaA, the main Na+/H+ antiporter of E. coli, serves as a prototype for Na+/H+ 
antiporter: E. coli NhaA is a model for the prokaryotic Na+/H+ antiporter that utilizes the 
proton electrochemical gradient to exchange sodium ions for protons in the cytoplasm and 
helps in adaptation to alkaline pH in the presence of sodium ions. Apart from Na+, NhaA 
also has the ability to transport Li+, thereby helping in lithium detoxification (Inaba, 
Kuroda et al. 1994). Topological analysis studies have suggested a 12-transmembrane 
helical structure for NhaA with N and C termini located in the cytoplasm as shown in Figure 
2.17 (Rothman, Padan et al. 1996).  
 
 
 
 
 
 
 
 
 
 
Figure 2.17. Model for the secondary structure of E. coli NhaA (Na+/H+ antiporter) 
containing 12-transmembrane domains. The roman numbers represent the number of 
transmembrane segments. The amino acids required for the function of NhaA in response 
to pH are represented. The amino acids involved in the transport activity is shown in a 
rectangle, residues important for pH response are shown in hexagon and circle represent 
the amino acid found in suppression mutation screening that upset pH response. Trypsin 
cleavage occurs at the K249 as shown by the arrow. The Figure was reproduced with the 
permission from Elsevier publishing group: Biochimica et Biophysica acta (Padan, Venturi 
et al. 2001). 
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 NhaA contains 362 amino acids with a molecular weight of 42 kDa and forms a 
homodimer in which two monomeric units are attached by a beta-hairpin at the periplasmic 
side of the membrane (Rimon, Tzubery et al. 2007). However, monomers are the functional 
unit for NhaA, and dimers are essential only in stress conditions because of better stability 
in a harsh environment (Rimon, Tzubery et al. 2007). Biochemical studies have revealed 
numerous properties of NhaA, which suggest its role in alkaline pH homeostasis. Most 
importantly, it is an electrogenic antiporter having a stoichiometry of 2H+/Na+ that 
facilitates the maintenance of cytoplasmic pH in alkaline conditions (Taglicht, Padan et al. 
1993). Additionally, the turnover rate of its transport activity is very high (105 exchanges 
per minute). Furthermore, the NhaA activity is strongly pH dependent, showing an increase 
in activity by three orders of magnitude between pH 6.5 and 8.5 (Taglicht, Padan et al. 
1993; Krulwich, Sachs et al. 2011). The predicted secondary structure of NhaA suggested 
six charged residues in putative transmembrane helices including four conserved aspartates 
(D65, D133, D163, and D164) towards the N-terminal and two lysines (K300 and K362) 
in the C-terminal region. Most of these residues are conserved in members of all NhaA 
antiporter family members except K362 (Rothman, Padan et al. 1996) (Padan, Venturi et 
al. 2001). Mutagenesis studies showed the importance of D133, D163 and D164 for cation 
binding or transport activity of NhaA and H225 and G338 a part of pH sensor region in 
NhaA (Inoue, Noumi et al. 1995) (Gerchman, Olami et al. 1993).  
 NhaA stays in its active conformation at pH > 6.5 and in downregulated 
conformation at pH below 6.5. The crystal structure in its downregulated conformation at 
pH 4 aided in understanding the antiporter’s mechanism and pH regulation. Additionally, 
molecular dynamics simulations elucidated the residues necessary for ion exchange in 
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NhaA. The protonation and deprotonation of aspartate residues (D164 and D163) help in 
the completion of transport cycle. Protonation of D164 leads to the release of Na+ and 
deprotonation cause Na+ to bind D164 of  NhaA. In addition to that, the protonation of 
D163 causes a conformational change in NhaA allowing Na+ to get released into the 
periplasm. However, if D163 is not protonated, Na+ is released back into the cytoplasm 
(Arkin, Xu et al. 2007) (Hunte, Screpanti et al. 2005). 
 NhaA with its 12 transmembrane segments (TMSs) forms a cytoplasmic funnel and 
periplasmic funnel that are separated by a barrier made of hydrophobic amino acids as 
shown in Figure.2.18, A. A negatively charged funnel consisting of TMSs II, IX, IV and 
V forms the cytoplasmic funnel and the periplasmic funnel is made by TMSs II, VIII and 
XI (Hunte, Screpanti et al. 2005). The ionizable residues forming the pH sensor region is 
located at the entry site of the cytoplasmic funnel and when these residues are mutated the 
pH profile but not the Na+/H+ antiporter activity is affected. However, amino acids at the 
bottom of cytoplasmic funnel forms the active site and affect the ion translocation 
(Gerchman, Rimon et al. 1999; Venturi, Rimon et al. 2000; Tzubery, Rimon et al. 2004). 
The amino acid residues playing a role in pH sensing and ion translocation are shown in 
(Figure. 2.18, B). The monomeric units of NhaA are organized in a unique inverted 
topology repeats as shown in (Figure. 2.18, (C)) containing three TMSs (TMSs III, IV, V 
and TMSs X, XI, XII). Remarkably, one of the TMs in each repeat is interrupted by an 
extended chain in the middle of the membrane leaving two short segments oriented to 
periplasm and cytoplasm respectively (Hunte, Screpanti et al. 2005).  
 The antiporter follows the classical alternating access mechanism. Cryo-electron 
microscopy of NhaA 2D crystals has found a two-step conformational change in response 
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to pH or substrate ions. As the pH rise from 6 to 7, the first transition occurs from inactive 
to pH- activated state. The pH activation causes the enlargement of the NhaA monomer 
and slight rearrangement of the N-terminus. The second conformational change occurs in 
the response to substrate (Na+ or Li+) at pH above 7 and causes movement of 
transmembrane IV leading to a charge imbalance at the ion binding site and prompting the 
release of substrate ion and open periplasmic funnel (Appel, Hizlan et al. 2009). The pH 
and substrate-induced conformational changes are shown in Figure 2.18, D.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.18. Overall structural and functional organization of E. coli NhaA (Na+/H+ 
antiporter). (A) A ribbon representation of the overall architecture of NhaA having 12-
transmembrane domains is shown as viewed parallel to the membrane. The funnels (black 
ellipses), novel fold showing the interrupted helices (green) and parts of transmembrane II 
and IX lining the cytoplasmic funnel (magenta) are represented. (B) The site-directed 
mutagenesis of amino acids shown in magenta result in failure in the pH response, yellow 
color represents the amino acids affecting both the pH response and ion translocation 
(yellow) and black color residues only affect the translocation process. (C) The inverted 
repeat formed by the transmembranes (TMSs) III, IV, and V and TMSs X, XI and XII is 
shown. (D) The conformational switch occurring due to pH change and ions transport is 
shown. The Figure was reproduced with the permission from nature publishing group: 
Nature review Microbiology (Krulwich, Sachs et al. 2011). 
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 NhaA also has the ability to use lithium (Li+) as its substrate for its transport 
activity. In general, Li+ binding to NhaA causes the displacement of two proton from the 
binding site. Mutational analysis showed that Li+ binding, H+ release, and antiporter 
activity get affected to similar magnitude when Li+ binding site residues (D163E, D163N, 
D164N, and D164E) are mutated. However, mutation of D133C causes the stoichiometry 
of Li+/H+ antiport to change to 1:4. Recently, the isothermal titration calorimetry studies 
have shown that the Li+/H+ binding to NhaA is antagonistically coupled. However, the 
antagonistic binding of NhaA can be changed to synergistic binding by the mutation of 
A167P, which has so far been only reported in the Cl-/H+ antiporter (Dwivedi, Sukenik et 
al. 2016). Expression analysis studies utilizing a LacZ fusion have shown that nhaA 
expression is induced by the presence of Na+ and Li+ ions in the medium thereby reflecting 
its necessity in adaptation to high salt and alkaline pH in E. coli (Karpel, Alon et al. 1991). 
Furthermore, Na+ induced nhaA expression is positively regulated by NhaR, a homolog of 
bacterial regulatory protein LysR, and has also affected the expression of nhaA (Dover, 
Higgins et al. 1996). 
 2.3.2 NhaB, second Na+/H+ antiporter of E. coli: NhaB-like antiporters belong to a 
second class of Na+/H+ antiporters and were recognized in bacteria more than 20 years ago. 
Although nhaB-like gene sequences have been found in many different bacterial genomes, 
only a few of them have been functionally characterized till now. Previous studies have 
identified a few pH-sensitive and -insensitive NhaB-like antiporters, but the mechanisms 
that regulate their pH responses still remain unknown (Kiriyama, Honma et al. 2013). In 
E. coli, NhaB is an IM protein having 504 amino acids that also works as cation/proton 
antiporter. Although NhaA and NhaB do not show noticeable sequence similarity, they 
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have similar putative secondary structures of twelve transmembrane segments linked with 
hydrophilic loops (Pinner, Padan et al. 1992). Overexpression of NhaB from a plasmid can 
complement the ∆nhaA strain (NM81) to the toxic effects of Na+ and Li+, and show 
increased Na+/H+ antiporter activity. The deletion of the nhaB gene in strain EP431 
revealed that nhaB is the housekeeping gene, which becomes essential only in the absence 
of nhaA (Pinner, Padan et al. 1992). EP431 lacks the Na+/H+ antiporter activity up to pH 
8, where other antiporters like NhaA and ChaA become active, although NhaA supports 
the viability through its activity in the background for all ranges of pH and Na+ 
concentration (Thelen, Tsuchiya et al. 1991; Pinner, Kotler et al. 1993). The mutant named 
EP432 lacking both nhaA and nhaB is the most Na+ sensitive strain and was used for 
cloning the E. coli third antiporter chaA which has Na+ (Ca+2)/H+ activity (Ivey, Guffanti 
et al. 1993; Pinner, Kotler et al. 1993). The two triple knock out strains (named KNabc and 
TO114) having a deletion of nhaA, nhaB and chaA have been used to identify novel 
Na+(K+)/H+ antiporter genes from various bacteria (Ohyama, Igarashi et al. 1994; Padan 
and Schuldiner 1994; Nozaki, Inaba et al. 1996). NhaB displays very low pH-dependent 
antiporter activity, and thus it is necessary for  Na+/H+ activity in the usual physiological 
pH range (Pinner, Padan et al. 1992). Kinetic and thermodynamic studies showed NhaB 
transport activity is electrogenic in nature with the stoichiometry of 2Na+/3H+ and thereby 
facilitates in cytoplasmic pH regulation in alkaline conditions (Pinner, Padan et al. 1994). 
Additionally, NhaB also helps in Li+ extrusion and protects the cell from lithium toxicity, 
however, to a lesser extent than NhaA (Inaba, Kuroda et al. 1994).  
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 2.3.3 ChaA, third Na+ (Ca+2) /H+ antiporter of E. coli: ChaA is a cytoplasmic protein 
having 11 TMSs. ChaA was recognized as Na+/H+ antiporter on the basis of its ability to 
complement the ∆nhaA ∆nhaB strain (EP432) when overexpressed from a multicopy 
plasmid (Ivey, Guffanti et al. 1993). Based on the biochemical analysis of everted 
membrane vesicles, ChaA also possesses Ca+2/H+ antiporter activity and thus participates 
in calcium ion circulation at alkaline pH (Ohyama, Igarashi et al. 1994). Moreover, ChaA 
has pH dependent Na+/H+ activity which increases as the pH becomes more alkaline 
(similar to NhaA on this note). Additionally, ChaA extrudes sodium ions primarily at an 
alkaline pH above 8 (Sakuma, Yamada et al. 1998). Mutational analysis has shown 
glutamate (E85) is important for the Na+/H+ activity of ChaA (Fukaya, Tanaka et al. 2010). 
Promoter activity assays using a LacZ fusion have suggested that expression of chaA is 
upregulated by pH and osmolarity of the medium (Shijuku, Yamashino et al. 2002). ChaA 
can also act as a  K+/H+ antiporter and help E. coli in adaptation to K+ stress at alkaline pH 
and maintain K+ homeostasis (Radchenko, Tanaka et al. 2006). 
 2.3.4 MdfA as Na+ (K+)/H+ antiporter of E. coli: Apart from acting as a multidrug 
transporter, MdfA also provides alkaline pH tolerance to E. coli through its Na+ (K+)/H+ 
activity. The ∆mdfA mutant is sensitive to alkaline pH and overexpression of mdfA rescues 
the alkaline sensitivity phenotype (Lewinson, Padan et al. 2004). Biochemical studies using 
inverted vesicles showed that MdfA act as Na+ (K+)/H+ antiporter at alkaline pH. It was 
suggested that MdfA provides alkaline tolerance at pH> 9 at which NhaA does not function 
and MdfA utilizes K+ as the main cation for its activity (Lewinson, Padan et al. 2004). 
 2.3.5 MdtM as Na+ (K+) /H+ antiporter of E. coli : MdtM is the most recently 
reported cation/proton antiporter playing a role in E. coli alkaline pH homeostasis. It is a 
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homolog of MdfA having 12- transmembrane segments and also belongs to the major 
facilitator superfamily. Through its drug/H+ activity MdtM provides intrinsic resistance to 
multiple drugs including ethidium bromide, chloramphenicol and quaternary compounds 
in E. coli (Holdsworth and Law 2012; Holdsworth and Law 2013). The deletion of mdtM 
causes alkaline pH sensitivity and millimolar concentrations of Na+ or K+ is required for 
MdtM mediated alkaline pH tolerance. Moreover, biochemical studies using inverted 
vesicles showed MdtM is a low-affinity antiporter that catalyzes electrogenic transport of 
Na+, K+, Rb+ or Li+ in exchange for H+ (Holdsworth and Law 2013). 
2.4 References 
Adler, J. and E. Bibi (2002). "Membrane topology of the multidrug transporter MdfA: 
complementary gene fusion studies reveal a nonessential C-terminal domain." J 
Bacteriol 184(12): 3313-3320. 
 
Adler, J. and E. Bibi (2004). "Determinants of substrate recognition by the Escherichia coli 
multidrug transporter MdfA identified on both sides of the membrane." J Biol 
Chem 279(10): 8957-8965. 
 
Adler, J., O. Lewinson, et al. (2004). "Role of a conserved membrane-embedded acidic 
residue in the multidrug transporter MdfA." Biochemistry 43(2): 518-525. 
 
Akama, H., M. Kanemaki, et al. (2004). "Crystal structure of the drug discharge outer 
membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane 
anchoring and occluded cavity end." J Biol Chem 279(51): 52816-52819. 
 
Akama, H., T. Matsuura, et al. (2004). "Crystal structure of the membrane fusion protein, 
MexA, of the multidrug transporter in Pseudomonas aeruginosa." J Biol Chem 
279(25): 25939-25942. 
 
Appel, M., D. Hizlan, et al. (2009). "Conformations of NhaA, the Na+/H+ exchanger from 
Escherichia coli, in the pH-activated and ion-translocating states." J Mol Biol 
388(3): 659-672. 
 
Arkin, I. T., H. Xu, et al. (2007). "Mechanism of Na+/H+ antiporting." Science 317(5839): 
799-803. 
 
Bapna, A., L. Federici, et al. (2007). "Two proton translocation pathways in a secondary 
active multidrug transporter." J Mol Microbiol Biotechnol 12(3-4): 197-209. 
61 
 
 
Bay, D. C., K. L. Rommens, et al. (2008). "Small multidrug resistance proteins: a multidrug 
transporter family that continues to grow." Biochim Biophys Acta 1778(9): 1814-
1838. 
 
Bibi, E., J. Adler, et al. (2001). "MdfA, an interesting model protein for studying multidrug 
transport." J Mol Microbiol Biotechnol 3(2): 171-177. 
 
Blair, J. M. and L. J. Piddock (2009). "Structure, function and inhibition of RND efflux 
pumps in Gram-negative bacteria: an update." Curr Opin Microbiol 12(5): 512-519. 
 
Blankenhorn, D., J. Phillips, et al. (1999). "Acid- and base-induced proteins during aerobic 
and anaerobic growth of Escherichia coli revealed by two-dimensional gel 
electrophoresis." J Bacteriol 181(7): 2209-2216. 
 
Borges-Walmsley, M. I., J. Beauchamp, et al. (2003). "Identification of oligomerization 
and drug-binding domains of the membrane fusion protein EmrA." J Biol Chem 
278(15): 12903-12912. 
 
Brown, M. H., I. T. Paulsen, et al. (1999). "The multidrug efflux protein NorM is a 
prototype of a new family of transporters." Mol Microbiol 31(1): 394-395. 
 
Caughlan, R. E., A. K. Jones, et al. (2012). "Mechanisms decreasing in vitro susceptibility 
to the LpxC inhibitor CHIR-090 in the gram-negative pathogen Pseudomonas 
aeruginosa." Antimicrob Agents Chemother 56(1): 17-27. 
 
Chang, A. B., R. Lin, et al. (2004). "Phylogeny as a guide to structure and function of 
membrane transport proteins." Mol Membr Biol 21(3): 171-181. 
 
Chen, Y. J., O. Pornillos, et al. (2007). "X-ray structure of EmrE supports dual topology 
model." Proc Natl Acad Sci U S A 104(48): 18999-19004. 
 
Cheng, J., K. Baldwin, et al. (1996). "Na+/H+ antiport activity conferred by Bacillus 
subtilis tetA(L), a 5' truncation product of tetA(L), and related plasmid genes upon 
Escherichia coli." Antimicrob Agents Chemother 40(4): 852-857. 
 
Chung, Y. J. and M. H. Saier, Jr. (2001). "SMR-type multidrug resistance pumps." Curr 
Opin Drug Discov Devel 4(2): 237-245. 
 
Clejan, S., T. A. Krulwich, et al. (1986). "Membrane lipid composition of obligately and 
facultatively alkalophilic strains of Bacillus spp." J Bacteriol 168(1): 334-340. 
 
Dawson, R. J. and K. P. Locher (2007). "Structure of the multidrug ABC transporter 
Sav1866 from Staphylococcus aureus in complex with AMP-PNP." FEBS Lett 
581(5): 935-938. 
 
62 
 
Delmar, J. A., C. C. Su, et al. (2014). "Bacterial multidrug efflux transporters." Annu Rev 
Biophys 43: 93-117. 
 
Deng, D., C. Xu, et al. (2014). "Crystal structure of the human glucose transporter 
GLUT1." Nature 510(7503): 121-125. 
 
Dover, N., C. F. Higgins, et al. (1996). "Na+-induced transcription of nhaA, which encodes 
an Na+/H+ antiporter in Escherichia coli, is positively regulated by nhaR and 
affected by hns." J Bacteriol 178(22): 6508-6517. 
 
Du, D., H. W. van Veen, et al. (2015). "Structure, mechanism and cooperation of bacterial 
multidrug transporters." Curr Opin Struct Biol 33: 76-91. 
 
Dwivedi, M., S. Sukenik, et al. (2016). "The Ec-NhaA antiporter switches from 
antagonistic to synergistic antiport upon a single point mutation." Sci Rep 6: 23339. 
 
Edgar, R. and E. Bibi (1997). "MdfA, an Escherichia coli multidrug resistance protein with 
an extraordinarily broad spectrum of drug recognition." J Bacteriol 179(7): 2274-
2280. 
 
Edgar, R. and E. Bibi (1999). "A single membrane-embedded negative charge is critical 
for recognizing positively charged drugs by the Escherichia coli multidrug 
resistance protein MdfA." EMBO J 18(4): 822-832. 
 
Evans, D. F., G. Pye, et al. (1988). "Measurement of gastrointestinal pH profiles in normal 
ambulant human subjects." Gut 29(8): 1035-1041. 
 
Fliegel, L. (2008). "Molecular biology of the myocardial Na+/H+ exchanger." J Mol Cell 
Cardiol 44(2): 228-237. 
 
Fluman, N., C. M. Ryan, et al. (2012). "Dissection of mechanistic principles of a secondary 
multidrug efflux protein." Mol Cell 47(5): 777-787. 
 
Foster, J. W. (2004). "Escherichia coli acid resistance: tales of an amateur acidophile." Nat 
Rev Microbiol 2(11): 898-907. 
 
Fralick, J. A. (1996). "Evidence that TolC is required for functioning of the Mar/AcrAB 
efflux pump of Escherichia coli." J Bacteriol 178(19): 5803-5805. 
 
Fukaya, F., K. Tanaka, et al. (2010). "Glutamate 85 is involved in the sodium/proton 
exchange activity of the Escherichia coli ChaA." Biosci Biotechnol Biochem 74(5): 
1116-1119. 
 
Gayen, A., M. Leninger, et al. (2016). "Protonation of a glutamate residue modulates the 
dynamics of the drug transporter EmrE." Nat Chem Biol 12(3): 141-145. 
 
63 
 
Ge, Q., Y. Yamada, et al. (2009). "The C-terminal domain of AcrA is essential for the 
assembly and function of the multidrug efflux pump AcrAB-TolC." J Bacteriol 
191(13): 4365-4371. 
 
Gerchman, Y., Y. Olami, et al. (1993). "Histidine-226 is part of the pH sensor of NhaA, a 
Na+/H+ antiporter in Escherichia coli." Proc Natl Acad Sci U S A 90(4): 1212-
1216. 
 
Gerchman, Y., A. Rimon, et al. (1999). "A pH-dependent conformational change of NhaA 
Na(+)/H(+) antiporter of Escherichia coli involves loop VIII-IX, plays a role in the 
pH response of the protein, and is maintained by the pure protein in dodecyl 
maltoside." J Biol Chem 274(35): 24617-24624. 
 
Gottfert, M. (1993). "Regulation and function of rhizobial nodulation genes." FEMS 
Microbiol Rev 10(1-2): 39-63. 
 
Greener, T., D. Govezensky, et al. (1993). "A novel multicopy suppressor of a groEL 
mutation includes two nested open reading frames transcribed from different 
promoters." EMBO J 12(3): 889-896. 
 
Griffith, J. K., M. E. Baker, et al. (1992). "Membrane transport proteins: implications of 
sequence comparisons." Curr Opin Cell Biol 4(4): 684-695. 
 
Helms, M., P. Vastrup, et al. (2002). "Excess mortality associated with antimicrobial drug-
resistant Salmonella typhimurium." Emerg Infect Dis 8(5): 490-495. 
 
Henderson, P. J. and M. C. Maiden (1990). "Homologous sugar transport proteins in 
Escherichia coli and their relatives in both prokaryotes and eukaryotes." Philos 
Trans R Soc Lond B Biol Sci 326(1236): 391-410. 
 
Heng, J., Y. Zhao, et al. (2015). "Substrate-bound structure of the E. coli multidrug 
resistance transporter MdfA." Cell Res 25(9): 1060-1073. 
 
Higgins, C. F. (2007). "Multiple molecular mechanisms for multidrug resistance 
transporters." Nature 446(7137): 749-757. 
 
Hoglund, P. J., K. J. Nordstrom, et al. (2011). "The solute carrier families have a 
remarkably long evolutionary history with the majority of the human families 
present before divergence of Bilaterian species." Mol Biol Evol 28(4): 1531-1541. 
Holdsworth, S. R. and C. J. Law (2012). "Functional and biochemical characterisation of 
the Escherichia coli major facilitator superfamily multidrug transporter MdtM." 
Biochimie 94(6): 1334-1346. 
 
Holdsworth, S. R. and C. J. Law (2013). "The major facilitator superfamily transporter 
MdtM contributes to the intrinsic resistance of Escherichia coli to quaternary 
ammonium compounds." J Antimicrob Chemother 68(4): 831-839. 
64 
 
 
Holdsworth, S. R. and C. J. Law (2013). "Multidrug resistance protein MdtM adds to the 
repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli." 
BMC Microbiol 13: 113. 
 
Hood, M. A. and G. E. Ness (1982). "Survival of Vibrio cholerae and Escherichia coli in 
estuarine waters and sediments." Appl Environ Microbiol 43(3): 578-584. 
 
Horikoshi, K. (1999). "Alkaliphiles: some applications of their products for 
biotechnology." Microbiol Mol Biol Rev 63(4): 735-750, table of contents. 
 
Hunte, C., E. Screpanti, et al. (2005). "Structure of a Na+/H+ antiporter and insights into 
mechanism of action and regulation by pH." Nature 435(7046): 1197-1202. 
 
Inaba, K., T. Kuroda, et al. (1994). "Lithium toxicity and Na+(Li+)/H+ antiporter in 
Escherichia coli." Biol Pharm Bull 17(3): 395-398. 
 
Inoue, H., T. Noumi, et al. (1995). "Essential aspartic acid residues, Asp-133, Asp-163 and 
Asp-164, in the transmembrane helices of a Na+/H+ antiporter (NhaA) from 
Escherichia coli." FEBS Lett 363(3): 264-268. 
 
Ito, M., A. A. Guffanti, et al. (1999). "mrp, a multigene, multifunctional locus in Bacillus 
subtilis with roles in resistance to cholate and to Na+ and in pH homeostasis." J 
Bacteriol 181(8): 2394-2402. 
 
Ivey, D. M., A. A. Guffanti, et al. (1993). "Cloning and characterization of a putative 
Ca2+/H+ antiporter gene from Escherichia coli upon functional complementation 
of Na+/H+ antiporter-deficient strains by the overexpressed gene." J Biol Chem 
268(15): 11296-11303. 
 
Jin, Q., Z. Yuan, et al. (2002). "Genome sequence of Shigella flexneri 2a: insights into 
pathogenicity through comparison with genomes of Escherichia coli K12 and 
O157." Nucleic Acids Res 30(20): 4432-4441. 
 
Jin, Y., A. Nair, et al. (2014). "Multidrug transport protein norM from vibrio cholerae 
simultaneously couples to sodium- and proton-motive force." J Biol Chem 289(21): 
14624-14632. 
 
Johnson, J. M. and G. M. Church (1999). "Alignment and structure prediction of divergent 
protein families: periplasmic and outer membrane proteins of bacterial efflux 
pumps." J Mol Biol 287(3): 695-715. 
 
Kakinuma, Y. and K. Igarashi (1995). "Potassium/proton antiport system of growing 
Enterococcus hirae at high pH." J Bacteriol 177(8): 2227-2229. 
 
65 
 
Karmazyn, M. (2013). "NHE-1: still a viable therapeutic target." J Mol Cell Cardiol 61: 
77-82. 
 
Karpel, R., T. Alon, et al. (1991). "Expression of a sodium proton antiporter (NhaA) in 
Escherichia coli is induced by Na+ and Li+ ions." J Biol Chem 266(32): 21753-
21759. 
 
Kashket, E. R. (1985). "The proton motive force in bacteria: a critical assessment of 
methods." Annu Rev Microbiol 39: 219-242. 
 
Kim, E. H., D. H. Nies, et al. (2011). "Switch or funnel: how RND-type transport systems 
control periplasmic metal homeostasis." J Bacteriol 193(10): 2381-2387. 
 
Kiriyama, W., K. Honma, et al. (2013). "Diversities and similarities in pH dependency 
among bacterial NhaB-like Na+/H+ antiporters." Microbiology 159(Pt 10): 2191-
2199. 
 
Klein, J. R., B. Henrich, et al. (1991). "Molecular analysis and nucleotide sequence of the 
envCD operon of Escherichia coli." Mol Gen Genet 230(1-2): 230-240. 
 
Kobayashi, K., N. Tsukagoshi, et al. (2001). "Suppression of hypersensitivity of 
Escherichia coli acrB mutant to organic solvents by integrational activation of the 
acrEF operon with the IS1 or IS2 element." J Bacteriol 183(8): 2646-2653. 
 
Kobayashi, N., K. Nishino, et al. (2001). "Novel macrolide-specific ABC-type efflux 
transporter in Escherichia coli." J Bacteriol 183(19): 5639-5644. 
 
Koronakis, V., J. Eswaran, et al. (2004). "Structure and function of TolC: the bacterial exit 
duct for proteins and drugs." Annu Rev Biochem 73: 467-489. 
 
Koronakis, V., J. Li, et al. (1997). "Structure of TolC, the outer membrane component of 
the bacterial type I efflux system, derived from two-dimensional crystals." Mol 
Microbiol 23(3): 617-626. 
 
Koronakis, V., A. Sharff, et al. (2000). "Crystal structure of the bacterial membrane protein 
TolC central to multidrug efflux and protein export." Nature 405(6789): 914-919. 
 
Krulwich, T. A., A. A. Guffanti, et al. (1990). "pH homeostasis and bioenergetic work in 
alkalophiles." FEMS Microbiol Rev 6(2-3): 271-278. 
 
Krulwich, T. A., D. B. Hicks, et al. (2009). "Cation/proton antiporter complements of 
bacteria: why so large and diverse?" Mol Microbiol 74(2): 257-260. 
 
Krulwich, T. A., M. Ito, et al. (1998). "Energetics of alkaliphilic Bacillus species: 
physiology and molecules." Adv Microb Physiol 40: 401-438. 
 
66 
 
Krulwich, T. A., G. Sachs, et al. (2011). "Molecular aspects of bacterial pH sensing and 
homeostasis." Nat Rev Microbiol 9(5): 330-343. 
 
Kulkarni, S., A. Ballal, et al. (2013). "Bioprecipitation of uranium from alkaline waste 
solutions using recombinant Deinococcus radiodurans." J Hazard Mater 262: 853-
861. 
 
Kumar, S., G. He, et al. (2016). ""Bacterial Multidrug Efflux Pumps of the Major 
Facilitator Superfamily as Targets for Modulation"." Infect Disord Drug Targets. 
 
Kumar, S., M. M. Mukherjee, et al. (2013). "Modulation of Bacterial Multidrug Resistance 
Efflux Pumps of the Major Facilitator Superfamily." Int J Bacteriol 2013. 
 
Kuroda, T. and T. Tsuchiya (2009). "Multidrug efflux transporters in the MATE family." 
Biochim Biophys Acta 1794(5): 763-768. 
 
Law, C. J., J. Almqvist, et al. (2008). "Salt-bridge dynamics control substrate-induced 
conformational change in the membrane transporter GlpT." J Mol Biol 378(4): 828-
839. 
 
Lewinson, O., J. Adler, et al. (2003). "The Escherichia coli multidrug transporter MdfA 
catalyzes both electrogenic and electroneutral transport reactions." Proc Natl Acad 
Sci U S A 100(4): 1667-1672. 
 
Lewinson, O. and E. Bibi (2001). "Evidence for simultaneous binding of dissimilar 
substrates by the Escherichia coli multidrug transporter MdfA." Biochemistry 
40(42): 12612-12618. 
 
Lewinson, O., E. Padan, et al. (2004). "Alkalitolerance: a biological function for a 
multidrug transporter in pH homeostasis." Proc Natl Acad Sci U S A 101(39): 
14073-14078. 
 
Li, X., M. Zolli-Juran, et al. (2004). "Multicopy suppressors for novel antibacterial 
compounds reveal targets and drug efflux susceptibility." Chem Biol 11(10): 1423-
1430. 
 
Livermore, D. M. (2003). "Bacterial resistance: origins, epidemiology, and impact." Clin 
Infect Dis 36(Suppl 1): S11-23. 
 
Lloris-Garcera, P., F. Bianchi, et al. (2012). "Antiparallel dimers of the small multidrug 
resistance protein EmrE are more stable than parallel dimers." J Biol Chem 
287(31): 26052-26059. 
 
Lloris-Garcera, P., J. S. Slusky, et al. (2013). "In vivo trp scanning of the small multidrug 
resistance protein EmrE confirms 3D structure models'." J Mol Biol 425(22): 4642-
4651. 
67 
 
 
Lu, M. (2015). "Structures of multidrug and toxic compound extrusion transporters and 
their mechanistic implications." Channels (Austin): 1-13. 
 
Ma, D., D. N. Cook, et al. (1995). "Genes acrA and acrB encode a stress-induced efflux 
system of Escherichia coli." Mol Microbiol 16(1): 45-55. 
 
Macnab, R. M. and A. M. Castle (1987). "A variable stoichiometry model for pH 
homeostasis in bacteria." Biophys J 52(4): 637-647. 
 
Marger, M. D. and M. H. Saier, Jr. (1993). "A major superfamily of transmembrane 
facilitators that catalyse uniport, symport and antiport." Trends Biochem Sci 18(1): 
13-20. 
 
Margesin, R. and F. Schinner (2001). "Biodegradation and bioremediation of hydrocarbons 
in extreme environments." Appl Microbiol Biotechnol 56(5-6): 650-663. 
 
Marquez, B. (2005). "Bacterial efflux systems and efflux pumps inhibitors." Biochimie 
87(12): 1137-1147. 
 
Martin, W., J. Baross, et al. (2008). "Hydrothermal vents and the origin of life." Nat Rev 
Microbiol 6(11): 805-814. 
 
Masuda, S., T. Terada, et al. (2006). "Identification and functional characterization of a 
new human kidney-specific H+/organic cation antiporter, kidney-specific 
multidrug and toxin extrusion 2." J Am Soc Nephrol 17(8): 2127-2135. 
 
Matin, A. (1999). "pH homeostasis in acidophiles." Novartis Found Symp 221: 152-163; 
discussion 163-156. 
 
McHaourab, H. S., S. Mishra, et al. (2008). "Role of sequence bias in the topology of the 
multidrug transporter EmrE." Biochemistry 47(31): 7980-7982. 
 
McKeegan, K. S., M. I. Borges-Walmsley, et al. (2003). "The structure and function of 
drug pumps: an update." Trends Microbiol 11(1): 21-29. 
 
Mikolosko, J., K. Bobyk, et al. (2006). "Conformational flexibility in the multidrug efflux 
system protein AcrA." Structure 14(3): 577-587. 
 
Mitchell, P. (1961). "Coupling of phosphorylation to electron and hydrogen transfer by a 
chemi-osmotic type of mechanism." Nature 191: 144-148. 
 
Mitchell, P. (1966). "Chemiosmotic coupling in oxidative and photosynthetic 
phosphorylation." Biol Rev Camb Philos Soc 41(3): 445-502. 
 
68 
 
Morino, M., T. Suzuki, et al. (2014). "Purification and functional reconstitution of a seven-
subunit mrp-type na+/h+ antiporter." J Bacteriol 196(1): 28-35. 
 
Morita, Y., A. Kataoka, et al. (2000). "NorM of vibrio parahaemolyticus is an Na(+)-driven 
multidrug efflux pump." J Bacteriol 182(23): 6694-6697. 
 
Morrison, E. A., G. T. DeKoster, et al. (2012). "Antiparallel EmrE exports drugs by 
exchanging between asymmetric structures." Nature 481(7379): 45-50. 
 
Murakami, S. (2008). "Multidrug efflux transporter, AcrB--the pumping mechanism." Curr 
Opin Struct Biol 18(4): 459-465. 
 
Murakami, S., R. Nakashima, et al. (2006). "Crystal structures of a multidrug transporter 
reveal a functionally rotating mechanism." Nature 443(7108): 173-179. 
 
Murakami, S., R. Nakashima, et al. (2002). "Crystal structure of bacterial multidrug efflux 
transporter AcrB." Nature 419(6907): 587-593. 
 
Nagakubo, S., K. Nishino, et al. (2002). "The putative response regulator BaeR stimulates 
multidrug resistance of Escherichia coli via a novel multidrug exporter system, 
MdtABC." J Bacteriol 184(15): 4161-4167. 
 
Nikaido, H. (1998). "Antibiotic resistance caused by gram-negative multidrug efflux 
pumps." Clin Infect Dis 27 Suppl 1: S32-41. 
 
Nikaido, H. (2011). "Structure and mechanism of RND-type multidrug efflux pumps." Adv 
Enzymol Relat Areas Mol Biol 77: 1-60. 
 
Nikaido, H. and Y. Takatsuka (2009). "Mechanisms of RND multidrug efflux pumps." 
Biochim Biophys Acta 1794(5): 769-781. 
 
Nilsen, I. W., I. Bakke, et al. (1996). "Isolation of cmr, a novel Escherichia coli 
chloramphenicol resistance gene encoding a putative efflux pump." J Bacteriol 
178(11): 3188-3193. 
 
Nishino, K. and A. Yamaguchi (2001). "Analysis of a complete library of putative drug 
transporter genes in Escherichia coli." J Bacteriol 183(20): 5803-5812. 
 
Nishino, K. and A. Yamaguchi (2002). "EvgA of the two-component signal transduction 
system modulates production of the yhiUV multidrug transporter in Escherichia 
coli." J Bacteriol 184(8): 2319-2323. 
 
Nozaki, K., K. Inaba, et al. (1996). "Cloning and sequencing of the gene for Na+/H+ 
antiporter of Vibrio parahaemolyticus." Biochem Biophys Res Commun 222(3): 
774-779. 
 
69 
 
Ohyama, T., K. Igarashi, et al. (1994). "Physiological role of the chaA gene in sodium and 
calcium circulations at a high pH in Escherichia coli." J Bacteriol 176(14): 4311-
4315. 
 
Omote, H., M. Hiasa, et al. (2006). "The MATE proteins as fundamental transporters of 
metabolic and xenobiotic organic cations." Trends Pharmacol Sci 27(11): 587-593. 
 
Orlowski, J. and S. Grinstein (2007). "Emerging roles of alkali cation/proton exchangers 
in organellar homeostasis." Curr Opin Cell Biol 19(4): 483-492. 
 
Oswald, C. and K. M. Pos (2011). "Drug resistance: a periplasmic menage a trois." Chem 
Biol 18(4): 405-407. 
 
Padan, E., E. Bibi, et al. (2005). "Alkaline pH homeostasis in bacteria: new insights." 
Biochim Biophys Acta 1717(2): 67-88. 
 
Padan, E., Y. Gerchman, et al. (1999). "The molecular mechanism of regulation of the 
NhaA Na+/H+ antiporter of Escherichia coli, a key transporter in the adaptation to 
Na+ and H+." Novartis Found Symp 221: 183-196; discussion 196-189. 
 
Padan, E. and M. Landau (2016). "Sodium-Proton (Na(+)/H(+)) Antiporters: Properties 
and Roles in Health and Disease." Met Ions Life Sci 16: 391-458. 
 
Padan, E. and S. Schuldiner (1987). "Intracellular pH and membrane potential as regulators 
in the prokaryotic cell." J Membr Biol 95(3): 189-198. 
 
Padan, E. and S. Schuldiner (1994). "Molecular biology of Na+/H+ antiporters: molecular 
devices that couple the Na+ and H+ circulation in cells." Biochim Biophys Acta 
1187(2): 206-210. 
 
Padan, E. and S. Schuldiner (1994). "Molecular physiology of the Na+/H+ antiporter in 
Escherichia coli." J Exp Biol 196: 443-456. 
 
Padan, E., M. Venturi, et al. (2001). "Na(+)/H(+) antiporters." Biochim Biophys Acta 
1505(1): 144-157. 
 
Parkhill, J., G. Dougan, et al. (2001). "Complete genome sequence of a multiple drug 
resistant Salmonella enterica serovar Typhi CT18." Nature 413(6858): 848-852. 
 
Paulsen, I. T. (2003). "Multidrug efflux pumps and resistance: regulation and evolution." 
Curr Opin Microbiol 6(5): 446-451. 
 
Paulsen, I. T., M. H. Brown, et al. (1996). "Proton-dependent multidrug efflux systems." 
Microbiol Rev 60(4): 575-608. 
 
70 
 
Paulsen, I. T., R. A. Skurray, et al. (1996). "The SMR family: a novel family of multidrug 
efflux proteins involved with the efflux of lipophilic drugs." Mol Microbiol 19(6): 
1167-1175. 
 
Pinner, E., Y. Kotler, et al. (1993). "Physiological role of nhaB, a specific Na+/H+ 
antiporter in Escherichia coli." J Biol Chem 268(3): 1729-1734. 
 
Pinner, E., E. Padan, et al. (1992). "Cloning, sequencing, and expression of the nhaB gene, 
encoding a Na+/H+ antiporter in Escherichia coli." J Biol Chem 267(16): 11064-
11068. 
 
Pinner, E., E. Padan, et al. (1994). "Kinetic properties of NhaB, a Na+/H+ antiporter from 
Escherichia coli." J Biol Chem 269(42): 26274-26279. 
 
Plack, R. H., Jr. and B. P. Rosen (1980). "Cation/proton antiport systems in Escherichia 
coli. Absence of potassium/proton antiporter activity in a pH-sensitive mutant." J 
Biol Chem 255(9): 3824-3825. 
 
Poole, K. (2003). "Overcoming multidrug resistance in gram-negative bacteria." Curr Opin 
Investig Drugs 4(2): 128-139. 
 
Pornillos, O. and G. Chang (2006). "Inverted repeat domains in membrane proteins." FEBS 
Lett 580(2): 358-362. 
 
Putman, M., H. W. van Veen, et al. (2000). "Molecular properties of bacterial multidrug 
transporters." Microbiol Mol Biol Rev 64(4): 672-693. 
 
Radchenko, M. V., K. Tanaka, et al. (2006). "Potassium/proton antiport system of 
Escherichia coli." J Biol Chem 281(29): 19822-19829. 
 
Rapp, M., E. Granseth, et al. (2006). "Identification and evolution of dual-topology 
membrane proteins." Nat Struct Mol Biol 13(2): 112-116. 
 
Reddy, V. S., M. A. Shlykov, et al. (2012). "The major facilitator superfamily (MFS) 
revisited." FEBS J 279(11): 2022-2035. 
 
Rimon, A., T. Tzubery, et al. (2007). "Monomers of the NhaA Na+/H+ antiporter of 
Escherichia coli are fully functional yet dimers are beneficial under extreme stress 
conditions at alkaline pH in the presence of Na+ or Li+." J Biol Chem 282(37): 
26810-26821. 
 
Rotem, D. and S. Schuldiner (2004). "EmrE, a multidrug transporter from Escherichia coli, 
transports monovalent and divalent substrates with the same stoichiometry." J Biol 
Chem 279(47): 48787-48793. 
 
71 
 
Rothman, A., E. Padan, et al. (1996). "Topological analysis of NhaA, a Na+/H+ antiporter 
from Escherichia coli." J Biol Chem 271(50): 32288-32292. 
 
Rottenberg, H. (1979). "The measurement of membrane potential and deltapH in cells, 
organelles, and vesicles." Methods Enzymol 55: 547-569. 
 
Saier, M. H., Jr. and I. T. Paulsen (2001). "Phylogeny of multidrug transporters." Semin 
Cell Dev Biol 12(3): 205-213. 
 
Saier, M. H., Jr., V. S. Reddy, et al. (2014). "The transporter classification database." 
Nucleic Acids Res 42(Database issue): D251-258. 
 
Saier, M. H., Jr., R. Tam, et al. (1994). "Two novel families of bacterial membrane proteins 
concerned with nodulation, cell division and transport." Mol Microbiol 11(5): 841-
847. 
 
Sakuma, T., N. Yamada, et al. (1998). "pH dependence of the function of sodium ion 
extrusion systems in Escherichia coli." Biochim Biophys Acta 1363(3): 231-237. 
 
Sanders, C. R. (2015). "Perplexing new insight into the dynamics of the EmrE transporter." 
J Gen Physiol 146(6): 441-444. 
 
Schaedler, T. A. and H. W. van Veen (2010). "A flexible cation binding site in the 
multidrug major facilitator superfamily transporter LmrP is associated with 
variable proton coupling." FASEB J 24(10): 3653-3661. 
 
Schuldiner, S. (2007). "When biochemistry meets structural biology: the cautionary tale of 
EmrE." Trends Biochem Sci 32(6): 252-258. 
 
Schuldiner, S. (2009). "EmrE, a model for studying evolution and mechanism of ion-
coupled transporters." Biochim Biophys Acta 1794(5): 748-762. 
 
Schuldiner, S. (2014). "Competition as a way of life for H(+)-coupled antiporters." J Mol 
Biol 426(14): 2539-2546. 
 
Seeger, M. A., A. Schiefner, et al. (2006). "Structural asymmetry of AcrB trimer suggests 
a peristaltic pump mechanism." Science 313(5791): 1295-1298. 
 
Seeger, M. A., C. von Ballmoos, et al. (2009). "Crucial role of Asp408 in the proton 
translocation pathway of multidrug transporter AcrB: evidence from site-directed 
mutagenesis and carbodiimide labeling." Biochemistry 48(25): 5801-5812. 
 
Sennhauser, G., P. Amstutz, et al. (2007). "Drug export pathway of multidrug exporter 
AcrB revealed by DARPin inhibitors." PLoS Biol 5(1): e7. 
 
72 
 
Shijuku, T., T. Yamashino, et al. (2002). "Expression of chaA, a sodium ion extrusion 
system of Escherichia coli, is regulated by osmolarity and pH." Biochim Biophys 
Acta 1556(2-3): 142-148. 
 
Sigal, N., D. Cohen-Karni, et al. (2006). "MdfA from Escherichia coli, a model protein for 
studying secondary multidrug transport." J Mol Microbiol Biotechnol 11(6): 308-
317. 
 
Sigal, N., O. Lewinson, et al. (2007). "E. coli multidrug transporter MdfA is a monomer." 
Biochemistry 46(17): 5200-5208. 
 
Sigal, N., S. Molshanski-Mor, et al. (2006). "No single irreplaceable acidic residues in the 
Escherichia coli secondary multidrug transporter MdfA." J Bacteriol 188(15): 
5635-5639. 
 
Sikdar, R., A. R. Simmons, et al. (2013). "Multiple envelope stress response pathways are 
activated in an Escherichia coli strain with mutations in two members of the DedA 
membrane protein family." J Bacteriol 195(1): 12-24. 
 
Sjuts, H., A. V. Vargiu, et al. (2016). "Molecular basis for inhibition of AcrB multidrug 
efflux pump by novel and powerful pyranopyridine derivatives." Proc Natl Acad 
Sci U S A 113(13): 3509-3514. 
 
Slonczewski, J. L., M. Fujisawa, et al. (2009). "Cytoplasmic pH measurement and 
homeostasis in bacteria and archaea." Adv Microb Physiol 55: 1-79, 317. 
 
Soskine, M., S. Mark, et al. (2006). "On parallel and antiparallel topology of a homodimeric 
multidrug transporter." J Biol Chem 281(47): 36205-36212. 
 
Stancik, L. M., D. M. Stancik, et al. (2002). "pH-dependent expression of periplasmic 
proteins and amino acid catabolism in Escherichia coli." J Bacteriol 184(15): 4246-
4258. 
 
Steiner-Mordoch, S., M. Soskine, et al. (2008). "Parallel topology of genetically fused 
EmrE homodimers." EMBO J 27(1): 17-26. 
 
Su, C. C., M. Li, et al. (2006). "Conformation of the AcrB multidrug efflux pump in 
mutants of the putative proton relay pathway." J Bacteriol 188(20): 7290-7296. 
 
Su, X. Z., J. Chen, et al. (2005). "AbeM, an H+-coupled Acinetobacter baumannii 
multidrug efflux pump belonging to the MATE family of transporters." Antimicrob 
Agents Chemother 49(10): 4362-4364. 
 
Sulavik, M. C., C. Houseweart, et al. (2001). "Antibiotic susceptibility profiles of 
Escherichia coli strains lacking multidrug efflux pump genes." Antimicrob Agents 
Chemother 45(4): 1126-1136. 
73 
 
Sun, L., X. Zeng, et al. (2012). "Crystal structure of a bacterial homologue of glucose 
transporters GLUT1-4." Nature 490(7420): 361-366. 
 
Swartz, T. H., S. Ikewada, et al. (2005). "The Mrp system: a giant among monovalent 
cation/proton antiporters?" Extremophiles 9(5): 345-354. 
 
Taglicht, D., E. Padan, et al. (1993). "Proton-sodium stoichiometry of NhaA, an 
electrogenic antiporter from Escherichia coli." J Biol Chem 268(8): 5382-5387. 
 
Takatsuka, Y. and H. Nikaido (2009). "Covalently linked trimer of the AcrB multidrug 
efflux pump provides support for the functional rotating mechanism." J Bacteriol 
191(6): 1729-1737. 
 
Tal, N. and S. Schuldiner (2009). "A coordinated network of transporters with overlapping 
specificities provides a robust survival strategy." Proc Natl Acad Sci U S A 
106(22): 9051-9056. 
 
Tamura, N., S. Murakami, et al. (2005). "Direct interaction of multidrug efflux transporter 
AcrB and outer membrane channel TolC detected via site-directed disulfide cross-
linking." Biochemistry 44(33): 11115-11121. 
 
Tanaka, Y., C. J. Hipolito, et al. (2013). "Structural basis for the drug extrusion mechanism 
by a MATE multidrug transporter." Nature 496(7444): 247-251. 
 
Thelen, P., T. Tsuchiya, et al. (1991). "Characterization and mapping of a major Na+/H+ 
antiporter gene of Escherichia coli." J Bacteriol 173(20): 6553-6557. 
 
Tirosh, O., N. Sigal, et al. (2012). "Manipulating the drug/proton antiport stoichiometry of 
the secondary multidrug transporter MdfA." Proc Natl Acad Sci U S A 109(31): 
12473-12478. 
 
Tornroth-Horsefield, S., P. Gourdon, et al. (2007). "Crystal structure of AcrB in complex 
with a single transmembrane subunit reveals another twist." Structure 15(12): 1663-
1673. 
 
Tseng, T. T., K. S. Gratwick, et al. (1999). "The RND permease superfamily: an ancient, 
ubiquitous and diverse family that includes human disease and development 
proteins." J Mol Microbiol Biotechnol 1(1): 107-125. 
 
Tzubery, T., A. Rimon, et al. (2004). "Mutation E252C increases drastically the Km value 
for Na+ and causes an alkaline shift of the pH dependence of NhaA Na+/H+ 
antiporter of Escherichia coli." J Biol Chem 279(5): 3265-3272. 
 
Van Bambeke, F., E. Balzi, et al. (2000). "Antibiotic efflux pumps." Biochem Pharmacol 
60(4): 457-470. 
74 
 
Venturi, M., A. Rimon, et al. (2000). "The monoclonal antibody 1F6 identifies a pH-
dependent conformational change in the hydrophilic NH(2) terminus of NhaA 
Na(+)/H(+) antiporter of Escherichia coli." J Biol Chem 275(7): 4734-4742. 
 
Von Heijne, G. (2006). "Membrane-protein topology." Nat Rev Mol Cell Biol 7(12): 909-
918. 
 
Wandersman, C. and P. Delepelaire (1990). "TolC, an Escherichia coli outer membrane 
protein required for hemolysin secretion." Proc Natl Acad Sci U S A 87(12): 4776-
4780. 
 
Wei, Y., A. A. Guffanti, et al. (2000). "Bacillus subtilis YqkI is a novel malic/Na+-lactate 
antiporter that enhances growth on malate at low protonmotive force." J Biol Chem 
275(39): 30287-30292. 
 
West, I. C. and P. Mitchell (1974). "Proton/sodium ion antiport in Escherichia coli." 
Biochem J 144(1): 87-90. 
 
Wisedchaisri, G., M. S. Park, et al. (2014). "Proton-coupled sugar transport in the 
prototypical major facilitator superfamily protein XylE." Nat Commun 5: 4521. 
 
Woodall, N. B., Y. Yin, et al. (2015). "Dual-topology insertion of a dual-topology 
membrane protein." Nat Commun 6: 8099. 
 
Yan, N. (2013). "Structural advances for the major facilitator superfamily (MFS) 
transporters." Trends Biochem Sci 38(3): 151-159. 
 
Yan, N. (2015). "Structural Biology of the Major Facilitator Superfamily Transporters." 
Annu Rev Biophys 44: 257-283. 
 
Yen, M. R., J. S. Chen, et al. (2010). "Multidrug resistance: phylogenetic characterization 
of superfamilies of secondary carriers that include drug exporters." Methods Mol 
Biol 637: 47-64. 
 
Yerushalmi, H., M. Lebendiker, et al. (1995). "EmrE, an Escherichia coli 12-kDa 
multidrug transporter, exchanges toxic cations and H+ and is soluble in organic 
solvents." J Biol Chem 270(12): 6856-6863. 
 
Yin, Y., X. He, et al. (2006). "Structure of the multidrug transporter EmrD from 
Escherichia coli." Science 312(5774): 741-744. 
 
Yu, E. W., J. R. Aires, et al. (2003). "AcrB multidrug efflux pump of Escherichia coli: 
composite substrate-binding cavity of exceptional flexibility generates its 
extremely wide substrate specificity." J Bacteriol 185(19): 5657-5664. 
 
75 
 
Zgurskaya, H. I. and H. Nikaido (1999). "AcrA is a highly asymmetric protein capable of 
spanning the periplasm." J Mol Biol 285(1): 409-420. 
 
Zgurskaya, H. I. and H. Nikaido (2000). "Cross-linked complex between oligomeric 
periplasmic lipoprotein AcrA and the inner-membrane-associated multidrug efflux 
pump AcrB from Escherichia coli." J Bacteriol 182(15): 4264-4267. 
 
Zhang, X. C., Y. Zhao, et al. (2015). "Energy coupling mechanisms of MFS transporters." 
Protein Sci 24(10): 1560-1579. 
 
Zheleznova, E. E., P. Markham, et al. (2000). "A structure-based mechanism for drug 
binding by multidrug transporters." Trends Biochem Sci 25(2): 39-43. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
76 
 
CHAPTER 3 
MEMBERS OF THE CONSERVED DedA FAMILY ARE LIKELY MEMBRANE 
TRANSPORTERS AND ARE REQUIRED FOR DRUG RESISTANCE IN 
ESCHERICHIA COLI * 
 
3.1 Introduction 
 
Bacterial multidrug resistance to biocides and antibiotics is increasing at a worrying 
speed and is a serious threat to the human health; therefore, there is a critical requirement 
to discover ways for battling the bacterial multidrug resistance. Mechanisms used by 
bacteria for multidrug resistance include antibiotic inactivation, biofilm formation, target 
alteration, membrane modification, and efflux by drug pumps (Khameneh, Diab et al. 
2016). Resistance is often conferred by expression of efflux pumps that can accommodate 
numerous unrelated drugs (Krulwich, Lewinson et al. 2005; Piddock 2006). There are a 
plethora of efflux pumps present in Gram-negative bacteria that transport a wide range of 
structurally different compounds including antibiotics, dyes, out of the bacterial cell 
thereby allowing bacteria to survive at higher drug concentration (Blair, Richmond et al. 
2014). Efflux pumps belonging to the major facilitator superfamily (MFS), small multidrug 
resistance (SMR) family and ABC transporter families are found widespread throughout 
evolution. The study of these efflux pumps is of significant importance, not only for 
understanding the function of efflux pumps, and its role in drug resistance but also as 
targets for the development of the novel drugs (Mahmood, Jamshidi et al. 2016).  While 
the functions of these protein families have been studied in detail, genome sequencing  
 
 
*This chapter is adapted and reprinted from Kumar et al. Reprint permission 
granted. Copyright © American Society for Microbiology, Antimicrob. Agents 
Chemother. February 2014 vol. 58 no. 2923-930 
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projects have revealed the existence of many families of membrane proteins whose 
functions are not well understood (Bernsel and Daley 2009).  
DedA is a large superfamily of membrane proteins found within all three domains 
of life and is present in nearly all sequenced bacterial genomes (Doerrler, Sikdar et al. 
2013). Protein databases do not classify the DedA family as membrane transporters. They 
bear no amino acid similarity to the MFS, SMR family, ABC transporters, ion channels or 
other types of transporters. They bear limited similarity to the LeuT family of transporters 
when analyzed using a novel type of evolutionary analysis called AlignMe (Khafizov, 
Staritzbichler et al. 2010).   The Escherichia coli genome encodes eight members of the 
DedA family displaying ~25-60% amino acid identity (annotated as dedA, yqjA, yghB, 
yabI, yohD, yqaA, ydjX, and ydjZ) (Blattner, Plunkett et al. 1997).  YqjA and YghB are 
DedA family proteins of 220 and 219 amino acids, respectively, with 61 % amino acid 
identity and partially redundant functions. Simultaneous in-frame deletion of these two 
DedA family genes in strain BC202 (W3110; yghB, yqjA) results in numerous 
phenotypes including temperature sensitivity (Thompkins, Chattopadhyay et al. 2008),  
cell division defects due to inefficient export of periplasmic amidases by the twin arginine 
pathway (Sikdar and Doerrler 2010), activation of envelope stress response pathways and 
compromised membrane protonmotive force (PMF) (Sikdar, Simmons et al. 2013). 
Viability at elevated temperatures and normal cell division can be restored to BC202 by 
growth at pH 6.0 (Sikdar, Simmons et al. 2013), overexpression of a subset of DedA family 
genes (Thompkins, Chattopadhyay et al. 2008; Boughner and Doerrler 2012) or mdfA 
(Sikdar, Simmons et al. 2013), encoding a Na+-K+/H+ antiporter belonging to the MFS 
(Krulwich, Sachs et al. 2011).  These results suggest roles for YqjA/YghB in the 
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maintenance of the pH gradient (ΔpH) component of the protonmotive force (PMF), 
composed of both the electrical potential (ΔΨ) and the ΔpH (Krulwich, Sachs et al. 2011). 
The ΔyqjA mutant is sensitive to alkaline pH (Price and Raivio 2009) and yqjA expression 
is repressed at low pH (Maurer, Yohannes et al. 2005), suggesting that one function of 
YqjA may be to promote alkaline tolerance. Similar functions have been shown for E. coli 
MdfA and Bacillus subtilis Tet(L) (Cheng, Guffanti et al. 1996; Lewinson, Padan et al. 
2004; Krulwich, Lewinson et al. 2005).  A role for YqjA/YghB in PMF maintenance is 
also supported by our own direct measurements of ΔΨ in BC202 using the JC-1 dye-based 
assay (Sikdar, Simmons et al. 2013). 
In addition to functioning as an ion transporter, MdfA exports numerous cationic 
and zwitterionic lipophilic compounds (Lewinson, Adler et al. 2003). Overexpression of 
MdfA increases resistance of E. coli to a wide variety of structurally diverse drugs and 
biocides (Edgar and Bibi 1997) and ΔmdfA mutants are sensitive to exposure to such 
compounds (Tal and Schuldiner 2009).  Given the ability of MdfA to correct the observed 
phenotypes of BC202, we measured the growth of BC202 and its parent strain W3110 in 
the presence of biocidal drugs and dyes belonging to different classes. We found that 
BC202 is hypersensitive to a number of structurally diverse compounds. Resistance can be 
restored to BC202 by expression of DedA family genes yghB or yqjA.  Mutation of 
membrane-embedded acidic amino acids compromised the ability of YghB and YqjA to 
restore resistance to BC202 suggesting that these E. coli membrane proteins are possibly a 
new class of membrane proton-dependent transporters. 
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3.2 Materials and Methods 
 Materials: All chemicals were reagent grade and purchased from Sigma-Aldrich or 
VWR. Restriction enzymes, DNA polymerases, and T4 DNA ligase were purchased from 
New England BioLabs. The following compounds were used for the susceptibility testing 
and their classes/mode of action and sources are represented in parenthesis: 
chloramphenicol (Sigma-Aldrich), erythromycin (macrolide; Sigma-Aldrich), 
ciprofloxacin (fluoroquinolone; Sigma-Aldrich), norfloxacin (fluoroquinolone; Sigma-
Aldrich), nalidixic acid (quinolone precursor; Sigma-Aldrich), sodium dodecyl sulfate 
(detergent; BioRad), acriflavine hydrochloride (intercalator; Acros Organics), ethidium 
bromide (intercalator; Amresco), cetyltrimethyl-ammonium bromide (quaternary 
ammonium compound; Amresco), benzalkonium chloride (quaternary amino compound; 
Alfa Aesar), methyl viologen (redox cycling drug, Acros Organics), Oxacillin (penicillin, 
Sigma), Cloxacillin (Penicillin, sigma), Piperacillin (Penicillin,TCI America). 
Table 3.1: E. coli Strains and plasmids in this study: 
Strain Genotype Source/reference 
W3110 Wild Type, F-,λ-,IN(rrnD-rrnE)1,rph-1 E. coli genetic stock 
center, Yale University 
BC202 W3110, ΔyqjA::TetR, ΔyghB781::KanR (Thompkins, 
Chattopadhyay et al. 
2008) 
BC202KS W3110, ΔyqjA::TetR, ΔyghB781<>FRT This work 
JW0826 Δ(araD-araB)567, ΔlacZ4787(::rrnB-
3), λ-, Δcmr-742::kan, rph-1, Δ(rhaD-
rhaB)568, hsdR514 
(Baba, Ara et al. 2006) 
JW0531 
 
Δ(araD-araB)567, ΔlacZ4787(::rrnB-
3), ΔemrE750::kan, λ-, rph-1, Δ(rhaD-
rhaB)568, hsdR514 
(Baba, Ara et al. 2006) 
JW0451 
 
 
Δ(araD-araB)567, ΔlacZ4787(::rrnB-
3), ΔacrB747::kan, λ-, rph-1, Δ(rhaD-
rhaB)568, hsdR514 
(Baba, Ara et al. 2006) 
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Strain Genotype Source/reference 
W3110∆mdfA W3110, ∆cmr-742::kan This work 
W3110∆emrE W3110,∆emrE-750::kan This work 
W3110∆acrB W3110,∆acrB-747::kan This work 
BC202∆mdfA BC202KS, ∆cmr-742::kan This work 
BC202∆emrE BC202KS, ∆emrE-750::kan This work 
BC202∆acrB BC202KS, ∆acrB-747::kan This work 
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (TetR) 
Stratagene 
Plasmids Genotype Source/reference 
pBADHisA Expression vector; araBAD promoter, 
AmpR 
Invitrogen. 
pCP20 FLP+, λ cI857+, λ ρR Repts, AmpR, 
CamR 
(Cherepanov and 
Wackernagel 1995) 
pBAD-yqjA H6-yqjA expression; araBAD 
promoter,Ampr 
(Sikdar, Simmons et al. 
2013) 
pBAD-
yqjA(E39A) 
H6-yqjA(E39A) expression; araBAD 
promoter, Ampr 
This work 
pBAD-
yqjA(E39Q) 
H6-yqjA(E39Q) expression; araBAD 
promoter, Ampr 
This work 
pBAD-
yqjA(D51A) 
H6-yqjA(D51A) expression; araBAD 
promoter, Ampr 
This work 
pBAD-
yqjA(D51N) 
H6-yqjA(D51N) expression; araBAD 
promoter, Ampr 
This work 
pBAD-YghB H6-yghB; araBAD promoter,Amp
R (Sikdar, Simmons et al. 
2013) 
pBAD-
yghB(E39A) 
H6-yghB(E39A) expression; araBAD 
promoter, Ampr 
This work 
pBAD-
yghB(D51A) 
H6-yghB(D51A) expression; araBAD 
promoter, Ampr 
This work 
pBAD-MdfA H6-mdfA expression; araBAD 
promoter,AmpR 
(Sikdar, Simmons et al. 
2013) 
pACYC184-yqjA pACYC184 expressing E.coli yqjA. 
CamR 
(Thompkins, 
Chattopadhyay et al. 
2008) 
pACYC184-yghB pACYC184 expressing E.coli yghB. 
CamR 
(Thompkins, 
Chattopadhyay et al. 
2008) 
pBB0250-GFP BB0250-GFP expression. lac promoter. 
AmpR 
(Liang, Xu et al. 2010) 
pBB0250(E39A)-
GFP 
BB0250(E39A)-GFP expression,  lac 
promoter. AmpR 
This work 
 (Table 3.1 continued) 
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Table 3.2 Primers used in the study 
 
Primer Name Sequence ( 5’-3’) 
YqjA 
E39A_FWD  
GTTCCTTGCAAACGGCTTGCTTCCGGCGGCCTTTTTACC  
YqjA 
E39A_REV 
GCCGTTTGCAAGGAACAAAATTACAAACAAGACAAAATAC  
YqjA D51A 
_FWD 
CCGGGCGCCAGTTTACTGGTATTGGTCGGCGTGTTGATTGC
G 
YqjA 
D51A_REV 
GTAAACTGGCGCCCGGTAAAAAGGCCGCCGGAAGCAAGC
CG  
YqjA 
E39Q_FWD  
GTTCCTTCAAAACGGCTTGCTTCCGGCGGCCTTTTTACC 
YqjA 
E39Q_REV 
GCCGTTTTGAAGGAACAAAATTACAAACAAGACAAAATAC
AAC 
YqjA 
D51N_FWD 
CGGGCAACAGTTTACTGGTATTGGTCGGCGTGTTGATTGCG 
YqjA 
D51N_REV 
GTAAACTGTTGCCCGGTAAAAAGGCCGCCGGAAGCAAGCC
G 
YghB 
E39A_FWD 
GTTTTTAGCAAACGGCCTGCTGCCCGCCTCATTTTTGCC 
YghB 
E39A_REV 
GCCGTTTGCTAAAAACAGCGTGGCAAACATGAC 
YghBD51A_F
WD 
GCCAGGCGCCAGCTTGTTGATACTGGCAGGCGCATTGATT
GCCCAGGGG 
YghB 
D51A_REV 
CAAGCTGGCGCCTGGCAAAAATGAGGCGGGCAGCAGGCC
GTTTTC  
BB0250 E39A 
_FWD 
CTATTTCTGCGGATGCAATAGTACTAATGGGTGGAATTTTA
TCTAG 
BB0250 E39A 
_REV 
GCATCCGCAGAAATAGGAACATTAAGTCCTGCTAAAATTA
GTAACG 
BB0250 D40A 
_FWD 
CCTATTTCTGAGGCTGCAATAGTACTAATGGGTGGAATTTT
ATC 
BB0250 D40A 
_REV 
 
CTATTGCAGCCTCAGAAATAGGAACATTAAGTCCTGCTAA
AATTAG 
Plasmids Genotype Source/reference 
pBB0250(D40A)-
GFP 
BB0250(D40A)-GFP expression.  lac 
promoter. AmpR 
This work 
pBB0 GFP expression vector.  lac promoter. 
AmpR 
(Liang, Xu et al. 2010) 
 (Table 3.1 continued) 
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 Bacterial growth conditions: Bacterial cultures were grown in Luria-Bertani broth 
(LB) (1% tryptone, 0.5% yeast extract and 1% NaCl) unless otherwise stated.  LB media 
of pH 6.0 was buffered with 100 mM 2-(N-morpholino)-ethanesulfonic acid (MES) 
(Sikdar, Simmons et al. 2013).  Solid media were obtained by addition of 1.5 % agar (w/v). 
When required, the media was supplemented with ampicillin (Amp) 100 µg/ml, kanamycin 
(Kan) 30 µg/ml, tetracycline (Tet) 12.5 µg/ml, chloramphenicol (Cam) 30 µg/ml), 
arabinose (0.002% or 0.1%, w/v) or isopropyl-1-thio-β-D-galactopyranoside (IPTG; 0.5 
mM).  All cultures were grown at 30 °C unless otherwise indicated. 
 Strain construction: The multiple-deletion mutants were generated in E. coli 
W3110 and correct configuration was verified through PCR with primers flanking the 
appropriate gene. In order to eliminate the kanamycin-resistance (kanR) gene from BC202, 
plasmid pCP20 expressing FLP recombinase was used as described previously 
(Cherepanov and Wackernagel 1995).  Since this protocol requires overnight incubation at 
42 C to cure pCP20 (nonpermissive for BC202), the yghB::kanR strain was first made 
markerless (W3110 background).  YqjA::tetR (Thompkins, Chattopadhyay et al. 2008) was 
then introduced by P1 transduction.  Additional mutations (i.e. ΔemrE::kanR, ΔmdfA::kanR, 
or ΔacrB::kanR) were introduced by P1 transduction with P1vir lysate prepared from the 
indicated E. coli strains (Table 3.1) obtained from the Keio collection (Baba, Ara et al. 
2006).  P1 transductions were carried out as described (Silhavy, Berman et al. 1984).  All 
strains and genotypes are listed in Table 3.1. 
 Microscopy:  Overnight cultures of E. coli strains were diluted 1:100 in fresh LB 
media with suitable antibiotics and additives, and grown to OD600 ~ 0.6 at 30 °C in a 
shaking incubator. Cells were resuspended to final OD600 1.0 in LB and 10 µL of cells were 
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applied to a 1% agarose coated glass slide for imaging. A Leica DM-RXA2 deconvolution 
microscope was used for all the Differential Interference Contrast (DIC) micrographs. 
Observations were made by a 100X, 1.30-numerical-aperture oil immersion objective lens. 
The images were captured through a DIC filter by a cooled Cooke SensiCamQE 12 bit, 1, 
3-megapixel, charge-coupled device digital camera and recorded using Slidebook software 
(Intelligent Imaging Innovation, Denver, CO). 
 Susceptibility to toxic compounds:  For testing the susceptibility on solid medium, 
overnight cultures of E. coli strains were freshly diluted 1:100 in LB media with 
appropriate antibiotics and additives, and grown to OD600 ~ 0.6 at 30°C in a shaking 
incubator. 5 μl of serially log10-diluted cells were spotted on LB agar plates containing 
various concentrations of corresponding biocides. Growth was analyzed after incubation 
for 20 to 24 hours at 30 °C. All experiments were repeated at least three times.  
 Minimal inhibitory concentration (MIC) determination: The MICs of biocides were 
carried out using a two-fold dilution technique in either 1.5 x 15 cm glass tube or in 96-
well microtiter plates in liquid medium (Wiegand, Hilpert et al. 2008). Overnight cultures 
were freshly diluted 1:100 into LB medium with suitable antibiotics and additives. 
Exponentially growing cultures at OD600 ~1.0 were inoculated at a density of 10
5 cells per 
ml into LB medium supplemented with a series of two-fold dilutions of indicated biocide. 
Cell growth was determined visually after incubation at 30°C for 24 hours. All experiments 
were repeated at least three times. 
 Site-directed mutagenesis: Site-specific mutants were created by using previously 
published protocol (Zheng, Baumann et al. 2004). The primers carrying the site-specific 
mutations (Table 3.2) were used in a PCR reaction to amplify a vector containing the 
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specified wild type gene.  The PCR product was then digested with Dpn1 and used to 
transform competent XL1-blue cells. Colonies obtained after transformation were screened 
by colony PCR using gene-specific primers. The mutations confirmed by DNA sequencing 
conducted at the LSU College of Science Genomics Facility.  
 Membrane preparation and Western blotting: Cell membranes was prepared from 
exponential phase cultures of BC202 containing appropriate plasmid DNA grown under 
inducing condition (arabinose or IPTG) using a previously published protocol (Doerrler 
and Raetz 2002).  Equal amounts of protein were resolved by 12 % SDS-PAGE and transfer 
to PVDF. Western blotting was done using penta-His (Qiagen) or GFP (JL-8; Clontech) 
primary antibody at 1:5000 dilution and goat-anti-mouse horseradish peroxidase (HRP) 
conjugated secondary antibody (Pierce) at 1:5000. Detection was carried out using the 
ImmunStar HRP kit (Bio-Rad). 
3.3 Results 
 A DedA family mutant is highly sensitive to a number of biocides.  Ethidium 
bromide (EthBr) efflux is a hallmark of several bacterial organic cation transporters 
including MdfA (Lewinson, Adler et al. 2003; Lewinson, Padan et al. 2004), EmrE 
(Purewal 1991) and QacA (Brown and Skurray 2001). We tested for sensitivity to EthBr 
using a standard growth assay and found that BC202 is significantly more sensitive than 
parent strain W3110 to this cationic dye (Figure.3.1A). We also observed increased 
sensitivity of BC202 to biocides known to be exported by other drug efflux proteins 
(Sulavik, Houseweart et al. 2001; Tal and Schuldiner 2009; Lim and Nikaido 2010) 
including methyl viologen (resistance conferred by EmrE), Benzalkonium chloride (mainly 
MdfA), cetyltrimethyl ammonium bromide (mainly AcrAB), nalidixic acid (AcrAB), 
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acriflavine (EmrE, AcrAB) and β-lactam antibiotics (AcrAB) on solid (Figure. 3.1, B, C) 
and/or liquid media (Figure  3.2).  
 
Figure 3.1. Sensitivity of BC202, multidrug resistance mutants and combination mutants 
to select biocides.  BC202 (yghB, yqjA) is sensitive to (A) ethidium bromide (EthBr), 
(B) methyl viologen (MV) and (C) acriflavine (Acr) while the corresponding multidrug 
resistance mutants display sensitivity approximately equal or less than BC202.  MdfA 
promotes EthBr resistance, EmrE promotes MV resistance, and AcrB is required for 
acriflavine resistance (Tal and Schuldiner 2009).  Combination mutants (multidrug 
resistance gene deletions in the BC202 genetic background) display additive or synergistic 
sensitivity (see also Table 1). (D) BC202 is not appreciably sensitive to SDS, 
chloramphenicol (CAM) or ciprofloxacin (Cipro), norfloxacin (Norflox) or erythromycin 
(Erythro) on solid LB plates. Dilutions of log phase cells of the indicated genotype were 
spotted onto LB plates containing the indicated concentrations of biocide. All strains grew 
equally well on LB plates with no added biocide. 
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Figure 3.2. Minimal inhibitory concentration (MIC) values for Escherichia coli strains. 
W3110 (parent), BC202, and efflux pump mutations in either the W3110 (ΔmdfA, ΔemrE 
and ΔacrB) or BC202 background strains (BC202M, BC202E and BC202A) were grown 
in liquid culture in the presence of a series of dilutions of the indicated compounds. In 
strain BC202, increased sensitivity to the indicated compounds is shown in bold. In strains 
BC202M, BC202E and BC202A additive or synergistic effects are shown in bold. 
Abbreviations (units are g/ml unless indicated in parentheses): SDS, sodium dodecyl 
sulfate (%); CAM, chloramphenicol; BC, benzalkonium chloride; NA, nalidixic acid; 
CTAB, cetyl trimethyl ammonium bromide; MV, methyl viologen; Acr, acriflavine 
hydrochloride; EthBr, ethidium bromide; Erythro, erythromycin; Cipro, ciprofloxacin 
(ng/ml); Norflox, norfloxacin (ng/ml); Ox, Oxacillin; Clox, cloxacillin; Pip, piperacillin. 
*BC202 was not sensitive to erythromycin, ciprofloxacin and norfloxacin on plates (Figure 
3. 1) but was slightly sensitive in liquid culture. 
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 We have tested BC202 for sensitivity to many antibiotics and other compounds 
(Thompkins, Chattopadhyay et al. 2008) and found BC202 is not generally hypersensitive 
to all biocides. For example, BC202 is not sensitive to SDS indicating that the outer 
membrane is intact in this strain or, intriguingly, chloramphenicol- a known substrate of 
the MdfA efflux pump (Figure. 3.1, D, Figure 3.2). Remarkably, BC202 is sensitive to 
concentrations of EthBr that are roughly ten-fold lower than what is needed to kill an 
mdfA mutant (Figure 3.1, A and Figure 3.2). Expression of either yqjA or yghB 
individually was capable of restoring resistance to BC202 indicating these proteins have 
redundant functions (Figure. 3.3). These results indicate that YqjA and YghB are either 
directly involved in drug efflux or are required for proper function of other membrane 
transporters.   
 
 
 
 
 
 
 
 
 
Figure 3.3. Expression of yqjA and/or yghB restores drug resistance to BC202. BC202 was 
transformed with plasmids pACYC184, pBADHisA, pACYC-yghB or pBAD-yqjA in all 
combinations and spotted on LB plates containing (A) no additives (B) CTAB, cetyl 
trimethyl ammonium bromide, 25 g/ml (C) acriflavine, 25 g/ml (D) MV, methyl 
viologen 20 g/ml or (E) BC, benzalkonium chloride 20 g/ml.  Plates were incubated 
overnight at 30 C.  
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 Deletion of known efflux pumps causes an increase in BC202 sensitivity. 
Introducing deletions of known transporters into BC202 consistently resulted in a marked 
increase in drug sensitivity on both solid and liquid media (Figure. 3.1, A-C; Figure 3.2).  
MdfA and EmrE have been proposed to be the major contributors to EthBr resistance of E. 
coli (Nishino and Yamaguchi 2001).  The presence of either the mdfA or ΔemrE mutation 
in the BC202 background strain results in additional sensitivity, suggesting independent 
resistance mechanisms by these protein families.  We see the same pattern with other 
biocides and the mutants of the corresponding export proteins involved in their efflux 
including EthBr, acriflavine and methyl viologen (Figure. 3.1, A-C; Figure 3.2). Strikingly, 
the presence of the ΔacrB deletion in BC202 results in a nearly synergistic increase in 
sensitivity to a number of compounds including SDS, many-fold higher than what is 
observed in either background individually (Figure 3.2). These results suggest that the 
effect on drug sensitivity of these DedA family deletions is independent of other known 
drug transporters. 
 Membrane embedded acidic amino acids are essential for function of DedA family 
members.  In many multi-drug resistance (MDR) transporters, including MdfA, TetL, and 
EmrE, it has been demonstrated that membrane embedded acidic residues such as glutamic 
acid (E) and aspartic acid (D) play a role in PMF-dependent drug transport (Table 3.4) 
(Edgar and Bibi 1999; Soskine, Adam et al. 2004; Seeger, von Ballmoos et al. 2009; Sigal, 
Fluman et al. 2009; Fluman, Ryan et al. 2012).  E26 and D34 both play roles in proton 
translocation in exchange of substrate by MdfA (Fluman, Ryan et al. 2012). Many DedA 
proteins contain a predicted membrane-embedded or membrane-proximal glutamic acid 
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and/or aspartic acid in the first transmembrane (TM) spanning region (E39 and D51 in 
YqjA and YghB).  
 
 
 
 
 
 
 
 
 
Figure 3.4. Membrane-embedded acidic amino acids in TM1 of DedA family proteins and 
select drug transport proteins.   Conserved acidic amino acids are shown in red. Database 
sequences were analyzed for predicted membrane domains using SOSUI (Hirokawa, 
Boon-Chieng et al. 1998). Table is for illustration purposes only and is not a complete list 
of transport proteins. Abbreviations: TM1, transmembrane region 1; MFS, major facilitator 
superfamily; SMR, small multidrug resistance. *YghB D51 is predicted to lie just outside 
TM1, but is also required for function. **BB0250 is an essential DedA family protein of 
Borrelia burgdorferi (Liang, Xu et al. 2010). E39 and D40 are each required for BB0250 
to complement growth and cell division defects of BC202.  ***E26 and D34 both play 
roles in transport by MdfA (Fluman, Ryan et al. 2012) 
 
  We performed site-directed mutagenesis on these residues and found the YqjA 
point mutants (YqjA-E39A, YqjA-D51A) no longer restore growth at 42 C (Figure. 3.5, 
A), cell division (Figure. 3.5, B) or drug resistance (Figure. 3.5, C) when expressed in 
BC202.  Protein expression levels were equivalent to wild type levels in purified 
membranes (Figure. 3.5, D) suggesting that the mutant proteins were correctly folded. Wild 
type yqjA completely restored growth and cell division (Figure. 3.5, A and B), in agreement 
with previous reports (Thompkins, Chattopadhyay et al. 2008; Boughner and Doerrler 
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2012), as well as drug resistance to BC202 (Figure.3.5, C). To further support this data, we 
created isosteric substitutions at positions E39 and D51 in YqjA, converting these residues 
to glutamine and asparagine, respectively.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Mutation of YqjA E39 or D51 abolishes ability to restore growth, cell division 
or drug resistance to BC202. (A) BC202 transformed with pBAD, or pBAD-yqjA, pBAD-
yqjA(E39A), or pBAD-yqjA(D51A) was grown at 30 C (left) or 42 C (center and right). 
Wild type yqjA but not point mutants restores growth to BC202 at 42 C. BC202/pBAD-
yqjA(D51A) also grew at 30 C (not shown). (B) Micrographs of BC202 transformed with 
pBAD, or pBAD-yqjA, pBAD-yqjA(E39A), or pBAD-yqjA(D51A) grown at 30 C. Wild 
type yqjA but not point mutants restores normal cell division to BC202. Bar = 10 m. (C) 
Sensitivity of BC202 transformed with control vector, cloned yqjA, yqjA(E39A), or 
yqjA(D51A) to EthBr (75 g/ml), acriflavine (25 g/ml), nalidixic acid (0.5 g/ml) and 
methyl viologen (25 g/ml). All strains grew on LB plates without biocides at 30 C. Wild 
type yqjA but not point mutants restores drug resistance to BC202 at 30 C. (D) Expression 
of yqjA, yqjA(E39A) and yqjA(D51A) in membrane fractions as determined by Western 
blotting with anti-hexahistidine antibody.  All growth with pBAD-yqjA was carried out in 
LB/amp/0.002% arabinose. 
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 YqjA-E39Q and YqjA-D51N were unable to restore drug resistance (Figure 3.6, 
A), growth at 42 C or normal cell division (Figure. 3.6, C,D) in spite of membrane 
expression levels similar to wild-type (Figure. 3.6, B).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Isosteric mutations of YqjA E39 or D51 abolish ability to restore drug 
resistance, growth and cell division to BC202.    (A) Sensitivity of BC202 transformed with 
control vector pBAD, cloned yqjA, yqjA(E39Q), or yqjA(D51N) to Benzalkonium chloride 
(20 g/ml), acriflavine (25 g/ml), CTAB (100 g/ml), EthBr (75 g/ml) and methyl 
viologen (25 g/ml). All strains grew on LB plates without biocides at 30 C. Wild type 
yqjA but not point mutants restores drug resistance to BC202 at 30 C. (B) Expression of 
yqjA, yqjA(E39Q) and yqjA(D51N) in membrane fractions as determined by Western 
blotting with anti-hexahistidine antibody.  All growth with pBAD-yqjA was carried out in 
LB/amp/0.002% arabinose. (C) BC202 transformed with pBAD, or pBAD-yqjA, pBAD-
yqjA(E39Q), or pBAD-yqjA(D51N) was grown at 30 C (left) or 42 C (right). Wild type 
YqjA but not point mutants restores growth to BC202 at 42 C. (D) Micrographs of BC202 
transformed with pBAD, or pBAD-yqjA, pBAD-yqjA(E39Q), or pBAD-yqjA(D51N) 
grown at 30 C. Wild type yqjA but not point mutants restores normal cell division to 
BC202. Bar = 10 m. 
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 Similar observations were made with YghB and its corresponding point mutants 
YghB-E39A and YghB-D51A (Figure. 3.7). The presence of membrane embedded acidic 
amino acids that are essential for activity strongly supports the notion that YqjA and YghB 
are proton dependent transporters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.7.  Inability of YghB E39A or D51A point mutants to restore growth, cell division 
or drug resistance to BC202.  (A) BC202 was transformed with empty vector pBADHisA, 
pBAD-yqjA, pBAD-yghB(E39A) or pBAD-yghB(D51A) and grown at 30 or 42 C. 
BC202/pBAD-yghB(D51A) also grew at 30 C (not shown). (B) BC202 was transformed 
with empty vector, pBAD-yqjA, pBAD-yghB(E39A) or pBAD-yghB(D51A) and grown at 
30 C in liquid media.  Cells were visualized using a with a Leica DM-RXA2 
deconvolution microscope. Wild type yghB, included as a positive control, could restore 
both growth and cell division to BC202, in agreement with our previously published results 
(Thompkins, Chattopadhyay et al. 2008; Boughner and Doerrler 2012). Bar = 10 m. (C) 
Sensitivity of BC202 with control vector, cloned yghB, yghB(E39A), yghB(D51A) or mdfA 
to EthBr (75 g/ml), acriflavine (25 g/ml), cetyltrimethyl-ammonium bromide (CTAB) 
(100 g/ml) and methyl viologen (25 g/ml). All strains grew on LB plates without 
biocides at 30 C. Wild type yghB or mdfA but not yghB point mutants restores drug 
resistance to BC202 at 30 C.  (D) Expression of yghB, yghB(E39A) and yghB(D51A) in 
membrane fractions as determined by Western blotting with anti-hexahistidine antibody. 
All growth with pBAD-yghB was carried out in LB/amp/0.002% arabinose.  This lower 
concentration of inducer was used due to toxicity observed when overexpressing yghB in 
0.1% arabinose.  
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We were interested in determining whether these properties applied to DedA family 
members found in other bacterial species.  BB0250 is the sole DedA family protein of the 
Lyme disease pathogen Borrelia burgdorferi and is essential for viability (Liang, Xu et al. 
2010).  Depletion of BB0250 in B. burgdorferi results in cell death preceded by defects in 
cell division.  In other words, the borrelia mutant phenotypes resemble those of BC202, 
with the exception being that bb0250 is essential at all temperatures.   
 
 
 
 
 
 
 
 
 
Figure 3.8.  Inability of Borrelia burgdorferi BB0250 E39A and D40A point mutants to 
restore growth, cell division or drug resistance to BC202.  (A) BC202 was transformed 
with empty vector pBB0, pBB0250-GFP, pBB0250 (E39A)-GFP or pBB0250 (D40A)-
GFP and grown at 30 or 42 C. BC202/pBB0250(D40A)-GFP also grew at 30 C (not 
shown). (B) BC202 was transformed with empty vector, pBB0250-GFP, pBB0250 
(E39A)-GFP or pBB0250 (D40A)-GFP and grown at 30 C in liquid media.  Cells were 
visualized using a with a Leica DM-RXA2 deconvolution microscope. Bar = 10 m. Wild 
type bb0250, included as a positive control, could restore both growth and cell division to 
BC202, in agreement with our previously published results (Liang, Xu et al. 2010).  (C) 
Sensitivity of BC202 transformed with control vector, pBB0250-GFP, pBB0250 (E39A)-
GFP or pBB0250(D40A) to EthBr (50 g/ml), acriflavine (25 g/ml), cetyltrimethyl-
ammonium bromide (CTAB) (100 g/ml) and methyl viologen (30 g/ml). All strains grew 
on LB plates without biocides at 30 C. Wild type bb0250 but not bb0250 point mutants 
restores drug resistance to BC202 at 30 C.  (D) Expression of bb0250, bb0250(E39A) and 
bb0250(D40A) in membrane fractions as determined by Western blotting with anti-GFP 
antibody.  All growth was carried out in LB/amp/0.5 mM IPTG. 
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In addition, cloned bb0250 can fully complement the growth and cell division 
phenotypes of E. coli BC202 even though BB0250 displays only ~19% amino acid identity 
to E. coli YqjA.  BB0250 also possesses acidic amino acids within its first predicted 
transmembrane domain (Figure 3.4). We performed site-directed mutagenesis on residues 
E39 and D40 in TM1 of BB0250 and show that each BB0250 point mutant is unable to 
restore cell division, temperature sensitivity and drug resistance to BC202 (Figure. 3.8, A-
C) while also being expressed at wild type levels (Figure. 3.8, D). This data collectively 
suggests that members of the larger DedA family are likely proton-dependent membrane 
transporters necessary for resistance to a number of structurally diverse compounds in E. 
coli and likely other species of bacteria. 
 Artificially increasing PMF restores drug resistance to BC202.  One potential 
explanation for these results is that YqjA/YghB are themselves drug efflux pumps. 
Alternatively, these DedA family proteins may indirectly affect the ability of other efflux 
pumps to function by compromising the proton motive force (PMF).  A role for 
YqjA/YghB in PMF maintenance is supported by our own published data showing 
correction of BC202 growth and cell division by growth at acidic pH or by overexpression 
of the Na+-K+/H+ antiporter MdfA (Sikdar, Simmons et al. 2013). PMF is also required for 
proper functioning of the twin arginine transport pathway (Palmer and Berks 2012), which 
functions inefficiently in BC202 leading to the observed cell division defect (Sikdar and 
Doerrler 2010).  To directly test this question, we expressed mdfA from a plasmid in BC202 
and tested its sensitivity to the collection of biocides to which it is sensitive.  If mdfA 
overexpression corrects sensitivity to all drugs, this would support a role for YqjA/YghB 
in PMF maintenance, which is indirectly affecting the drug export mechanism. We found 
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that expression of mdfA corrects sensitivity of BC202 to all drugs, including those that are 
not transported directly by MdfA (i.e. acrifavine, methyl viologen and nalidixic acid) 
(Figure. 3.9, A).  Growth at pH 6.0 (increasing the pH component of the PMF) also 
restores drug resistance to BC202 (Figure. 3.9, B and Figure 3.10) indicating the sensitivity 
is likely due to loss of PMF.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. MdfA overexpression or Growth at pH 6.0 restores drug resistance to BC202.  
(A) BC202 harboring vector alone or pBAD-MdfA was spotted on plates containing LB 
(Amp, 0.1% arabinose) alone or this media supplemented with 20 g/ml benzalkonium 
chloride (BC; exported by MdfA), 1 g/ml nalidixic acid (NA, exported by AcrAB), 30 
g/ml methyl viologen (MV, exported by EmrE), 25 g/ml acriflavine (Acr, exported by 
AcrAB), 100 g/ml cetyl trimethyl ammonium bromide (CTAB, mainly exported by 
AcrAB) or 50 g/ml ethidium bromide (EthBr, exported by MdfA, EmrE and others).  (B) 
BC202 and parent W3110 was spotted on LB plates containing buffered to pH 6.0 or 7.0 
containing no additive, 10 g/ml BC, 1g/ml NA, 25 g/ml MV, 25 g/ml Acr, 50 g/ml 
CTAB or 100 g/ml EthBr. LB media was buffered at pH 6.0 or 7.0 as described (Sikdar, 
Simmons et al. 2013). Nalidixic acid was toxic to both strains at pH 6.0 for reasons 
unknown.  
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Figure 3.10. Minimal inhibitory concentration (MIC) values of W3110 and BC202 in LB 
media at pH 6.0. The pH of LB media was adjusted to pH 6 as described in materials and 
methods. Abbreviations are as for Table 1 and all units are g/ml. BC, Benzalkonium 
chloride; NA, nalidixic acid; CTAB, Cetyl trimethyl ammonium bromide; MV, methyl 
viologen; Acr, acriflavine hydrochloride; EthBr, ethidium bromide. 
 
 Growth in the presence of 400 mM NaCl or 10 mM Mg++, both conditions that 
restore growth and cell division to BC202 (Thompkins, Chattopadhyay et al. 2008; Sikdar, 
Simmons et al. 2013), also restores BC202 drug resistance to most compounds tested 
(Figure.3.11).  Each of these conditions that restore resistance (mdfA expression, growth at 
pH 6.0 or in the presence of 400 mM NaCl or 10 mM Mg++)  likely assists in restoring pH 
homeostasis to BC202 (see discussion and (Sikdar, Simmons et al. 2013)). 
3.4 Discussion 
  Members of the DedA family of membrane proteins are found in the vast majority 
of sequenced bacterial genomes (Doerrler, Sikdar et al. 2013) and there are virtually 
thousands of DedA members in the protein databases. While it has been reported that 
members of this family are evolutionarily related to the LeuT superfamily of transporters 
(Khafizov, Staritzbichler et al. 2010), they have never been defined as true membrane 
transporters.  Deletion of functionally redundant genes yqjA and yghB in strain BC202 
causes a number of pleiotropic effects on E. coli.   
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Figure 3.11. Growth on LB media containing high salt or 10 mM MgCl2 restores drug 
resistance to BC202.  BC202 and parent W3110 was spotted on plates containing LB 
(normally containing 170 mM NaCl), LB containing a total of 400 mM NaCl, or LB with 
170 mM NaCl and 10 mM MgCl2.  Each of these growth media was used alone or 
additionally supplemented with 10 g/ml benzalkonium chloride (BC), 1 g/ml nalidixic 
acid (NA), 25 g/ml methyl viologen (MV), 25 g/ml acriflavine (Acr), 50 g/ml cetyl 
trimethyl ammonium bromide (CTAB) or 100 g/ml ethidium bromide (EthBr).  The 
control plates grown on LB in the left column are identical to the controls shown in Figure 
3B from the main article. 400 mM NaCl did not restore resistance to 50 g/ml CTAB for 
reasons that are not clear. Plates were incubated at 30 C overnight. 
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BC202 is unable to grow at elevated temperatures or complete cell division (Thompkins, 
Chattopadhyay et al. 2008; Sikdar and Doerrler 2010) and activates numerous envelope 
stress responses (Sikdar, Simmons et al. 2013). In this work, we show that BC202 is highly 
sensitive to several cationic biocides that are known substrates of PMF dependent efflux 
pumps. It appears that loss of YqjA and YghB may indirectly cause massive drug 
sensitivity due to impairment of the PMF in BC202. This is likely the reason that 
Salmonella ΔyqjA mutants are sensitive to magainin (Shi, Cromie et al. 2004), a cationic 
antimicrobial peptide that likely disrupts the membrane PMF (Westerhoff, Juretic et al. 
1989). Moreover, recently it is shown that ∆yqjA is also sensitive to a model cationic 
antimicrobial peptide (CAMP), protamine (Weatherspoon-Griffin, Yang et al. 2014). In 
addition, PMF disrupting lipopeptides have recently been reported to sensitize E. coli to a 
number of antibiotics (Goldberg, Sarig et al. 2013). Overexpression of DedA family genes 
in BC202 does not by itself increase resistance to any of the biocides tested here beyond 
the level of resistance seen in parent strain W3110. However, the essentiality of membrane 
embedded amino acids strongly suggests that DedA proteins themselves are proton 
dependent transporters as similar acidic amino acids are found in many other classes of 
such transporters.  In the case of MdfA, it is has been shown that acidic amino acids E26 
and D34 play roles in proton translocation during substrate transport (Fluman, Ryan et al. 
2012).  It is possible that such amino acids serve a similar function for DedA family 
proteins.  Whether this family also functions as antiporters and the nature of the transported 
substrate(s) is currently unknown.  
 Growth at 42 C, normal cell division and wild type drug resistance can be restored 
to BC202 by over expression of mdfA (Figure. 3.9, A) growth at pH 6.0 (Figure. 3.9, B) or 
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in the presence of 400 mM NaCl or 10 mM Mg++ (Figure 3.11). (400 mM NaCl did not 
restore resistance to 50 g/ml CTAB for reasons that are unclear.)  It is likely that each of 
these conditions helps to restore an altered cytoplasmic pH. For example, MdfA is an 
antiporter that can provide proton influx in exchange for Na+ or K+ (Lewinson, Padan et 
al. 2004).  In a similar manner, media buffered to pH 6.0 results in an increased ΔpH 
component of the PMF.  An increase in extracellular Mg++ can enhance membrane integrity 
and can also inhibit the activity of the F0/F1 proton extruding ATPase (Bulygin and 
Vinogradov 1991) which is upregulated in response to alkaline growth conditions 
(Krulwich, Sachs et al. 2011). Finally, high levels of monovalent cations such as Na+ or K+ 
can stimulate a number of proton dependent antiporters such as NhaA and MdfA which 
play critical roles in cellular pH homeostasis (Lewinson, Padan et al. 2004; Mager, Rimon 
et al. 2011).  Interestingly, the ability of 400 mM Na+ or 10 mM Mg+2 to restore growth 
and cell division to BC202 is dependent upon an intact Cpx envelope stress response 
pathway suggesting that some Cpx-induced gene may be required for this effect (Sikdar, 
Simmons et al. 2013). 
One of the more interesting properties of the DedA family that sets it apart from 
many membrane transporter families is its apparent essentiality. This is supported by 
several lines of evidence. First, the DedA family is collectively essential in E. coli 
(Boughner and Doerrler 2012) and essential DedA genes are found in Borrelia burgdorferi 
(BB0250) (Liang, Xu et al. 2010) and Caulobacter crescentus (CCNA_01607) (Christen, 
Abeliuk et al. 2011).  Furthermore, expression of a DedA family gene from Mycobacterium 
bovis BCG (BCG2664) confers resistance to and may be the target of the anti-tuberculosis 
drug halicyclamine A (Arai, Liu et al. 2011). In this work, we show that members of the 
100 
 
DedA family are likely membrane transporters required for the normal function of several 
families of drug efflux pumps possibly due to their requirement for PMF maintenance. 
DedA family proteins are thus an intriguing class of membrane proteins and potential 
targets for anti-bacterial drug design. 
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CHAPTER 4 
ESCHERICHIA COLI YqjA, A MEMBER OF THE CONSERVED DedA/Tvp38 
MEMBRANE PROTEIN FAMILY, IS A PUTATIVE OSMOSENSING 
TRANSPORTER REQUIRED FOR GROWTH AT ALKALINE pH* 
4.1 Introduction 
Bacterial alkaline pH tolerance is a key feature of pathogenic, ecological and 
industrially important bacteria. Microbes have many naturally occurring alkaline habitats 
including the human body (Krulwich, Sachs et al. 2011). Neutralophilic bacteria including 
Escherichia coli and Vibrio cholerae can stay viable in alkaline marine environments and 
can cause threats to public health (Herz, Vimont et al. 2003).  They have the ability to 
maintain their intracellular pH in range of 7.5-7.7 when grown within a wide range of pH 
values between 5.5 and 9.0. Cytoplasmic pH maintenance is vital for structural integrity 
and function of essential proteins needed for growth (Padan, Bibi et al. 2005; Krulwich, 
Sachs et al. 2011).  In order to survive at alkaline pH, bacteria employ various strategies 
including increased expression and activity of cation/proton antiporters, which play a 
crucial role in alkaline pH homeostasis (Padan, Bibi et al. 2005).  To date, five such 
antiporters (NhaA, NhaB, ChaA, MdfA, and MdtM) have been reported to function in 
alkaline pH homeostasis in E. coli (Pinner, Kotler et al. 1993; Lewinson, Padan et al. 2004; 
Padan, Bibi et al. 2005; Radchenko, Tanaka et al. 2006; Holdsworth and Law 2013). 
Inward active transport of protons by these antiporters is coupled to the export of cations 
such as Na+, K+ or Ca++.  
  
*This chapter is adapted and reprinted from Kumar et al. Reprint permission granted. 
Copyright © American Society for Microbiology, J. Bacteriol. July 2015 vol. 197 no. 
14 2292-2300 
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 The DedA/Tvp38 family is a highly conserved membrane protein family with the 
corresponding genes present in most sequenced genomes (Doerrler, Sikdar et al. 2013).  
However, the functions of these proteins are not well understood. YqjA and YghB are 
members of the DedA family sharing 62 % amino acid identity and partially redundant 
functions. We have previously shown that an E. coli strain lacking these two genes (named 
BC202) is defective in twin arginine transport (Tat) pathway protein export and cell 
division (Thompkins, Chattopadhyay et al. 2008; Sikdar and Doerrler 2010), maintenance 
of the proton motive force (PMF) (Sikdar, Simmons et al. 2013), and is sensitive to a 
number of antibiotics and biocides normally subject to efflux in a PMF-dependent manner 
(Kumar and Doerrler 2014). Interestingly, all BC202 phenotypes appear to be corrected if 
the strain is grown in slightly acidified growth medium of pH 6.0 (Sikdar, Simmons et al. 
2013; Kumar and Doerrler 2014).   
 Many DedA proteins contain membrane-embedded acidic amino acids in the first 
predicted transmembrane spanning region (Glu39 and Asp51 in both YqjA and YghB as 
predicted using SOSUI (Hirokawa, Boon-Chieng et al. 1998)).  Such membrane acidic 
amino acids are found in many proton dependent transporters belonging to several different 
families (Edgar and Bibi 1999; Soskine, Adam et al. 2004; Seeger, von Ballmoos et al. 
2009; Sigal, Fluman et al. 2009; Fluman, Ryan et al. 2012).  We have also shown that 
DedA proteins require these acidic amino acids for their ability to complement the 
phenotypes of BC202 described above, suggesting they may represent a new family of 
proton dependent transporters (Kumar and Doerrler 2014). 
 In this study, we show that the E. coli ∆yqjA mutant (but not the ∆yghB mutant) is 
unable to grow at an external pH range of 8.5-9.5; unlike the parent E. coli strain. 
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Overexpression of yqjA from a plasmid restores growth at alkaline pH, but only if 
monovalent cation sodium or potassium is supplied in the growth media. Moreover, acidic 
amino acids within the first transmembrane domain are functionally important for YqjA to 
support growth at pH>9.  We also observed that YqjA could rescue growth of the mutant 
at elevated pH in the absence of any salt if grown in the presence of higher osmotic pressure 
provided by sucrose, mannitol or sorbitol, raising the possibility that YqjA may possess an 
osmosensing capability. Based upon these data, we suggest that YqjA is a newly identified 
proton-dependent transporter playing a significant role in alkaline pH homeostasis in E. 
coli. 
4.2 Materials and Methods 
 Bacterial growth conditions: Bacteria cultures were grown in LB medium (1% 
tryptone, 0.5% yeast extract and 1% NaCl) with antibiotics (ampicillin (Amp), 100 µg/ml, 
kanamycin (Kan) 30 µg/ml, tetracycline (Tet) 12.5 µg/ml where specified.  In certain 
experiments growth media was additionally supplemented with 0.002% or 0.02% 
arabinose (w/v). Media were buffered with 70 mM BTP (Bis-Tris propane) and pH was 
adjusted as required with HCl. Cultures were grown at 37 °C in a shaking incubator unless 
otherwise indicated. 
 Strains and molecular techniques: All strains and plasmids are listed in Table 1. 
Mutations from Keio collection strains (Baba, Ara et al. 2006) were typically introduced 
into E. coli W3110 by P1 transduction (Silhavy, Berman et al. 1984) and correct 
configuration was verified through PCR and DNA sequencing with primers flanking the 
appropriate gene. DNA sequencing was conducted at the LSU College of Science 
Genomics Facility. 
108 
 
 Alkaline pH sensitivity growth assay on solid medium: For testing the alkaline pH 
sensitivity on solid medium, overnight cultures of E. coli were freshly diluted 1:100 in LB 
media with appropriate antibiotics and additives, and grown to OD600 ~ 0.6 at 37°C in a 
shaking incubator. 5 μl of serially log10-diluted cells were spotted on LB agar plates of 
various pH’s with appropriate antibiotics and additives. For testing the effect of Na+ and 
K+ ions at alkaline pH on growth of bacteria salt free media (1% tryptone (w/v), 0.5% yeast 
extract (w/v)) was supplemented with different concentrations of salts as indicated.  
Although we refer to this media as “salt-free”, residual amounts (1-10mM) of both sodium 
and potassium are likely present (Ohyama, Igarashi et al. 1994; Radchenko, Tanaka et al. 
2006). The bacterial cells were washed at least two times in salt free media before making 
dilutions and plating. Growth was analyzed after incubation for 20 to 24 hours at 37°C.  
All the experiments were repeated at least three times.  
Table 4.1: Strain and plasmid in this study: 
 
Strains                Description Source or Reference 
W3110 Wild Type, F-,λ-,IN(rrnD-rrnE)1,rph-1 E. coli genetic stock 
center, Yale University 
BC203 W3110,∆yqjA::TetR Thompkins et al.(2008) 
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (TetR) 
Stratagene 
Plasmids   
pBADHisA Expression Vector; araBAD promoter, 
AmpR 
Invitrogen. 
pBAD-YqjA H6-yqjA expression vector; araBAD 
promoter,Ampr 
Sikdar et al.(2013) 
pBAD-MdfA H6-mdfA expression vector; araBAD 
promoter,AmpR 
Sikdar et al.(2013) 
pBAD-YqjA 
E39A 
H6-yqjA E39A expression vector; 
araBAD promoter,Ampr 
Kumar et al.(2014) 
 
pBAD-YqjA 
D51A 
H6-yqjA D51A expression vector; 
araBAD promoter,Ampr 
Kumar et al.(2014) 
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 Alkaline pH sensitivity growth assay in liquid medium: Overnight cultures from a 
single colony were freshly diluted to 1:100 in LB media with appropriate antibiotics and 
additives, and grown to OD600 ~ 1.0 at 37°C in a shaking incubator. 1ml of culture was 
further inoculated into 20ml of prewarmed fresh LB medium buffered to indicated pH and 
containing appropriate antibiotics and additives. During growth at pH 7, 0.002% arabinose 
was used when inducing expression of yqjA due to toxicity issues. At higher pH, 0.02% 
arabinose was used. The cells were further grown aerobically at 37°C in a shaking 
incubator and OD600 was measured each hour for 8 hours. In order to see the dependency 
of sodium and potassium ions at alkaline pH, the cells were first washed in salt-free media 
twice before growth was initiated in LB media containing additives at the indicated 
concentrations. 
4.3 Results 
 E. coli lacking yqjA is unable to grow at alkaline pH.  In order to study the 
physiological roles of YqjA, we tested the growth of wild type E. coli and a ∆yqjA mutant 
at different alkaline pH’s in liquid media. .At pH 7 and pH 8, both the strains grew well at 
37 C (Figure. 4.1, A).  However, as the pH increased above pH 8.25 to pH 9.5 the growth 
of ∆yqjA mutant was diminished compared to the wild type strain.  Similar results were 
observed when dilutions of these strains were spotted and grown on solid growth media 
(Figure. 4.1, B). Above pH 9.5 both wild type and the ∆yqjA mutant did not show any or 
only marginal growth on either solid or in liquid media (data not shown). Our results are 
in agreement with the alkaline sensitivity of a ∆yqjA mutant observed previously (Price 
and Raivio 2009).  These observations show that YqjA plays an important role in providing 
alkaline tolerance to E. coli. While YghB displays 62 % amino acid identity to YqjA, and 
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can substitute for YqjA in many processes (Doerrler, Sikdar et al. 2013), the ∆yghB mutant 
did not display sensitivity to growth under alkaline conditions ( Figure. 4.2). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. An E. coli ΔyqjA mutant fails to grow at elevated pH. (A) Parent E. coli W3110 
(filled squares) and ΔyqjA (open triangles) were grown to mid log phase at pH 7, and 
inoculated into liquid LB medium at pH 7.0, 8.0, 8.25, 8.5, 8.75, 9.0, 9.25, 9.5 or 9.75. 
Growth at 37 C was monitored hourly. (B) Parent strain W3110 and ΔyqjA were grown 
to mid log phase at pH 7.0, then 5 l of serially diluted cells were spotted onto LB medium 
plates at pH 7.0, 8.5, 8.75, 9.25 and 9.5 and the plates were incubated at 37 C for 20-24 
hours. 
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Figure 4.2. YqjA, but not YghB, is required for growth at elevated pH. ΔyqjA, ΔyghB and 
BC202 (ΔyqjA, ΔyghB) were grown to mid log phase at pH 7.0, and 5 l of serially diluted 
cells were spotted onto LB-Amp plates at pH 8.5, 8.75, 9.0, 9.25 and 9.5.  The plates were 
subsequently incubated at 37 C for 20-24 hours. BC202, but not the single deletion strains, 
grows slowly at 37 C, perhaps explaining its increased sensitivity at pH 8.5 and pH 8.75 
compared to that of the ΔyqjA strain. 
 
 Overexpression of yqjA from a multicopy plasmid corrects the alkaline sensitive 
phenotype.  We next examined the ability of overexpression of yqjA from an inducible 
multicopy plasmid to rescue the alkaline pH sensitivity phenotype. In liquid media at pH 
7.0, the ΔyqjA mutant harboring either empty vector or vector expressing yqjA grew 
similarly (Figure. 4.3, A).  As the pH increased into the range of 8.5-9.5, the mutant 
harboring the control vector grew more and more poorly while plasmid expression yqjA 
was capable of supporting growth of the ΔyqjA mutant to wild type levels under these 
conditions.  On solid plates, ΔyqjA cells containing vector or expressing wild type yqjA 
grew well until about pH 8.5. However, as the pH was increased above 8.5 the cells 
overexpressing yqjA were able to survive as compared to cells containing control vector 
(Figure.4.3, B). Taken together, these results suggest that expression of functional YqjA is 
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necessary for a ΔyqjA mutant to survive at alkaline pH.  Expression of yghB can restore 
normal growth and cell division to BC202 (yqjA, yghB), suggesting it possesses 
functions in common with YqjA (Thompkins, Chattopadhyay et al. 2008; Boughner and 
Doerrler 2012).  We tested the ability of plasmid expression of yghB to facilitate growth of 
yqjA at elevated pH.  At pH 8.75 and 9.0, yghB expression could enhance growth of the 
ΔyqjA mutant compared to the vector control, but only yqjA expression could restore 
growth at the higher pH of 9.25 (Figure.4.4).  This result suggests a partial but not complete 
overlap of functions of these DedA family proteins.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Expression of yqjA or mdfA display differing capacities to support growth of 
the ΔyqjA mutant at elevated pH. (A) ΔyqjA harboring control vector pBAD (open 
triangles) or pBADyqjA (filled squares) were grown to mid log phase at pH 7.0, and 
inoculated into liquid LB-Amp medium at pH 7.0, 8.5, 8.75, 9.0, 9.25 or 9.5.  Growth was 
monitored hourly by measuring OD600. (B) ΔyqjA harboring control vector pBAD, 
pBADyqjA or pBADmdfA was grown to mid log phase at pH 7.0, and 5 l of serially diluted 
cells were spotted onto LB-Amp plates at pH 8.75, 9.0 and 9.25.  The plates were 
subsequently incubated at 37 C for 20-24 hours. In both experiments, growth at pH 7.0 
was carried out in the presence of 0.002% arabinose while growth at higher pH was in the 
presence of 0.02% arabinose due to toxicity issues with yqjA expression at pH 7.0. 
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Figure 4.4. YghB can partially support growth of yqjA up to pH 9.0 but no higher. (A) 
ΔyqjA harboring control vector pBAD, pBADyqjA or pBADyghB was grown to mid log 
phase at pH 7.0, and 5 l of serially diluted cells were spotted onto LB-Amp plates 
containing 0.02% arabinose at pH 8.75, 9.0, and 9.25.  The plates were subsequently 
incubated at 37 C for 20-24 hours. (B) ΔyqjA harboring control vector pBAD (open 
triangles) or pBADyghB (filled squares) were grown to mid log phase at pH 7.0, and 
inoculated into liquid LB-Amp medium at pH 8.5, 8.75, 9.0, or 9.25. Growth was 
monitored hourly by measuring OD600. 
 
 Overexpression of MdfA partially complements the alkaline pH sensitivity of the 
∆yqjA mutant.  We reported previously that overexpression of mdfA could rescue growth, 
cell division, and drug sensitivity of BC202 (∆yqjA, ∆yghB) (Sikdar, Simmons et al. 2013; 
Kumar and Doerrler 2014).  MdfA is a Na+-K+/H+ antiporter belonging to the major 
facilitator superfamily and is involved in both alkaline tolerance (Lewinson, Padan et al. 
2004) and drug resistance (Edgar and Bibi 1997; Lewinson, Adler et al. 2003) in E. coli. 
Therefore, we tested whether mdfA overexpression can correct the alkaline pH sensitivity 
of the ∆yqjA mutant. We found that MdfA can partially complement the alkaline sensitivity 
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of ∆yqjA up to about pH 9.0, but not at higher pH’s on both solid media (Figure.4.3, B) and 
when grown in liquid media ( Figure. 4.5), suggesting that YqjA plays a significant role in 
survival of E. coli at extreme alkaline pH.  
 
 
 
 
 
 
 
 
 
 
Figure 4.5. MdfA can partially restore growth to yqjA up to pH 8.75 but not at higher pH 
in liquid media. ΔyqjA harboring control vector pBAD (open triangles) or pBADmdfA 
(filled squares) were grown to mid log phase at pH 7.0, and inoculated into liquid LB-Amp 
medium at pH 8.5, 8.75, or 9.0. Growth was monitored hourly by measuring OD600. 
 
 
 
 
 
 
Figure 4.6. yqjA and nhaA mutants but not mdfA and mdtM mutants are sensitive to 
alkaline pH. Parent W3110, ΔyqjA, ΔmdfA, as well as ΔmdfA, ΔmdtM, ΔnhaA and ΔnhaB 
(in the Keio parent strain BW25113) were grown to mid log phase at pH 7.0, and 5 l of 
serially diluted cells were spotted onto LB-Amp plates at pH 8.75, 9.0 and 9.25.  The plates 
were subsequently incubated at 37 C for 20-24 hours. 
 
 We could not perform the reverse experiment, expressing yqjA in a mdfA mutant 
or, for that matter, a mdtM mutant, because both mutants (obtained from the Keio 
collection, Table 4.1) grew well at all pH’s in our hands (Figure.4.6). These observations 
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are not in agreement with previous reports (Lewinson, Padan et al. 2004; Holdsworth and 
Law 2013).  In contrast, the nhaA mutant does display pH sensitivity in our hands, 
consistent with previous reports (Padan, Maisler et al. 1989).  The reasons for these 
differences are unclear and may be related to differences in the genetic backgrounds of the 
strains. We have reported that the mdfA mutant is sensitive to drugs and biocides in our 
hands (Kumar and Doerrler 2014), consistent with previous reports (Tal and Schuldiner 
2009), and the genetic identity of all Keio strains was confirmed by PCR with primers 
flanking each gene and DNA sequencing.  Plasmid overexpression of yqjA did not reverse 
the pH sensitivity of nhaA (data not shown). 
 Transmembrane acidic amino acids are required for YqjA dependent alkaline 
tolerance. In many proton-dependent transporters including those involved in drug efflux, 
it has been demonstrated that membrane embedded acidic residues play a role in proton 
transport and recognition of cationic substrates (Edgar and Bibi 1999; Soskine, Adam et 
al. 2004; Seeger, von Ballmoos et al. 2009; Sigal, Fluman et al. 2009; Fluman, Ryan et al. 
2012). Many DedA proteins contain membrane-embedded glutamic acids and/or aspartic 
acids in the first predicted transmembrane spanning region (E39 and D51 in both YqjA and 
YghB).  We have shown that these residues are required for YqjA to restore growth, cell 
division and drug resistance to BC202 (Kumar and Doerrler 2014).  Similar acidic residues 
are found in the B. burgdorferi DedA protein BB0250 (E39 and D40) that are essential for 
its ability to complement the growth, cell division and drug sensitivity phenotypes of 
BC202 (Kumar and Doerrler 2014). We tested whether YqjA residues E39 and D51 are 
individually required for YqjA to provide alkaline tolerance to E. coli.  In both liquid and 
on solid media buffered at pH 9.0 and above, each acidic amino acid is required 
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(Figure.4.7). However at pH 8.75, E39 appears to be dispensable for this activity, as growth 
was observed for the yqjA mutant expressing YqjA (E39A) at this pH (Figure. 4.7, A, B). 
This suggests that residue D51 plays a major role in the ability of YqjA to provide alkaline 
tolerance while E39 is only required at the more extreme alkaline pH’s above 9.0. 
 
 
 
Figure 4.7. YqjA acidic amino acids E39 and D51 are required for YqjA to support growth 
of E. coli at elevated pH. (A) ΔyqjA harboring either control vector pBAD (open triangles), 
pBADyqjA (filled squares), pBADyqjA-E39A (filled triangles), or pBADyqjA-D51A 
(filled circles) were grown to mid log phase at pH 7.0, and inoculated into liquid LB-Amp 
medium at pH 8.75, 9.0 and 9.25. (B) ΔyqjA harboring control vector pBAD, pBADyqjA, 
pBADyqjA-E39A, or pBADyqjA-D51A was grown to mid log phase at pH 7.0, and 5 l of 
serially diluted cells were spotted onto LB-Amp medium plates at pH 8.75, 9.0 and 9.25, 
and 9.5. The plates were subsequently incubated at 37 C for 20-24 hours. 
 
 Sodium or potassium is required for YqjA to support growth under alkaline 
conditions. Many of the proteins that have been reported to be necessary for alkaline 
tolerance (NhaA, NhaB, ChaA, MdtM and MdfA) in bacteria are antiporters that exchange 
protons for other cations such as sodium, potassium, lithium, or calcium (Pinner, Kotler et 
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al. 1993; Lewinson, Padan et al. 2004; Padan, Bibi et al. 2005; Radchenko, Tanaka et al. 
2006; Holdsworth and Law 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Sodium or potassium is required for YqjA to support growth at alkaline pH. (A, 
B) ΔyqjA harboring pBADyqjA was grown to mid log phase at pH 7.0, then inoculated into 
liquid LB-Amp medium at pH 9.25 containing 0 mM (open triangles), 25 mM (filled 
circles), 50 mM (filled triangles) or 100 mM (filled squares) sodium chloride (A) or sodium 
gluconate (B) and growth was monitored. (C, D) ΔyqjA harboring either control vector 
pBAD or pBADyqjA were grown to mid log phase at pH 7.0, and 5 l of serially diluted 
cells were spotted onto LB-Amp medium plates at pH 9.25 containing 75, 100 or 150 mM 
NaCl or sodium gluconate (C) and KCl or potassium gluconate (D). The plates were 
incubated at 37 C for 20-24 hours.  For reasons that are not understood, slight differences 
were observed in optimal salt concentrations needed for growth when strains were grown 
on solid or in liquid media. 
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 We tested the cation requirements for YqjA to support alkaline tolerance by 
growing strains at elevated pH in the presence of varying concentrations of extracellular 
salts.  Either sodium or potassium was found to be necessary for this YqjA activity.  While 
no growth was seen in the yqjA-complemented ΔyqjA mutant at pH’s above 8.75 in the 
absence of extracellular salts (Figure. 4.8A, Figure.4.9 and 4.10), YqjA could support 
growth of the ΔyqjA mutant at pH 9.25 if 100 mM sodium was included in the growth 
media (Figure. 4.8 A-C). Sodium could be provided in the form of either sodium chloride 
or sodium gluconate thereby demonstrating that the chloride anion is not necessary. 
Similarly, potassium, supplied as potassium chloride or potassium gluconate at 100 mM 
could support growth at pH 9.25 under these conditions (Figure. 4.8 D and Figure.4.9).  
Choline chloride could not support the ability of YqjA to provide alkaline tolerance at any 
concentration up to 150 mM (Figure. 4.11, D), further supporting no role for the chloride 
anion. 
 
 
 
 
 
 
 
 
Figure 4.9. Growth of yqjA::pBADyqjA in liquid media at pH 9.25 containing potassium 
salts. (A, B) ΔyqjA harboring pBADyqjA was grown to mid log phase at pH 7.0, then 
inoculated into liquid LB-Amp medium at pH 9.25 containing 0 mM (open triangles), 25 
mM (filled circles), 50 mM (filled triangles) or 100 mM (filled squares) potassium chloride 
(A) or potassium gluconate (B) and growth was monitored hourly by measuring OD600. 
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Figure 4.10. Growth of yqjA in media containing no salt at alkaline pH’s.  ΔyqjA was 
grown to mid log phase at pH 7.0, and inoculated into salt-free liquid LB-Amp medium at 
pH 8.5 (filled squares), 8.75 (filled triangles), 9.0 (open triangles), 9.25 (open circles) or 
9.5 (open diamonds).  Growth was monitored hourly by measuring OD600. 
 
 Raising osmotic pressure can enhance YqjA mediated alkaline tolerance.  While no 
growth was seen when the ΔyqjA mutant expressing yqjA was grown at pH 9.25 in the 
absence of extracellular salt (Figure. 4.10), we were surprised to find that sucrose, mannitol 
or sorbitol could enhance the growth of this strain at this elevated pH (Figure. 4.11). While 
the growth rate in the presence of increased osmotic pressure was only ~25 % of that seen 
in the presence of 150 mM NaCl or KCl (Figure.4.11, B), it was reproducible and 
significantly better than the undetectable growth rate seen in the absence of salt (although 
trace levels of both sodium and potassium are present in the broth; see materials and 
methods). This growth rate enhancement was seen with 100-300 mM sucrose (Figure.4.11, 
C), as well as with mannitol or sorbitol (Figure. 4.11, D) but was not seen with a molar 
equivalent amount of choline chloride (Figure. 4.11, D). 
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Figure 4.11. Increasing the osmotic pressure can partially substitute for cations in 
supporting the ability of YqjA to permit growth at elevated pH. (A) ΔyqjA harboring 
pBADyqjA was grown to mid log phase at pH 7.0, then inoculated into salt-free liquid LB-
Amp medium at pH 9.25 containing 0 mM (open triangles), 100 mM (filled circles), 200 
mM (filled triangles) or 300 mM sucrose (filled squares) and growth was monitored. (B) 
Comparison of growth rates between ΔyqjA harboring pBADyqjA in salt-free LB-Amp 
medium (open triangles), salt-free LB-Amp medium containing 300 mM sucrose (closed 
circles) and LB-Amp medium containing 150 mM NaCl (filled squares).  ΔyqjA harboring 
control vector pBAD or pBADyqjA was grown to mid log phase at pH 7.0, then 5 l of 
serially diluted cells were spotted onto LB-Amp medium plates at pH 9.25 containing 100, 
200 or 300 mM sucrose (C), 300 mM mannitol, 300 mM sorbitol or 150 mM choline 
chloride (D). The plates were incubated at 37 C for 20-24 hours. 
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Figure 4.12. Sucrose enhances the ability of YqjA to provide alkaline tolerance in the 
presence of a suboptimal concentration of sodium. (A) ΔyqjA harboring pBADyqjA was 
grown to mid log phase at pH 7.0, then inoculated into salt-free liquid LB-Amp medium at 
pH 9.25 containing 0 mM sucrose, 0 mM NaCl (open triangles), 300 mM sucrose, 0 mM 
NaCl (open circles), 0 mM sucrose, 50 mM NaCl (filled circles), 300 mM sucrose, 50 mM 
NaCl (filled triangles) or 0 mM sucrose, 100 mM NaCl (filled squares) and growth was 
monitored. (B) ΔyqjA harboring control vector pBAD or pBADyqjA was grown to mid log 
phase at pH 7.0, then 5 l of serially diluted cells were spotted onto LB-Amp medium 
plates at pH 9.25 containing 0 mM NaCl, 50 mM NaCl, 100 mM sucrose, 50 mM NaCl + 
100 mM sucrose, or 100 mM NaCl. The plates were incubated at 37 C for 20-24 hour. 
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Figure 4.13. Sodium and potassium salts or sucrose can support growth of W3110 but not 
yqjA at elevated pH.  Parent W3110 and ΔyqjA were grown to mid log phase at pH 7.0, 
and 5 l of serially diluted cells were spotted onto salt-free LB plates containing the 
additional salts or sucrose at pH 7.0, 9.0 and 9.25.  The plates were subsequently incubated 
at 37 C for 20-24 hours. 
 
 We further tested if increased osmotic pressure could enhance YqjA function by 
growing the ΔyqjA mutant expressing yqjA at pH 9.25 in the presence of a sub-optimal 
concentration of sodium chloride (50 mM; see Figure 4.8) with or without 300 mM sucrose.  
On both plates and in liquid medium, sucrose could enhance the growth of this strain in 50 
mM NaCl to levels close to what is seen at 100 mM NaCl in the absence of additional 
osmotic pressure (Figure 4.12).  No growth was seen under these conditions with the ΔyqjA 
mutant harboring a control vector.  As expected, the wild type parent strain W3110 also 
grows poorly at high pH in the absence of added salt, but growth can be restored by the 
inclusion of NaCl, KCl or sucrose in the growth media (Figure. 4.13).  To our knowledge, 
this is the first time it has been demonstrated that sucrose can aid growth of E. coli at 
elevated pH in the presence of limiting salts and our data suggests that YqjA alone is 
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responsible for this.  This data collectively supports the hypothesis that the transport 
activity of YqjA required for growth at elevated pH and is stimulated in the presence of 
increased osmotic pressure. 
4.4 Discussion 
 Adaptation to alkaline conditions by neutralophiles remains a poorly understood 
process. A key process necessary is maintenance of an acidic cytoplasm relative to the pH 
of the surrounding environment. This can be accomplished in a number of ways, but import 
of protons from the outside of the cell is one of the most common. This is usually 
accomplished by the activity of high affinity proton dependent antiporters. To control 
cytoplasmic pH, the cell by definition must control its internal proton concentration, doing 
this by dictating the relative magnitudes of the transmembrane proton gradient (ΔpH) and 
the membrane electrical potential (ΔΨ), the two components of the protonmotive force 
(PMF).  Under conditions of alkaline stress, neutralophiles like E. coli cannot use the ΔpH 
to drive proton accumulation inside the cell because the cytoplasm is already more acidic 
than the outside. To overcome this, antiporters use ΔΨ to promote electrogenic Na+/H+ 
and/or K+/H+ exchange to acidify the cytoplasm (Krulwich, Sachs et al. 2011).  In E. coli, 
there are five known membrane transporters that play a role in adaptation to alkaline 
conditions: MdfA, NhaA, NhaB, ChaA and MdtM (Pinner, Kotler et al. 1993; Lewinson, 
Padan et al. 2004; Padan, Bibi et al. 2005; Radchenko, Tanaka et al. 2006; Holdsworth and 
Law 2013). All are proton dependent antiporters that function under specific environmental 
conditions. Mutants lacking these genes are often sensitive to alkaline pH (Krulwich, Sachs 
et al. 2011). We asked whether E. coli DedA family mutants can grow at elevated pH. 
Surprisingly, we found that YqjA, but not YghB, is required for growth in the range of pH 
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8.5-9.5, in support of previous observations (Price and Raivio 2009).  A ΔyqjA mutant 
cannot grow above pH 9.0 (Figure. 4.1) and expression of yqjA from a plasmid can restore 
growth to the ΔyqjA mutant, but only if sufficient extracellular sodium or potassium is 
supplied (> ~100 mM) (Figures. 4.3 and 4.8).  Mutation of YqjA acidic amino acids E39 
or D51 abolishes this activity (Figure.4.7), in spite of the expression and membrane 
association of the mutant proteins at levels equivalent to the wild type proteins (Kumar and 
Doerrler 2014). 
 We also observed that increasing the osmotic pressure by the addition of sucrose, 
mannitol, and sorbitol at concentrations of 100-300 mM could enhance the ability of YqjA 
to provide adaptation to alkaline growth conditions (Figure.4.11 and 4.12).  Each of these 
agents is capable of imposing increased osmotic pressure on bacteria (Verkhovskaya, 
Barquera et al. 1998; van den Bogaart, Hermans et al. 2007; Kitko, Wilks et al. 2010).  One 
interpretation of this surprising result is that YqjA may additionally possess osmosensing 
capabilities. A number of osmosensing transporters are known and belong to different 
membrane transporter families. These include ProP of E. coli (Major facilitator 
superfamily), OpuA of Lactococcus lactis (ABC transporter superfamily) and BetP of 
Corynebacterium glutamicum (betaine-carnitine-choline transporter family (Wood 2011). 
Interestingly, BetP is a homotrimer of 12 transmembrane helix subunits (Ressl, Terwisscha 
van Scheltinga et al. 2009) possessing the LeuT fold (Forrest, Kramer et al. 2011). 
Members of the DedA are predicted to be evolutionarily related to LeuT and are predicted 
to also possess LeuT fold transmembrane helices (Khafizov, Staritzbichler et al. 2010).  
 The yqjA gene is found in an operon with yqjB, also known as MzrA. MzrA was 
reported to modulate the activity of the EnvZ/OmpR two component system which 
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responds to osmotic stress (Gerken, Charlson et al. 2009).  MzrA interacts with inner 
membrane sensors kinases EnvZ and CpxA and promotes enhanced phosphorylation of 
these proteins perhaps coordinating the output of the osmolarity sensing EnvZ and the 
stress sensing CpxA. Therefore, it is quite intriguing that we find an osmotic pressure 
stimulated activity of YqjA in promoting adaptation to alkaline growth conditions.   EnvZ 
is not necessary for YqjA to promote adaptation to alkaline growth conditions (Kumar S 
and Doerrler WT, unpublished observations), consistent with the previous determination 
that the EnvZ regulator MzrA functions independently of YqjA (Gerken, Charlson et al. 
2009). 
 YqjA is also a member of the Cpx regulon (Price and Raivio 2009), which responds 
to periplasmic stress caused by alkaline conditions and overexpression of certain envelope 
proteins among other stressors (Raivio and Silhavy 1999).  These stresses cause the 
activation of sensor kinase CpxA which in turn results in the activation of response 
regulator CpxR.  CpxR activation results in the upregulation a number of periplasmic 
chaperones and proteases. YqjA is therefore one member of the Cpx regulon required for 
adaptation to alkaline conditions (Price and Raivio 2009), suggesting a specific 
environmental niche for YqjA activity. 
 The DedA/Tvp38 family of membrane proteins are highly conserved and found 
within all domains of life (Doerrler, Sikdar et al. 2013).  Nearly all sequenced bacterial 
genomes possess at least one DedA family member.  Our genetic approaches support roles 
for YqjA and its close homologue YghB in maintenance of the protonmotive force, 
possibly by acting as proton-dependent transporters (Sikdar, Simmons et al. 2013; Kumar 
and Doerrler 2014).  Our findings reported herein support a critical role for YqjA in 
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adaptation to alkaline conditions by the neutralophile Escherichia coli.  Furthermore, YqjA 
appears to possess characteristics similar to a number of reported osmosensing transporters 
(Wood 2011) although additional work, including in vitro studies, are required to prove 
this.  While other transporters have been reported to counteract alkaline stress (Pinner, 
Kotler et al. 1993; Lewinson, Padan et al. 2004; Padan, Bibi et al. 2005; Radchenko, 
Tanaka et al. 2006; Holdsworth and Law 2013), we believe YqjA and possibly other DedA 
family members are candidates to serve major roles in adaptation to alkaline and possibly 
other stressful environments. 
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 CHAPTER 5 
IDENTIFICATION OF ESSENTIAL ARGININE RESIDUES OF E. COLI 
DedA/Tvp38 FAMILY MEMBRANE PROTEINS YqjA AND YghB* 
 
5.1 Introduction 
The DedA/Tvp38 family is a highly conserved and poorly understood family of 
membrane proteins present in most bacteria as well as many archaea and eukaryotes 
(Doerrler, Sikdar et al. 2013).  Computational analysis has suggested DedA family proteins 
share an evolutionary relationship and structural fold with LeuT, belonging to the 
neurotransmitter: sodium symporter family (Khafizov, Staritzbichler et al. 2010; Keller, 
Ziegler et al. 2014). Our laboratory has pioneered characterization of the DedA/Tvp38 
membrane protein family in E. coli. (Thompkins, Chattopadhyay et al. 2008; Liang, Xu et 
al. 2010; Sikdar and Doerrler 2010; Boughner and Doerrler 2012; Sikdar, Simmons et al. 
2013; Kumar and Doerrler 2014; Kumar and Doerrler 2015).  
YqjA and YghB of E. coli are the best characterized members of the DedA family. 
YqjA and YghB possess 220 and 219 amino acids, respectively, along with multiple 
predicted membrane-spanning domains, sharing 62 % amino acid identity and partially 
redundant functions (Thompkins, Chattopadhyay et al. 2008). Simultaneous in-frame 
deletions of these two genes in strain BC202 results in numerous phenotypes including 
temperature sensitivity (Thompkins, Chattopadhyay et al. 2008), cell division defects due 
to inefficient export of periplasmic amidases by the twin arginine pathway (Sikdar and 
Doerrler 2013), and sensitivity to various antibiotics and biocides which are normally  
 
 
*This chapter is adapted and reprinted from Kumar et al. Reprint permission 
granted. Copyright © FEMS 2016, FEMS Microbiology letters 2016; doi: 
10.1093/femsle/fnw133 
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in a PMF-dependent manner from the cytoplasm (Kumar and Doerrler 2014). Phenotypes 
of BC202 can be rescued by growth at pH 6.0 or overexpression of either yqjA, yghB or 
mdfA (Sikdar, Simmons et al. 2013; Kumar and Doerrler 2014). MdfA is an unrelated Na+-
K+/H+ antiporter and drug efflux pump belonging to the major facilitator superfamily 
(Lewinson, Adler et al. 2003). The ∆yqjA mutant (but not the ∆yghB mutant) is unable to 
survive above pH 8.5 and sodium or potassium is required for YqjA-mediated alkaline 
tolerance (Kumar and Doerrler 2015). Cation/proton antiporters play a major role in 
alkaline pH homeostasis in E. coli (Pinner, Kotler et al. 1993; Lewinson, Padan et al. 2004; 
Padan, Bibi et al. 2005; Holdsworth and Law 2013).  Based on these results, we suggested 
YqjA/YghB are proton-dependent membrane transporters (Sikdar, Simmons et al. 2013; 
Kumar and Doerrler 2014; Kumar and Doerrler 2015).   
Charged amino acids are known to play essential roles in various secondary 
transporters including MdfA, NhaA, MdtM and LacY (Gerchman, Olami et al. 1993; 
Noumi, Inoue et al. 1997; Abramson, Iwata et al. 2004; Adler and Bibi 2004; Sigal, Vardy 
et al. 2005; Fluman, Ryan et al. 2012; Holdsworth and Law 2012). Membrane embedded 
acidic amino acids were shown to be important for the function of YqjA and YghB of E. 
coli (E39 and D51 of both proteins) (Kumar and Doerrler 2014).  Furthermore, the 
significance of membrane embedded basic amino acids like arginine are well documented 
in the literature and shown to be crucial in several biological processes including regulation 
of redox potential (Cutler, Davies et al. 1989; Winn, Ludemann et al. 2002), voltage 
detection across a lipid bilayer (Jiang, Ruta et al. 2003; Long, Campbell et al. 2005; Tao, 
Lee et al. 2010), and proton transport (Cain and Simoni 1989; Hellmer, Teubner et al. 2003; 
Sigal, Vardy et al. 2005).  Here, we analyze the effect of point mutations of conserved basic 
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amino acids on the function of YqjA and YghB and show that conserved arginines at 
positions 130 and 136 of YqjA and YghB are essential for the function of both proteins.  
Furthermore, mutation of R130 to lysine results in a functional protein indicating a charge 
dependence at this position. In contrast, the R136K mutation remains nonfunctional 
indicating an important role played by arginine at this position.  This study provides 
mechanistic insight into YqjA and YghB and supports the hypothesis that they function as 
membrane transporters. 
5.2 Materials and Methods 
 Materials: All chemicals were reagent grade and purchased from Sigma-Aldrich, 
VWR, New England Biolabs or Qiagen. 
 Bacterial growth conditions: Bacteria cultures were grown in LB medium (1% 
tryptone, 0.5% yeast extract and 1% NaCl) with antibiotics ampicillin (Amp) at 100 µg/ml, 
kanamycin (Kan) at 30 µg/ml and tetracycline (Tet) at 12.5 µg/ml where specified.  In 
certain experiments growth media was additionally supplemented with 0.002% or 0.02% 
arabinose (w/v). For pH experiments, the growth media were buffered with 70mM BTP 
(Bis-Tris propane) and pH was adjusted as required with HCl.  
 Site-directed mutagenesis:  Point mutants were created according to a previously 
published protocol (Kumar and Doerrler 2014). The point mutation was introduced using 
primers carrying the site-specific mutations (Table S2) in a PCR reaction to amplify a 
vector having the indicated wild type gene.  The Dpn1-digested PCR products were used 
to transform competent XL1 blue cells. Amp resistant colonies were screened by colony 
PCR by means of gene-specific primers. Mutations were confirmed by DNA sequencing 
conducted at the LSU College of Science Genomics Facility.  
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Strains 
 
               Description Source or Reference 
W3110 Wild Type, F-,λ-,IN(rrnD-rrnE)1,rph-1 E. coli genetic stock 
center, Yale University 
∆yqjA  W3110, ∆yqjA::TetR (BC203) (Thompkins, 
Chattopadhyay et al. 
2008) 
BC202 W3110, ΔyqjA::TetR, ΔyghB781::KanR Thomkins et al.(2008) 
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZΔM15 Tn10 
(TetR) 
Stratagene 
Plasmids 
 
  
pBADHisA Expression vector; araBAD promoter, 
AmpR 
Invitrogen. 
pBAD-YqjA H6-yqjA expression vector; araBAD 
promoter,Ampr 
(Sikdar, Simmons et al. 
2013) 
pBAD-YqjA 
D15A 
H6-yqjA D15A expression vector; araBAD 
promoter, Ampr 
This study 
pBAD-YqjA 
H121A 
H6-yqjA H121A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YqjA 
R130A 
H6-yqjA R130A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YqjA 
R130K 
H6-yqjA R130K expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YqjA 
R136A 
H6-yqjA R136A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YqjA 
R136K 
H6-yqjA R136K expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YqjA 
E185A 
H6-yqjA E185A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YqjA 
D186A 
H6-yqjA D186A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YghB H6-yghB expression vector; araBAD 
promoter,Ampr 
(Sikdar, Simmons et al. 
2013) 
pBAD-YghB 
R130A 
H6-yghB R130A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YghB 
R130K 
H6-yghB R130K expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YghB 
R136A 
H6-yghB R136A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YghB 
R136K 
H6-yghB R130K expression vector; 
araBAD promoter, Ampr 
This study 
Table 5.1 Strains and plasmids used in this study: 
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Primer Name Sequence ( 5’-3’) 
YqjA 
D15A_FWD  
GGGCGCAGGCTTTTGAAACCCTGGCCAATCCATCGATGATTG 
YqjA 
D15A_REV 
GTTTCAAAAGCCTGCGCCCACAGGGCTTGCAGCAATTGGGTC
AAAAG  
YqjA H121A 
_FWD 
CTTTTTCATAAAGCAGGTTTATCGGCGCTGTTAATTGGTCGC 
YqjA 
H121A_REV 
CCGATAAACCTGCTTTATGAAAAAGATGGTGTGCGCGTTGAT
G 
YqjA 
R130A_FWD 
GTTAATTGGTGCCTTTATTGCGTTTGTCAGAACACTGCTGCCG 
YqjA 
R130A_REV 
GCAATAAAGGCACCAATTAACAGCGCCGATAAACCGTGTTTA
TG 
YqjA 
R130K_FWD 
GTTAATTGGTAAGTTTATTGCGTTTGTCAGAACACTGCTGCCG 
YqjA 
R130K_REV 
GCAATAAACTTACCAATTAACAGCGCCGATAAACCGTG  
YqjA 
R136A_FWD  
CGTTTGTCGCAACACTGCTGCCGACGATTGCCGGGTTATCAG
G 
YqjA 
R136A_REV 
CAGCAGTGTTGCGACAAACGCAATAAAGCGACCAATTAACA
GCG 
YqjA 
R136K_FWD  
CGTTTGTCAAAACACTGCTGCCGACGATTGCCGGGTTATCAG
G  
YqjA R136K 
_REV 
CAGCAGTGTTTTGACAAACGCAATAAAGCGACCAATTAACAG
CG 
YqjA 
E185A_FWD 
TAAAGTACGCGGACCAGCTGATGTCATGCCTGATGCTGCTC 
YqjA 
E185A_REV 
CAGCTGGTCCGCGTACTTTAAAAATACCGGCGTTTTGC 
YqjA 
D186A_FWD 
GTACGAGGCCCAGCTGATGTCATGCCTGATGCTGCTCCCGGT
GGTG 
YqjA 
D186A_ REV 
CATCAGCTGGGCCTCGTACTTTAAAAATACCGGCGTTTTGC 
Plasmids 
 
               Description Source or Reference 
pBAD-YghB 
E185A 
H6-yghB E185A expression vector; 
araBAD promoter, Ampr 
This study 
pBAD-YghB 
D186A 
H6-yghB D186A expression vector; 
araBAD promoter, Ampr 
This study 
Table 5.2: Primers used in the study 
(Table 5.1 continued) 
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Primer Name Sequence ( 5’-3’) 
YghB 
R130A_FWD 
GCTGGCTGGAGCTTTTCTTGCATTTGTCCGTACGCTGCTG 
YghB 
R130A_REV 
GCAAGAAAAGCTCCAGCCAGCAGCGCCAGCAGACCGTG 
YghB 
R130K_FWD 
GCTGGCTGGAAAGTTTCTTGCATTTGTCCGTACGCTGCTG 
YghB 
R130K_REV 
GCAAGAAACTTTCCAGCCAGCAGCGCCAGCAGACCGTG 
YghB 
R136A_FWD 
GCATTTGTCGCTACGCTGCTGCCAACCATGGCG 
YghB 
R136A_REV 
CAGCAGCGTAGCGACAAATGCAAGAAAACGTCCAGCCAGCA
GC 
YghB 
R136K_FWD 
GCATTTGTCAAGACGCTGCTGCCAACCATGGCG 
YghB 
R136K_REV 
CAGCAGCGTCTTGACAAATGCAAGAAAACGTCCAGCCAGCA
GC 
YghB 
E185A_FWD 
GTTAAACGCCATGCAGATCAGGTAATGACGTTCCTG 
YghB 
E185A_REV 
CATTACCTGATCTGCATGGCGTTTAACGAACGGAATCATACTT
AAGGC 
YghB 
D186A_FWD 
CGCCATGAAGCTCAGGTAATGACGTTCCTGATGATCCTGCCA
ATTGC 
YghB 
D186A_REV 
CATTACCTGAGCTTCATGGCGTTTAACGAACGGAATCATACTT
AAGGC 
 
Microscopy:  Microscopy was performed as previously described (Kumar and Doerrler 
2014).  Overnight cultures of specified strains were diluted 1:100 in LB media with 
appropriate antibiotics and additives, and grown shaking to OD600 ~ 0.6 at 30 °C. The cells 
were resuspended to a final OD600 of 1.0 and 10 µl of cells were used for imaging on a 1% 
agarose coated glass slide. Differential interference contrast (DIC) micrographs were 
obtained using a Leica DM-RXA2 deconvolution microscope (LSU Shared Instrument 
Facility).  
Table 5.2 continued 
(Table 5.2 Continued) 
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 Drug resistance measurements: Growth was carried out on solid media as described 
(Kumar and Doerrler 2014). Overnight cultures of E. coli were diluted 1:100 into LB media 
containing Amp and 0.1 % arabinose and grown to OD600 ~ 0.6 at 30°C.  5 μl of serially 
log10-diluted cells were spotted on LB agar plates containing 0.002 % arabinose and the 
indicated drugs/biocides. Plates were incubated at 30 °C for 20 to 24 hours.  
 Alkaline pH sensitivity: Alkaline pH sensitivity was tested as previously described 
(Kumar and Doerrler 2015). Overnight cultures of E. coli were diluted 1:100 in LB media 
with appropriate antibiotics and additives, and grown to OD600 ~ 0.6 at 37°C. 5 μl of serially 
log10-diluted cells were spotted on LB agar plates at the indicated pH with appropriate 
antibiotics and additives. Plates were incubated at 37°C for 20 to 24 hours. All experiments 
were repeated three times. 
 Membrane Preparation and Western Blotting:  Isolation of membranes and Western 
blotting was performed as previously described (Kumar and Doerrler 2014). Cell 
membranes were prepared from the log phase cultures of BC202 expressing the indicated 
proteins. Protein samples were incubated with 2X SDS PAGE buffer and heated at 95 °C 
for 5 minutes before 12 % SDS-PAGE and transfer to PVDF. Western blotting was done 
using Penta-His primary antibody (Qiagen) at 1:5000 dilution and goat-anti-mouse IgG 
horseradish peroxidase secondary antibody (Pierce) at 1:10,000 and detection with the 
ImmunStar HRP kit (Bio-Rad). 
5.3 Results 
 Identification of amino acids required for YqjA and YghB function: Numerous 
studies have confirmed the role of charged amino acids in the transport mechanism of 
membrane transporters (Gerchman, Olami et al. 1993; Wiebe, Dibattista et al. 2001; Adler 
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and Bibi 2004; Sigal, Vardy et al. 2005; Holdsworth and Law 2012).  Therefore, we 
investigated the significance of conserved, charged residues in YqjA and YghB by site 
directed mutagenesis. Previously, we reported the importance of membrane embedded 
acidic amino acids E39 and D51 in the function of both proteins (Kumar and Doerrler 
2014).  In addition, a mutational analysis of YqjA identified numerous non-essential 
residues (Keller, Schleppi et al. 2015).  Here, we studied the effect of mutations of 
conserved and charged amino acids of YqjA and YghB, mutating amino acids that were 
found at identical positions in both YqjA and YghB (Figure.5.1). Mutations were 
introduced into YqjA at 6 different positions (D15, H121, R130, R136, E185 or D186) and 
YghB at four positions (R130, R136, E185 and D186). All genes were cloned into vector 
pBAD in-frame with an N-terminal His6 tag which allows detection of expression and 
membrane association of proteins using Western blot. The vector with the desired mutation 
in yqjA or yghB was transformed into BC202 or ∆yqjA to study its ability to complement 
certain mutant phenotypes.    
 Rescue of temperature sensitivity of BC202 by point mutants: We first tested the 
ability of the mutant proteins to complement temperature sensitivity of BC202.  Of the six 
YqjA mutants, YqjA-D15A, -H121A and -D186A were functional; able to support growth 
of BC202 at 42 ºC (Figure.5.2, A, top panel).  Of the four YghB mutants, only YghB-
D186A supported growth at 42 ºC (Figure 5.2, C, top panel).  All mutants are well 
expressed in membranes indicating proper folding of the expressed mutant proteins with 
the exception of YqjA-D15A (Figure. 5.2, B), in spite of its ability to complement BC202 
at 42 ºC (Figure. 5.2, A).  While the reasons for poor expression are unclear, residue D15 
appears to be dispensable for YqjA function from our data.   
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Figure 5.1. Amino acid alignment of YqjA and YghB and summary of mutation data. (A). 
Amino acid alignment of YqjA and YghB.  ClustalW (Larkin, Blackshields et al. 2007) 
was used to create an alignment between the two protein sequences. The charged amino 
acids which are conserved between both the proteins were chosen for site directed 
mutagenesis study. Essential acidic (blue) and basic (red) residues are highlighted. (B) 
Predicted membrane topology model of YqjA/YghB based on the TMHMM program 
(Sonnhammer, von Heijne et al. 1998). The amino acids E39 and D51 (white type, black 
background) were previously shown important for the function of YqjA/YghB (Kumar and 
Doerrler 2014). YqjA/YghB residues mutated in this study are represented as ovals.  
Mutation of YqjA/YghB R130, R136 or E185 results in loss of function (yellow type, black 
background).  Mutation of YqjA D15, H121, and YqjA/YghB D186 results in proteins with 
wild type activity (black type, white background). *Mutation of YqjA/YghB E185 results 
in a partial loss of function in certain assays (See Figure. 2 and 3).  All other amino acids 
shown in the model are non-essential for the function for YqjA (Keller, Schleppi et al. 
2015). (C) A hydrophobicity profile of YqjA and YghB. The profiles were generated by 
using the AlignMe program (Khafizov, Staritzbichler et al. 2010; Stamm, Staritzbichler et 
al. 2013; Stamm, Staritzbichler et al. 2014) along with the scale from Hessa, White & van 
Heinje (HWvH) with a threshold for gap penalty of -0.05. The green and red plots represent 
the hydrophobicity profile of YghB and YqjA, respectively.  
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Figure 5.2. Correction of temperature sensitivity of BC202 by YqjA, YghB and point 
mutants. (A, C) BC202 transformed with vector, pBAD-yqjA and YqjA point mutants (A), 
and vector, pBAD-yghB and YghB point mutants (C) were grown for 24 hours at 30 C or 
42 C.  (B, D) Expression of YqjA and point mutants (B) and YghB and point mutants (D) 
in membrane fractions as determined by Western blotting with anti-hexahistidine antibody. 
 
  Since the R130A and R136A mutants of YqjA and YghB failed to rescue growth 
of BC202, we constructed R130K and R136K mutants replacing the positively charged 
arginine with positively charged lysine to distinguish between the effect of size or charge 
in their loss of function.  Notably, the R130K but not the R136K mutant of both YqjA and 
YghB regain their ability to support growth of BC202 at 42 ºC (Figure. 5.2A, C bottom).  
This suggests that amino acid charge at position 130 is critical for the function of both these 
proteins. However, arginine is absolutely required at position R136 as lysine cannot 
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substitute.  YqjA-E185A and YghB-E185A also fail to restore growth to BC202 at 42 ºC 
(Figure. 5.2, A, C). These mutants gave contradictory results in some of our assays and are 
discussed in more detail below. 
 Rescue of BC202 cell division by point mutants: We proceeded to measure the 
ability of each mutant to support proper cell division of BC202.  These results largely agree 
with the data from Figure 5.2.  BC202 transformed with control vector forms long chains 
of incompletely constricted cells (Figure 5.3, A, B) as previously reported (Thompkins, 
Chattopadhyay et al. 2008).  BC202 transformed with pBAD-yqjA or pBAD-yghB displays 
proper cell division and there is no sign of elongated cells. YqjA-D15A, -H121A and -
D186A were functional in that they were each capable of restoring cell division to BC202 
while YqjA-R130A, –R136A and E185A were nonfunctional in that they failed to restore 
cell division to BC202.  When we made arginine-to-lysine substitutions at positions 130 
and 136 of YqjA, we again found that YqjA-R130K regained function but not YqjA-
R136K, suggesting an absolute dependence upon arginine at position 136 of YqjA (Figure 
5.3, A). Similar observations were made in the corresponding YghB mutants with the 
exception of YghB-E185A, which was functional in that it did restore normal cell division 
to BC202 (Figure. 5.3, B). 
 Rescue of drug sensitivity of BC02 by point mutants : BC202 is also sensitive to 
several biocides and antibiotics which are normally effluxed from the cell via PMF-
dependent pumps including EmrE, MdfA and AcrB (Kumar and Doerrler 2014).  BC202 
transformed with control vector displays sensitivity to acriflavine, benzalkonium-Cl, 
ethidium bromide, and methyl viologen (Figure 5.4, A and B).  Resistance to these 
compounds is normally conferred by AcrB, MdfA/AcrB, MdfA/EmrE/AcrB and EmrE, 
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respectively (Sulavik, Houseweart et al. 2001; Tal and Schuldiner 2009).  BC202 
expressing wild type yqjA or yghB display normal resistance to these compounds as do 
cells expressing YqjA-D15A, -H121A, and -D186A or YghB-E185A and D186A.  Once 
again, YqjA and YghB-R130A, R136A and E185A mutants were nonfunctional in that 
they failed to restore resistance to BC202.  Lysine could substitute for arginine at position 
130 but not position 136 in each of the two proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Correction of cell division defects of BC202 by YqjA, YghB and point mutants. 
BC202 transformed with vector, pBAD-yqjA and YqjA point mutants (A) or vector, 
pBAD-yghB and YghB point mutants (B) grown at 30C in liquid media having 0.1 % 
arabinose were visualized with a Leica DM-RXA2 deconvolution microscope. Bar = 10 
m.  
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Figure 5.4. Correction of drug sensitivity of BC202 by YqjA, YghB and point mutants. 
BC202 transformed with vector, pBAD-yqjA, and YqjA point mutants (A) and vector, 
pBAD-yghB, and YghB point mutants (B) was tested for sensitivity to acriflavine (25 
g/ml), Benzalkonium chloride (40 g/ml), ethidium bromide (100 g/ml) and methyl 
viologen (30 g/ml). All strains grew well on LB plates without biocides at 30 C.   
 
 Rescue of alkaline sensitivity of yqjA by point mutants: The E. coli yqjA mutant 
(but not the yghB mutant) cannot grow at a pH exceeding 8.5 (Kumar and Doerrler 2015).  
Plasmid copies of yqjA or yghB rescue growth of yqjA up to pH 9.5 or 9.0, respectively. 
We therefore tested each point mutant for their ability to rescue growth of the yqjA mutant 
at elevated pH (Figure 5.5). Our results largely agree with the results for BC202 in Figures 
5.2-4 in that only YqjA and YghB -R130A and -R136A mutants are nonfunctional in that 
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they fail to restore growth to theyqjA mutant at alkaline pH.  Again, lysine can substitute 
for arginine at position 130 but not 136 in each protein (Figure. 5.5, A and B).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Correction of alkaline sensitivity of ΔyqjA by YqjA, YghB and point mutants. 
The ΔyqjA mutant transformed with vector, yqjA and YqjA point mutants (A) and vector, 
pBAD-yghB, and YghB point mutants (B) was grown to mid log phase at pH 7.0 and 5 l 
of serially diluted cells were spotted onto LB plates at pH 7.0, 9.0 and 9.25 (A) or pH 7.0, 
8.75 and 9.0 (B). The plates were incubated at 37 C for 20-24 hours. Growth at pH 7.0 
was carried out with 0.002% arabinose and 0.02% arabinose was used at pH 9 and 9.25.  
 
To our surprise, we found a discrepancy in the ability of YghB-E185A to rescue 
BC202 compared to the YqjA-E185A mutant. While YqjA-E185A rescues drug (Figure 
5.3, A) and pH sensitivity (Figure 5.4, A), it fails to rescue temperature sensitivity (Figure. 
5.1, A) and cell division (Figure 5.2, A). In contrast, YghB-E185A corrects the drug 
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sensitivity (Figure. 5.3, B) and cell division defect (Figure. 5.2, B) of BC202 and the pH 
sensitivity of ∆yqjA (Figure. 5.4, B), while not correcting the temperature sensitivity of 
BC202 (Figure. 5.1, C). All mutants proteins are expressed well in the membrane fraction, 
indicating proper folding and targeting (Figure 5.1, B, D).  The reasons for the differing 
ability of E185A mutants of YqjA and YghB to rescue cell division are at present unclear 
but both mutants are classified here as partially functional.   
5.4 Discussion 
YqjA and YghB belong to DedA/Tvp38 membrane protein family of E. coli and 
genes encoding homologs are present in most sequenced bacterial genomes (Doerrler, 
Sikdar et al. 2013). Previously, we characterized the importance of YqjA/YghB in growth 
at elevated temperatures, cell division, drug resistance, and alkaline pH tolerance in E. coli 
(Thompkins, Chattopadhyay et al. 2008; Sikdar and Doerrler 2010; Doerrler, Sikdar et al. 
2013; Kumar and Doerrler 2014; Kumar and Doerrler 2015).  Our observations suggest 
DedA/Tvp38 is a new family of membrane transporters (Sikdar, Simmons et al. 2013; 
Kumar and Doerrler 2014; Kumar and Doerrler 2015).  In spite of our genetic and 
physiological evidence, mechanistic and structural details of this protein family remain 
unclear.  A structural model of one DedA family member, Slr0305 of Synechocystis sp. 
PCC6803, has been published based upon a predicted similar fold to LeuT (Keller, Ziegler 
et al. 2014).   
To provide mechanistic insight into DedA family proteins, we introduced mutations 
of conserved and charged amino acids of YqjA and YghB and measured the effect of the 
mutant proteins on numerous phenotypes of BC202 and ∆yqjA.  We observed that R130A 
and R136A mutations abolish the ability of YqjA and YghB to rescue BC202 and ∆yqjA 
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suggesting an essential role of these amino acid in their function. In order to distinguish 
whether the effect was due to changes in size or charge we created the R130K and R136K 
variants of YqjA and YghB. We found that YqjA-130K and YghB-R130K regain full 
function suggesting that charge at this position is important for the function of both 
proteins.  However, in spite of being well expressed, the R136K mutant of both proteins 
were not able to complement the BC202 and ∆yqjA phenotypes implying that arginine at 
this position is essential for their function.   
The importance of membrane embedded arginines has been observed in a number 
of different families of membrane transporters including GlpT (Law, Almqvist et al. 2008), 
UhpT (Fann, Davies et al. 1998; Law, Almqvist et al. 2008), F0F1 ATPase (Cain and 
Simoni 1989), MjNhaP1 (Hellmer, Teubner et al. 2003), TetA (Kimura, Nakatani et al. 
1998), MdtM (Holdsworth and Law 2012) and MdfA (Fann, Davies et al. 1998; Sigal, 
Vardy et al. 2005; Law, Almqvist et al. 2008; Holdsworth and Law 2012).  In these 
examples, arginine is thought to be directly involved in substrate binding and faces the 
translocation channel.   
MdfA appears to share some functional similarity to YqjA. Both the yqjA and the 
mdfA E. coli strains display alkaline sensitivity (Lewinson, Padan et al. 2004; Kumar and 
Doerrler 2015).  Overexpression of MdfA is sufficient to suppress each mutant phenotype 
of BC202 and to partially restore pH resistance to yqjA (Sikdar, Simmons et al. 2013; 
Kumar and Doerrler 2014; Kumar and Doerrler 2015). Therefore the importance of charged 
residues in the membrane domains of both proteins is potentially significant.  Acidic 
residues residing in the first transmembrane domain of both proteins (MdfA E26/D34 and 
YqjA/YghB E39/D51) have been shown to be functionally important (Fluman, Ryan et al. 
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2012; Kumar and Doerrler 2014).  Substitutions resulting in a loss of the positive charge at 
amino acid R112 in MdfA resulted in sensitivity to antibiotics (Sigal, Vardy et al. 2005).  
It was suggested that R112 of MdfA could function in proton recognition (Sigal, Vardy et 
al. 2005) similar to R302 of LacY (Abramson, Iwata et al. 2004).  Recently, the inward 
facing substrate bound structure of E. coli MdfA was published and confirmed the 
importance of membrane embedded R112 for transport activity (Heng, Zhao et al. 2015).   
LeuT, a member of the neurotransmitter: sodium symporter family appears to share 
structural features with DedA based upon computational analysis (Khafizov, Staritzbichler 
et al. 2010; Keller, Ziegler et al. 2014). In this transporter, a water mediated salt bridge 
formed between amino acids R30 and D404 is thought to form the extracellular gate 
(Noskov 2008; Singh, Piscitelli et al. 2008; Krishnamurthy, Piscitelli et al. 2009).  We 
propose, based on these studies that R130 and R136 of both YghB and YqjA are either 
exposed to the substrate translocation pore or play a role in substrate binding. An alternate 
possibility is that these residues form salt bridges with negatively charged amino acids 
helping to maintain protein conformation during the transport cycle (Law, Almqvist et al. 
2008). Their involvement in the specific transport mechanism may differ from those 
examples cited above and clarification awaits future structural studies.  In conclusion, we 
have demonstrated that R130 and R136 are critical for the function of YqjA and YghB. 
These results will aid in elucidating the mechanism of transport of DedA/Tvp38 family 
members. 
5.5 References 
Abramson, J., S. Iwata, et al. (2004). "Lactose permease as a paradigm for membrane 
transport proteins (Review)." Mol Membr Biol 21(4): 227-236. 
 
147 
 
Adler, J. and E. Bibi (2004). "Determinants of substrate recognition by the Escherichia coli 
multidrug transporter MdfA identified on both sides of the membrane." J Biol 
Chem 279(10): 8957-8965. 
 
Boughner, L. A. and W. T. Doerrler (2012). "Multiple deletions reveal the essentiality of 
the DedA membrane protein family in Escherichia coli." Microbiology 158(Pt 5): 
1162-1171. 
 
Cain, B. D. and R. D. Simoni (1989). "Proton translocation by the F1F0ATPase of 
Escherichia coli. Mutagenic analysis of the a subunit." J Biol Chem 264(6): 3292-
3300. 
 
Cutler, R. L., A. M. Davies, et al. (1989). "Role of arginine-38 in regulation of the 
cytochrome c oxidation-reduction equilibrium." Biochemistry 28(8): 3188-3197. 
 
Doerrler, W. T., R. Sikdar, et al. (2013). "New functions for the ancient DedA membrane 
protein family." J Bacteriol 195(1): 3-11. 
 
Fann, M., A. H. Davies, et al. (1998). "Identification of two essential arginine residues in 
UhpT, the sugar phosphate antiporter of Escherichia coli." J Membr Biol 164(2): 
187-195. 
 
Fluman, N., C. M. Ryan, et al. (2012). "Dissection of mechanistic principles of a secondary 
multidrug efflux protein." Mol Cell 47(5): 777-787. 
 
Gerchman, Y., Y. Olami, et al. (1993). "Histidine-226 is part of the pH sensor of NhaA, a 
Na+/H+ antiporter in Escherichia coli." Proc Natl Acad Sci U S A 90(4): 1212-
1216. 
 
Hellmer, J., A. Teubner, et al. (2003). "Conserved arginine and aspartate residues are 
critical for function of MjNhaP1, a Na+/H+ antiporter of M. jannaschii." FEBS Lett 
542(1-3): 32-36. 
 
Heng, J., Y. Zhao, et al. (2015). "Substrate-bound structure of the E. coli multidrug 
resistance transporter MdfA." Cell Res 25(9): 1060-1073. 
 
Holdsworth, S. R. and C. J. Law (2012). "Functional and biochemical characterisation of 
the Escherichia coli major facilitator superfamily multidrug transporter MdtM." 
Biochimie 94(6): 1334-1346. 
 
Holdsworth, S. R. and C. J. Law (2013). "Multidrug resistance protein MdtM adds to the 
repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli." 
BMC Microbiol 13: 113. 
 
Jiang, Y., V. Ruta, et al. (2003). "The principle of gating charge movement in a voltage-
dependent K+ channel." Nature 423(6935): 42-48. 
148 
 
 
Keller, R., N. Schleppi, et al. (2015). "Mutational analyses of YqjA, a Tvp38/DedA protein 
of E. coli." FEBS Lett 589(7): 842-848. 
 
Keller, R., C. Ziegler, et al. (2014). "When Two Turn Into One: Evolution of Membrane 
Transporters From Half Modules." Biol Chem. 
 
Khafizov, K., R. Staritzbichler, et al. (2010). "A study of the evolution of inverted-topology 
repeats from LeuT-fold transporters using AlignMe." Biochemistry 49(50): 10702-
10713. 
 
Kimura, T., M. Nakatani, et al. (1998). "Roles of conserved arginine residues in the metal-
tetracycline/H+ antiporter of Escherichia coli." Biochemistry 37(16): 5475-5480. 
 
Krishnamurthy, H., C. L. Piscitelli, et al. (2009). "Unlocking the molecular secrets of 
sodium-coupled transporters." Nature 459(7245): 347-355. 
 
Kumar, S. and W. T. Doerrler (2014). "Members of the conserved DedA family are likely 
membrane transporters and are required for drug resistance in Escherichia coli." 
Antimicrob Agents Chemother 58(2): 923-930. 
 
Kumar, S. and W. T. Doerrler (2015). "Escherichia coli YqjA, a Member of the Conserved 
DedA/Tvp38 Membrane Protein Family, Is a Putative Osmosensing Transporter 
Required for Growth at Alkaline pH." J Bacteriol 197(14): 2292-2300. 
 
Law, C. J., J. Almqvist, et al. (2008). "Salt-bridge dynamics control substrate-induced 
conformational change in the membrane transporter GlpT." J Mol Biol 378(4): 828-
839. 
 
Lewinson, O., J. Adler, et al. (2003). "The Escherichia coli multidrug transporter MdfA 
catalyzes both electrogenic and electroneutral transport reactions." Proc Natl Acad 
Sci U S A 100(4): 1667-1672. 
 
Lewinson, O., E. Padan, et al. (2004). "Alkalitolerance: a biological function for a 
multidrug transporter in pH homeostasis." Proc Natl Acad Sci U S A 101(39): 
14073-14078. 
 
Liang, F. T., Q. Xu, et al. (2010). "BB0250 of Borrelia burgdorferi is a conserved and 
essential inner membrane protein required for cell division." J Bacteriol 192(23): 
6105-6115. 
 
Long, S. B., E. B. Campbell, et al. (2005). "Voltage sensor of Kv1.2: structural basis of 
electromechanical coupling." Science 309(5736): 903-908. 
 
Noskov, S. Y. (2008). "Molecular mechanism of substrate specificity in the bacterial 
neutral amino acid transporter LeuT." Proteins 73(4): 851-863. 
149 
 
 
Noumi, T., H. Inoue, et al. (1997). "Identification and characterization of functional 
residues in a Na+/H+ antiporter (NhaA) from Escherichia coli by random 
mutagenesis." J Biochem 121(4): 661-670. 
 
Padan, E., E. Bibi, et al. (2005). "Alkaline pH homeostasis in bacteria: new insights." 
Biochim Biophys Acta 1717(2): 67-88. 
 
Pinner, E., Y. Kotler, et al. (1993). "Physiological role of nhaB, a specific Na+/H+ 
antiporter in Escherichia coli." J Biol Chem 268(3): 1729-1734. 
 
Sigal, N., E. Vardy, et al. (2005). "3D model of the Escherichia coli multidrug transporter 
MdfA reveals an essential membrane-embedded positive charge." Biochemistry 
44(45): 14870-14880. 
 
Sikdar, R. and W. T. Doerrler (2010). "Inefficient Tat-dependent export of periplasmic 
amidases in an Escherichia coli strain with mutations in two DedA family genes." 
J Bacteriol 192(3): 807-818. 
 
Sikdar, R., A. R. Simmons, et al. (2013). "Multiple envelope stress response pathways are 
activated in an Escherichia coli strain with mutations in two members of the DedA 
membrane protein family." J Bacteriol 195(1): 12-24. 
 
Singh, S. K., C. L. Piscitelli, et al. (2008). "A competitive inhibitor traps LeuT in an open-
to-out conformation." Science 322(5908): 1655-1661. 
 
Sulavik, M. C., C. Houseweart, et al. (2001). "Antibiotic susceptibility profiles of 
Escherichia coli strains lacking multidrug efflux pump genes." Antimicrob Agents 
Chemother 45(4): 1126-1136. 
 
Tal, N. and S. Schuldiner (2009). "A coordinated network of transporters with overlapping 
specificities provides a robust survival strategy." Proc Natl Acad Sci U S A 
106(22): 9051-9056. 
 
Tao, X., A. Lee, et al. (2010). "A gating charge transfer center in voltage sensors." Science 
328(5974): 67-73. 
 
Thompkins, K., B. Chattopadhyay, et al. (2008). "Temperature sensitivity and cell division 
defects in an Escherichia coli strain with mutations in yghB and yqjA, encoding 
related and conserved inner membrane proteins." J Bacteriol 190(13): 4489-4500. 
 
Wiebe, C. A., E. R. Dibattista, et al. (2001). "Functional role of polar amino acid residues 
in Na+/H+ exchangers." Biochem J 357(Pt 1): 1-10. 
 
 
150 
 
Winn, P. J., S. K. Ludemann, et al. (2002). "Comparison of the dynamics of substrate 
access channels in three cytochrome P450s reveals different opening mechanisms 
and a novel functional role for a buried arginine." Proc Natl Acad Sci U S A 99(8): 
5361-5366. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
151 
 
CHAPTER 6 
EXPRESSION ANALYSIS OF yqjA 
6.1 Introduction 
 Alkaline pH tolerance is a vital feature of pathogenic, ecological and industrially 
important bacteria. Neutrophilic bacteria like E. coli have the capability to retain their 
intracellular pH in the range of 7.5-7.7 when grown under alkaline pH conditions. Recent 
physiological and genetic studies have shown several adaptations which contribute towards 
alkaline pH homeostasis including higher expression of transporters and enzymes which 
stimulate proton transport into the cell (for example the ATP synthase and monovalent 
cation/proton antiporters), metabolic changes which lead to up-regulation of amino acids 
deaminase such as tryptophan deaminase, or catabolic pathways that yield organic acids 
(Padan, Bibi et al. 2005). Na+ and H+ are the predominant ions necessary for bioenergetics 
inside the cell. A correct balance of these ions is critical for protein function and any 
fluctuation in the concentration causes stress to the cell (Padan, Venturi et al. 2001).  Cation 
proton antiporters have been found in most prokaryotes, and some species have multiple 
antiporters. For instance, five cation/proton antiporters (NhaA, NhaB, ChaA, MdfA, and 
MdtM) are known to function in E. coli  alkaline pH homeostasis (Padan and Landau 2016). 
Inward active transport of protons by these antiporters is coupled to the export of cations 
such as Na+, K+, Li+ or Ca2+. 
The presence of multiple sodium ion extrusion systems in bacteria can be explained 
based on the use of different systems under different environmental conditions (Kobayashi, 
Saito et al. 1999; Kobayashi, Saito et al. 2000; Shijuku, Yamashino et al. 2002). For 
example, ChaA extrudes sodium ions primarily at alkaline pH above 8, and NhaB functions 
at pH below 8, whereas NhaA is mainly responsible for adaptation to Li+ toxicity and 
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growth at alkaline pH in the presence of Na+ ions  (Karpel, Alon et al. 1991) (Sakuma, 
Yamada et al. 1998). nhaB does not play a role in adaptation to high salinity at alkaline pH 
but becomes essential in the absence of nhaA activity (Ohyama, Imaizumi et al. 1992; 
Pinner, Padan et al. 1994). The gene expression of nhaA is most studied and has been well 
documented (Karpel, Alon et al. 1991; Dover, Higgins et al. 1996; Dover and Padan 2001; 
Shijuku, Saito et al. 2001). A study using nhaA’-lacZ’ fusion showed the expression of 
nhaA is specifically regulated by intracellular Na+ and Li+ ions and not by ionic strength 
or osmolarity (Karpel, Alon et al. 1991; Dover, Higgins et al. 1996). Additionally, the 
transcription of nhaA in response to the high intracellular Na+ ions is positively regulated 
by NhaR (Rahav-Manor, Carmel et al. 1992), a member of LysR- OxyR family of 
regulatory proteins (Schell 1993; Storz and Altuvia 1994). The increase in pH by itself 
does not alter  nhaA expression but does affect the sensitivity of expression towards Na+ 
or Li+ ions (Karpel, Alon et al. 1991). Two promoters, P1, and P2 were identified by primer 
extension analysis for nhaA, of which only P1 is Na+ and NhaR –dependent (Dover and 
Padan 2001). Furthermore, the expression of chaA is dependent on osmolarity and pH of 
the medium (Shijuku, Yamashino et al. 2002). Additionally, experiments with a ∆chaA 
mutant have shown that ChaA is necessary for survival in a high concentration of K+ at 
alkaline pH (Radchenko, Tanaka et al. 2006).  
The DedA/Tvp38 family is a highly conserved but poorly understood family of 
membrane proteins and is present in most sequenced genomes including bacteria, archaea, 
and eukaryotes (Doerrler, Sikdar et al. 2013). Our lab has pioneered the characterization of 
the DedA/Tvp38 membrane protein family in E. coli (Thompkins, Chattopadhyay et al. 
2008; Liang, Xu et al. 2010; Sikdar and Doerrler 2010; Boughner and Doerrler 2012; 
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Doerrler, Sikdar et al. 2013; Sikdar, Simmons et al. 2013; Kumar and Doerrler 2014; 
Kumar and Doerrler 2015). YqjA and YghB are the best-characterized members of the 
DedA family and share 62% amino acid identity and partially redundant functions 
(Thompkins, Chattopadhyay et al. 2008). Simultaneous deletion of these two genes in a 
strain named BC202 (W3110 ∆yqjA, ∆yghB) results in various phenotypes such as 
temperature sensitivity (Thompkins, Chattopadhyay et al. 2008), cell division defects due 
to inefficient export of amidases by the twin-arginine transport pathway (Sikdar and 
Doerrler 2010), and drug sensitivity due inefficient function of PMF-dependent efflux 
pumps (Kumar and Doerrler 2014). These phenotypes of BC202 are rescued by 
overexpression of mdfA or by growth at pH 6.0 suggesting a role for YqjA/YghB in the 
maintenance of proton motive force (PMF) (Sikdar, Simmons et al. 2013). Furthermore, 
membrane-embedded charged amino acids are essential for the function of YqjA and YghB 
(Kumar and Doerrler 2014; Kumar and Doerrler 2015; Kumar, Bradley et al. 2016), that 
were previously shown to be important for the function of numerous secondary proton-
dependent transporters including MdfA, NhaA, MdtM and LacY(Abramson, Kaback et al. 
2004) (Sigal, Vardy et al. 2005; Fluman, Ryan et al. 2012; Holdsworth and Law 2012). 
The ∆yqjA mutant (but not the ∆yghB mutant) is sensitive to alkaline pH and the presence 
of Na+ or K+ is also necessary for the function of YqjA at alkaline pH (Kumar and Doerrler 
2015). Based on these observations, we have recently shown YqjA is a putative 
osmosensing transporter required for the growth at alkaline pH (Kumar and Doerrler 2015).  
yqjA gene expression is under the regulation of both Cpx and σE stress response 
pathways (Dartigalongue, Missiakas et al. 2001; Price and Raivio 2009). The Cpx 
(conjugative pilus expression) stress response pathway is mediated by a two- component 
154 
 
system comprising of an inner membrane sensor histidine kinase (CpxA) and a cytoplasmic 
response regulator (CpxR) (Vogt and Raivio 2012). CpxR becomes activated in response 
to the overexpression of envelope proteins such as NlpE or pilus subunits, elevated pH, 
altered membrane composition, high osmolarity, adhesion, indole, and metal ions (Cu2+, 
Zn2+) (Raivio 2014). CpxR controls the expression of genes that participate in numerous 
cellular processes including degradation of misfolded proteins in the periplasm (proteases 
like DegP), protein secretion, motility, multidrug efflux, regulation of  two component 
systems, cell division, biogenesis and modifications of phospholipids and 
lipopolysaccharide and other uncharacterized physiological processes (Vogt and Raivio 
2012; Raivio 2014; Guest and Raivio 2016). The σE stress response pathway is facilitated 
by the essential sigma factor σE ( RpoE), which senses stress that compromises the envelope 
integrity like misfolded polypeptides and is involved in regulating extracytoplasmic and 
extracellular functions (Danese and Silhavy 1997; Dartigalongue, Missiakas et al. 2001). 
Cpx and σE   have partially overlapping regulon (Raivio and Silhavy 1999; Vogt and Raivio 
2012). 
In order to distinguish the uses of various transport systems and their physiological 
roles, it is important to study the effects of environmental stimuli on the expression of these 
genes (Shijuku, Yamashino et al. 2002). Therefore, in this study, we have analyzed the 
expression of yqjA using a reporter gene fusion of the yqjA promoter to lacZ. We found 
that yqjA expression was higher at alkaline pH than at acidic and neutral pH. Moreover, 
increased expression of yqjA at elevated pH also required sodium or potassium salts. We 
observed that the transcriptional regulator CpxR is responsible for the expression of yqjA 
at alkaline pH and presence of Na+ or K+ ions at alkaline pH. These results further support 
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our previous observations and help in better understanding of the role of this newly 
identified family of membrane transporters in E. coli. 
6.2 Materials and Methods 
 Materials: All chemicals were reagent grade and purchased from Sigma-Aldrich, 
VWR, New England Biolabs or Qiagen.  
 Bacterial growth conditions: Bacteria cultures were grown in LB medium (1% 
tryptone, 0.5% yeast extract and 1% NaCl) with antibiotics ampicillin (Amp) at 100 µg/ml, 
kanamycin (Kan) at 30 µg/ml, tetracycline (Tet) at 12.5 µg/ml, and chloramphenicol (Cam) 
at 30 µg/ml where indicated. For studies at alkaline pH, the growth media were buffered 
with 70mM BTP (Bis-Tris propane) and pH was adjusted as required with HCl. For acidic 
conditions (pH 5 and pH 6) the growth media were buffered with 100mM 2-(N-
morpholino)-ethane sulfonic acid (MES) as previously described (Sikdar, Simmons et al. 
2013). For some experiments growth media was additionally supplemented with 0.002% 
or 0.02% arabinose (w/v). Cells were grown at 37°C.  
 Alkaline pH sensitivity on solid plate media: Alkaline pH sensitivity was tested as 
previously described (Kumar and Doerrler 2015). Overnight cultures of E. coli were diluted 
1:100 in LB media with appropriate antibiotics and additives, and grown to OD600 ~ 0.6 at 
37°C. 5μl of serially log10-diluted cells were spotted on LB agar plates at the indicated pH 
with appropriate antibiotics and additives. During growth at pH 7, 0.002% arabinose was 
used when inducing expression of yqjA and cpxR due to toxicity issues. At higher pH, 
0.02% arabinose was used. Plates were incubated at 37°C for 20 to 24 hours. All 
experiments were repeated three times. 
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 Alkaline pH sensitivity growth assay in liquid medium: Alkaline pH sensitivity in 
liquid growth media was carried out as previously described (Kumar and Doerrler 2015).  
Overnight cultures from a single colony were freshly diluted to 1:100 in LB media with 
appropriate antibiotics, and grown to OD600 ~ 1.0 at 37°C in a shaking incubator. 1ml of 
culture was further inoculated into 20ml of prewarmed fresh LB medium at required pH 
and containing appropriate antibiotics. The cells were grown aerobically at 37°C in a 
shaking incubator and OD600 was measured each hour for 8 hours. All growth curves were 
repeated three times. 
 Strain construction: All strains used are listed in Table 6.1. Strain TB28 (Bernhardt 
and de Boer 2003) was used to provide a lacZYA background for certain strains. 
Mutations from Keio collection strains (Baba, Ara et al. 2006) were typically introduced 
into E. coli W3110 or TB28 background by P1 transduction (Silhavy, Berman et al. 1984) 
and correct configuration was verified by PCR and DNA sequencing with primers flanking 
the appropriate gene. DNA sequencing was conducted at the LSU College of Science 
Genomics Facility. 
 Construction of plasmids (pSK1, pSK2, pSK3) for β-galactosidase assay: All PCR 
primers are listed in table 6.2. The E. coli lacZ gene was amplified from W3110 genomic 
DNA. The PCR product obtained was purified using QIAquick PCR purification kit 
(Qiagen, Valencia CA), digested with SphI and BamHI, and cloned into a likewise treated 
and dephosphorylated pACYC184 vector (NEB). The upstream region containing the 
promoter of the particular genes (yqjA, alx, nhaA) in the study was amplified using W3110 
genomic DNA and cloned into pACYC184 plasmid at SalI and SphI sites such that the 
promoter of that gene lies upstream of lacZ on the plasmid and controls the expression of 
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the lacZ gene. The plasmids generated are listed in table 6.1. Sequencing of all constructs 
was performed at the LSU College of Science Genomics Facility. 
 β-Galactosidase Assay: The β-galactosidase (β-gal) assays were performed by 
using the method of Miller (Miller 1972). Overnight cultures of indicated strains were 
diluted 1:100 in fresh LB supplemented with appropriate antibiotics and grown shaking at 
37°C to an OD600 of ~1.0. 1ml of culture was then diluted into 5ml of fresh growth media 
at desired pH and salt concentrations and grown for an additional 1 hour. To analyze the 
effect of Na+ and K+ ions on the expression of genes, salt-free media (1% tryptone (w/v), 
0.5% yeast extract (w/v)) was supplemented with different concentrations of salts as 
specified. Although we refer to this media as “salt-free”, residual amounts (1-10mM) of 
both sodium and potassium are likely present (Ohyama, Igarashi et al. 1994; Radchenko, 
Tanaka et al. 2006). Cells were washed at least two times in salt-free media before adding 
the fresh media. After growing the cells in the experimental conditions, 0.1ml of cells were 
then added to Z buffer (Miller 1972) to a total volume of 1 ml and the cells were lysed by 
the addition of 50 µl chloroform and 25 µl 0.1% SDS and vortexing. The reaction was 
started by addition of 0.1 ml of 8 mg/ml (w/v) 2-nitrophenyl β-D-galactopyranoside 
(ONPG) and the tubes were incubated at 30°C till sufficient yellow color developed 
(reaction time varied from 20 minutes to 6 hrs). The reaction was stopped by adding 0.4 
ml of 1.25 M Na2CO3 to the reaction mix and vortexing. The mixture was centrifuged at 
13,000 rpm for 5 min to remove cell debris and absorbance was read at 420 nm. Cells 
harboring the empty vector gave a reading at 420 nm that was not above background. The 
β-galactosidase units were corrected for the culture density and correspond to 1nmole 
ONPG hydrolyzed per minute at 30⁰C. 
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Table 6.1. E. coli strains and plasmids used in this study 
 
 
Strains Relevant Genotype/Genetic Markers Source or Reference 
W3110 Wild-type, F-,λ- E. coli genetic stock center, 
Yale University 
BC203 W3110, ΔyqjA::TetR (Thompkins, 
Chattopadhyay et al. 2008) 
BC202 W3110, ΔyqjA::TetR  ΔyghB:: KanR (Thompkins, 
Chattopadhyay et al. 2008) 
BC203C W3110, ΔyqjA::TetR ΔcpxR772:: KanR This work 
TB28 MG1655, lacIZYA<>frt (Bernhardt and de Boer 
2003) 
RS28A TB28,  ΔyqjA::TetR (Sikdar, Simmons et al. 
2013) 
RS28C TB28,  ΔcpxR772:: KanR (Sikdar, Simmons et al. 
2013) 
SK28AC TB28,  ΔyqjA::TetR,  ΔcpxR772:: KanR This work 
Plasmids   
pBADHisA Expression Vector; araBAD promoter, 
AmpR 
Invitrogen. 
pACYC184 Low Copy Expression Vector;  TetR, KanR New England Biolabs. 
pSK1 yqjA promoter responsive vector;  CamR, 
pACYC184  (yqjA  promoter – lacZ) 
This work. 
pSK2 alX responsive vector;  CamR, pACYC184  
(alx  promoter – lacZ) 
This work. 
pSK3 nhaA responsive vector;  CamR, 
pACYC184  (nhaA  promoter – lacZ) 
This work. 
pBAD-
YqjA 
H6-yqjA expression vector;  araBAD 
promoter, AmpR 
(Boughner and Doerrler 
2012) 
pBAD-
CpxR 
H6-cpxR expression vector;  araBAD 
promoter, AmpR 
This work. 
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Table 6.2 PCR primers used in this study. 
 
6.3 Results 
 Effect of pH on the expression of yqjA: We have previously shown that the ∆yqjA 
mutant is alkaline sensitive (Kumar and Doerrler 2015). In order to further explore the 
physiological roles of yqjA, we analyzed the expression of yqjA at different pH’s. We used 
a ∆lacZYA parent strain, TB28 (Bernhardt and de Boer 2003) for our expression analysis 
study. In agreement with our previous observation, the RS28A (TB28∆yqjA) (Table 6.1) 
Name  Sequence (5’->3’) [Restriction Sites Underlined] 
CpxR_FP (XhoI) CGGCGCCTCGAGATGAATAAAATCCTGTTAGTTG 
CpxR_RP 
(HindIII) 
GCCGGCAAGCTTTCATGAAGCAGAAACCATCAGATAGCC
G  
LacZ_FP (SphI) CGCGGCATGCACCATGATTACGGATTCACTGGCC 
LacZ_RP 
(BamHI) 
CGCGGGATCCTTATTTTTGACACCAGACCAACTG 
YqjA_PR_FP 
(SalI) 
CCGGGTCGACAATTCCTGTCCGACAGGCGCTGCAATGCG 
YqjA_PR_RP 
(SphI) 
CCGGGCATGCCATTCATTATTCCTGGTGAATCGGTTAAC
GCC 
Alx_PR_FP 
(SalI) 
CCGGGTCGACATTGCCAAAGTAAAACAGTGTAAAAGGT
ATGTAAC 
Alx_PR_RP 
(SphI) 
GCCGGCATGCCATAGAAGTTCCTTACACATAAAAAAACG 
NhaA_PR_FP 
(SalI) 
CCGGGTCGACTCTATCTGCCGTTCAGCTAATGCCTGAGA
CAGAC 
NhaA_PR_RP(Sp
hI) 
 
CCGGGCATGCCACTTTTTATTTCTCTTTCAGGTGAATAGA
TCG 
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was also alkaline sensitive and was used similarly as BC203 (Table 6.1) depending upon 
requirements of the specific experiments. We constructed plasmids pSK1, pSK2, and pSK3 
(Table 6.1), in which expression of lacZ was under the control of the yqjA, alx (ygjT), and 
nhaA promoter respectively (Figure. 6.1, A) and measured β-galactosidase activity (Miller 
units). We tested the expression of yqjA in the range of pH from 5 to 9.25. We found that 
expression of yqjA increased as the pH of the media was increased and decreased in the 
acidic pH range (Figure. 6.1, B) consistent with a previously published observation 
(Maurer, Yohannes et al. 2005). Previously, a microarray study has reported that yqjA 
expression is repressed at acidic pH (Maurer, Yohannes et al. 2005). Additionally, the alx 
(ygjT) gene appeared in the same acid low cluster as yqjA, showing its lowest expression 
at pH 5, higher expression at pH 7 and highest at pH 9 and served as a control for our 
experiment (Maurer, Yohannes et al. 2005).  Alx (YgjT) is a predicted membrane bound 
redox regulator (Stancik, Stancik et al. 2002). We also observed the expression of alx was 
low at pH 5 and highest at pH 9 (Figure. 6.1, C) in agreement with the previous observation 
(Maurer, Yohannes et al. 2005). Furthermore, the expression of nhaA was strongly induced 
by the presence of Na+ ion at alkaline pH (Karpel, Alon et al. 1991; Dover and Padan 2001). 
We also observed the similar expression profile for nhaA in our experiment (Figure. 6.1, 
D). These observations suggest yqjA is induced at alkaline pH. 
 Effect of sodium or potassium on the expression of yqjA. We have also shown 
previously that Na+ and K+ are required for YqjA mediated growth at alkaline pH (Kumar 
and Doerrler 2015). We measured the expression profile of yqjA in response to changes in 
sodium or potassium in the medium at various pH. At pH 7, the expression of yqjA is not 
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Figure 6.1. Expression of the yqjA-promoter-lacZ fusion gene at different pH. (A). 
Schematic representation of the construct yqjA-promoter-lacZ fusion used to carry out 
expression analysis. TB28 containing plasmid pSK1 (B), pSK2 (C), or pSK3 (D) were 
cultured in LB(NaCl) media at 37⁰C at the desired pH and assayed for β-galactosidase 
activity. The alx(C) and nhaA(D) construct acted as control for the experiment and showed 
expression pattern as previously reported (Maurer, Yohannes et al. 2005) (Karpel, Alon et 
al. 1991). Each bar represents the average and standard deviation of three replicates of a 
particular experiment. The β-galactosidase activity is in miller units. 
 
dependent on the presence of sodium or potassium ion (Figure. 6.2, A), however as the pH 
of media (above pH> 8.5) was increased the expression of yqjA was increased with the 
increase in concentration of sodium or potassium (Figure. 6.2, B). We observed a similar 
pattern of expression with both chloride and gluconate form of sodium and potassium salts 
(Figure. 6.2, B). The effect of Na+ and K+ on expression was not connected to the change 
in osmolarity caused by ions since the addition of sucrose does not increase the expression 
of yqjA (Figure. 6.2, B). NhaA served as a control in our experiment since it is specifically 
regulated by Na+ or Li+ and not by ionic strength or osmolarity (Karpel, Alon et al. 1991). 
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In agreement with the previous study (Karpel, Alon et al. 1991), we also observed that the 
expression of nhaA was related specifically to Na+ ions, and not associated with a change 
in osmolarity caused by ions (Figure. 6.2, C and 6.2, D). These observations suggest that 
yqjA expression is induced in the presence of Na+ and K+ ion at alkaline pH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Effect of Na+ and K+ ions on the expression of the yqjA at pH 7 and pH 9. TB28 
containing plasmid pSK1(A, B) or pSK3 (C, D) were cultured in LB media at 37⁰C at the 
desired pH containg increasing concentrations (0mM, 100mM, 200mM) of either NaCl, 
KCl, Sucrose, Na-Gluconate, K-Gluconate and assayed for β-galactosidase activity. The 
nhaA(C, D) construct acted as control for the experiment and showed an expression pattern 
as previously reported (Karpel, Alon et al. 1991). Each bar represents the average and 
standard deviation of three replicates of a particular experiment. The β-galactosidase 
activity is in miller units. 
 
 Deletion of cpxR causes an increase in ∆yqjA mutant alkaline pH sensitivity:  It has 
been previously shown that the E. coli ∆yqjA mutant displays an induction of the Cpx stress 
response and is alkaline sensitive (Price and Raivio 2009; Sikdar, Simmons et al. 2013; 
Kumar and Doerrler 2015). CpxR is the cytoplasmic response regulator of the two-
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component systems of Cpx stress response pathway and controls the expression of a 
plethora of genes in response to  a variety of perturbations (e.g., pH changes, and change 
in membrane composition) related to the bacterial cell envelope (Raivio and Silhavy 2001). 
Additionally, the ∆cpxR mutant was shown to be alkaline sensitive signifying its critical 
role in the adaptation to alkaline pH stress (Danese and Silhavy 1998; Price and Raivio 
2009).  yqjA transcription is regulated by both CpxR (Price and Raivio 2009) as shown in 
Figure 6.3, (A) and σE (RpoE) (Dartigalongue, Missiakas et al. 2001). In the previous study 
of genes under the control of CpxR responsible for the growth at alkaline pH only yqjA 
mutant showed an alkaline sensitive phenotype (Price and Raivio 2009).  
 We wanted to know whether yqjA is the only gene under the control of CpxR 
responsible for alkaline pH tolerance or there are additional genes under CpxR regulation 
necessary for alkaline pH tolerance. The introduction of a ∆cpxR mutation into a ∆yqjA 
mutant resulted in increased alkaline pH sensitivity on both solid and liquid media (Figure. 
6.3, B and 6.3, C) suggesting that there might be other genes apart from yqjA under the 
control of CpxR regulation required for alkaline tolerance. The overexpression of cpxR 
from a plasmid does not correct the alkaline pH sensitivity of ∆yqjA mutant (Figure. 6.3, 
D). Similarly, overexpression of yqjA does not provide alkaline pH tolerance to ∆cpxR 
mutant to wild-type level (Figure. 6.3, D). Furthermore, as expected deletion of cpxR 
reduces the expression of yqjA at alkaline pH (Figure. 6.3, E). Altogether, these results 
suggest that other genes in the CpxR regulon apart from yqjA are important for alkaline pH 
tolerance in E. coli. 
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Figure 6.3. Effect of ∆cpxR deletion in ∆yqjA mutant background. (A). The schematic 
representation of yqjA regulation by CpxR. (B). Parent E. coli W3110, ∆yqjA, ∆cpxR, 
BC203C (∆yqjA, ∆cpxR) mutants were grown to mid-log phase till OD600≈0.6 at pH 7 and 
then 5µl of serially diluted cells was spotted onto LB media plates at pH 7.0, 8.25, 8.5, 
8.75, 9, and 9.25 and the plates were incubated at 37⁰C for 20 to 24 hours. (C). All strains 
were grown till OD≈ 1.0 and inoculated into fresh LB media at pH 7, 8.25, 8.5, 8.75, 9.0. 
The growth of the cells at 37⁰C were measured hourly. The error bars indicate standard 
deviations of three independent measurements. (D). The ∆yqjA, ∆cpxR, BC203C (∆yqjA, 
∆cpxR) mutants harboring the control vector pBAD or pBAD-yqjA, or pBAD-cpxR were 
grown to mid-log phase till OD600≈ 0.6 at pH 7, and 5µl of serially diluted cells were 
spotted onto LB-Amp plates at pH 7, 8.5, 8.75, 9. The plates were then incubated at 37⁰C 
for 20 to 24 hours. The growth at pH 7.0 was carried out in the presence of 0.002% 
arabinose, while growth at higher pH was in the presence of 0.02% arabinose (E). The 
expression of the yqjA at pH 7, 8, 8.5 in TB28 and TB28∆cpxR strains. Each bar represents 
the average and standard deviation of three replicates of a particular experiment. 
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6.4 Discussion 
 For neutralophiles like E. coli, the maintenance of acidic cytoplasm relative to the 
surrounding environment is critical for the survival at alkaline pH. The proton motive force 
(PMF) consists of two components: the transmembrane proton gradient (∆pH) and the 
membrane electrical potential (∆ψ) (Krulwich, Sachs et al. 2011). The relative magnitudes 
of these two components help in controlling the cytoplasmic pH. Although there are 
numerous strategies for alkaline pH homeostasis, the cation/proton antiporters play a vital 
and dominant role (Padan, Bibi et al. 2005). In E. coli, there are five known cation/proton 
transporters that help in adaptation to alkaline conditions: NhaA, NhaB, ChaA, MdfA, 
MdtM (Padan and Landau 2016). E. coli utilizes these antiporters under different 
environmental conditions.   
 We have previously shown that the ∆yqjA mutant is sensitive to alkaline pH and 
that Na+ and K+ are required for YqjA mediated growth at alkaline pH (Kumar and Doerrler 
2015). If any gene product is required for survival at alkaline pH then its expression should 
increase under alkaline conditions (Padan, Bibi et al. 2005). Therefore, we measured the 
expression of yqjA at various pH’s and salt concentrations. The expression of yqjA was 
higher at alkaline pH as compared to neutral pH (Figure. 6.1, B) and expression was low 
at acidic pH (Figure. 6.1, B) consistent with previous observations (Maurer, Yohannes et 
al. 2005). The expression profile of alx (Figure. 6.1, C) and nhaA (Figure 6.1, D) was also 
in agreement with previous reports and served as controls in these experiments (Maurer, 
Yohannes et al. 2005) (Karpel, Alon et al. 1991).  
 We also observed that increasing the Na+ and K+ concentration in the medium does 
not have much effect on yqjA expression at pH 7 (Figure 6.2, A) but increases the 
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expression of yqjA at alkaline pH (Figure. 6.2, B). NhaA, the main Na+-K+/H+ antiporter of 
E. coli was suggested to function primarily at alkaline pH containing a high level of sodium 
(Sakuma, Yamada et al. 1998; Padan, Venturi et al. 2001; Shijuku, Saito et al. 2001). We 
observed using nhaA-promoter-lacZ gene fusion that the expression of nhaA is induced 
specifically by Na+ and not by K+ or medium osmolarity (Figure. 6.2, C and 6.2, D) in 
agreement with the previous reports (Karpel, Alon et al. 1991; Dover and Padan 2001). 
YqjA mediated growth at alkaline pH required the presence of Na+ or K+ in the medium 
(Kumar and Doerrler 2015). Our present results suggest that yqjA expression at high pH is 
specific to the presence of Na+ and K+ ions but independent of osmolarity of the medium. 
The presence of multiple systems for one function can be explained on the basis of different 
usage of multiple systems under different environmental conditions (Kobayashi, Saito et 
al. 2000) (Kobayashi, Saito et al. 1999; Shijuku, Yamashino et al. 2002). For example, the 
transcription of nhaA is induced by Na+ or Li+ ions, however varying the pH by itself does 
not affect the expression but increases the sensitivity of expression towards Na+ or Li+ 
(Karpel, Alon et al. 1991) (Dover and Padan 2001). NhaB functions at neutral and acidic 
pH whereas ChaA extrude sodium ions at alkaline pH (Sakuma, Yamada et al. 1998; 
Shijuku, Yamashino et al. 2002). Moreover, chaA expression is regulated by osmolarity 
and pH of the medium (Shijuku, Yamashino et al. 2002).  
 YqjA is a member of Cpx regulon (Price and Raivio 2009) that gets activated in 
response to disturbances to the cell envelope and to periplasmic stress caused by alkaline 
conditions (Raivio and Silhavy 1999). The Cpx stress response pathway is controlled by a 
two-component system consisting of the sensor kinase CpxA and the response regulator 
CpxR (Raivio, Leblanc et al. 2013). CpxR activation results in upregulation of many 
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periplasmic proteases and chaperones. An important role in adaptation to alkaline pH was 
proposed for YqjA based on alkaline pH sensitivity of  both ∆cpxR and  ∆yqjA mutants 
(Price and Raivio 2009) which was further confirmed by us previously (Kumar and 
Doerrler 2015). The deletion of ∆cpxR in the ∆yqjA mutant background resulted in 
additional alkaline pH sensitivity suggesting the presence of another gene responsible for 
alkaline pH tolerance under CpxR regulation (Figure. 6.3, A and 6.3, B). However, the 
expression of yqjA at alkaline pH is mainly under the CpxR control as deletion of cpxR 
abolishes induction of yqjA (Figure. 6.3, E). Autokinase and phosphotransfer activities of 
the reconstituted CpxAR system were stimulated by KCl, NaCl whereas osmotic active 
solutes as glycine betaine, sucrose, and proline had no effect (Fleischer 2006). 
 YqjA and YghB are the best-studied members of the DedA/Tvp38 membrane 
protein family. Previously, we characterized the importance of YqjA/YghB in PMF-
dependent processes in E. coli (Thompkins, Chattopadhyay et al. 2008; Sikdar and Doerrler 
2010; Sikdar, Simmons et al. 2013; Kumar and Doerrler 2014; Kumar and Doerrler 2015). 
MdfA, a well-known Na+-K+/H+ antiporter, is a suppressor of the BC202 phenotypes and 
also partially rescues ∆yqjA mutant growth at alkaline pH (Sikdar, Simmons et al. 2013; 
Kumar and Doerrler 2014; Kumar and Doerrler 2015). Moreover, DedA proteins appear to 
share evolutionary structural fold similarity to LeuT, a member of neurotransmitter : 
sodium symporter family based on  computational analysis (Khafizov, Staritzbichler et al. 
2010). These observations suggest that YqjA and YghB may function as proton dependent 
membrane transporters (Sikdar, Simmons et al. 2013; Kumar and Doerrler 2014; Kumar 
and Doerrler 2015). The results of the present study further supports our previous 
observations and helps in better understanding the physiological role of yqjA in E. coli. 
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CHAPTER 7 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
            In the final chapter of this dissertation, the important findings from this research 
will be summarized in a point by point manner. Based on the present knowledge and 
experimental data, a model will be presented for YqjA/YghB proteins. Moreover, new 
experimental data that are not incorporated in the major chapters will also be presented. At 
the end, future experiments will be proposed as the extension of present findings to 
elucidate the function of these proteins. 
7.1  Important Conclusions 
 YqjA and YghB of E. coli are the two best-characterized members of the conserved 
DedA/Tvp38 protein family. However, the actual function of these proteins is not known 
yet. In order to decipher the function of these proteins, we investigated the phenotypes of 
the ∆yqjA mutant and double mutant named BC202 (∆yqjA ∆yghB). BC202 displays 
multiple phenotypes including cell division defects, drug sensitivity, and alkaline pH 
sensitivity, induction of Cpx and Psp stress responses, weak biofilm formation and motility 
defects. The research presented here mainly focuses on the alkaline pH sensitivity of ∆yqjA 
and drug sensitivity of BC202. 
  BC202 is highly sensitive to numerous compounds like ethidium bromide, 
benzalkonium chloride, methyl viologen, and acriflavine as compared to wild type W3110. 
However, BC202 is not hypersensitive to all biocides. Deletion of known efflux pumps 
causes additional drug sensitivity in BC202 suggesting the drug sensitivity phenotype is 
independent of other drug transporters. Overexpression of either YqjA or YghB corrects 
the drug sensitivity phenotypes, indication of an overlapping function of these proteins. 
Artificially increasing PMF either by overexpression of the Na+-K+/H+ antiporter MdfA or 
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growing BC202 in acidic media of pH 6 restores the drug sensitivity to most drugs 
signifying the indirect role of YqjA and YghB in E. coli drug resistance. 
 The ∆yqjA mutant is not able to grow at alkaline pH, unlike wild-type W3110. 
While YqjA and YghB show 62% amino acid similarity and redundant function, the ∆yghB 
mutant does not display alkaline sensitivity likely due to the presence of yqjA on the 
chromosome. However, the double mutant BC202 shows a more pronounced alkaline pH 
sensitivity. Overexpression of yqjA can complement the alkaline sensitivity of the ∆yqjA 
mutant, but only in the presence of Na+ or K+ . Additionally, overexpression of  mdfA or 
yghB partially rescues the growth of the ∆yqjA mutant at alkaline pH. Moreover, increasing 
the osmotic pressure also boosts the YqjA-mediated alkaline tolerance. 
 We found that membrane-embedded acidic amino acids, a hallmark of the proton-
dependent transporters, are important for the function of YqjA and YghB. We also 
identified conserved arginines (Figure 7.1) which are present at the same position in YqjA 
and YghB and found that they are essential for the function of these proteins. Charged 
amino acids are known to play important roles in numerous secondary transporters. 
  The expression of yqjA is highly induced at alkaline pH as compared to pH 7. 
Moreover, the expression of yqjA is increased with increasing concentration of Na+ or K+ 
salt at alkaline pH, but not at pH 7. The osmolarity of the medium does not control the 
expression of yqjA since increasing the concentration of sucrose does not have much effect. 
Lastly, deletion of cpxR  in ∆yqjA causes increase in alkaline pH sensitivity, suggesting 
that there may be other genes controlled by CpxR that play a role in alkaline pH tolerance. 
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7.2  Putative transporter function of YqjA and YghB in E. coli 
 Based on the genetic and physiological evidence, we propose that YqjA and YghB 
are novel membrane transporters linked to roles in the stabilization of membrane and 
quality control, and helping in the maintenance of PMF. Although the structural and 
mechanistic details of these proteins remain unclear, we propose a model (Figure 7.1) 
supported by knowledge gathered by us and other labs over the past several years in support 
of  YqjA and YghB as putative membrane transporters and PMF maintainance. The 
evidence is summarized below: 
 The deletion of both  genes in the same strain (BC202) causes cell division defects 
due to the inefficient export of periplasmic amidases by the twin-arginine transport 
pathways (Sikdar and Doerrler 2010) and drug sensitivity due to inefficient function of 
drug efflux pumps (Kumar and Doerrler 2014). The common factor for these phenotypes 
is the dependence on the PMF and we have shown using a JC-1 dye-based assay that BC202 
has significant loss of PMF (Sikdar, Simmons et al. 2013). 
  A known transporter, MdfA, has the ability to complement the phenotypes of 
BC202 and ∆yqjA (Sikdar, Simmons et al. 2013; Kumar and Doerrler 2014; Kumar and 
Doerrler 2015). To date, two functions of MdfA have been reported that include efflux of 
drugs from the cytoplasm using the PMF and a role in alkaline pH homeostasis as a Na+-
K+/H+ dependent transporter (Lewinson, Padan et al. 2004). 
 YqjA is required for the growth of E. coli at alkaline pH and Na+ or K+ is required 
for YqjA mediated growth at alkaline pH (Kumar and Doerrler 2015). Generally, 
cation/proton antiporters play a major role in alkaline pH homeostasis in E. coli (Padan, 
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Bibi et al. 2005). Moreover, expression of yqjA increases at alkaline pH and also with the 
presence of Na+ and K+ alkaline pH (manuscript in preparation).  
 The importance of charged amino acids for the function of YqjA and YghB. 
Membrane-embedded acidic amino acids, a hallmark of proton-dependent transporters 
were shown to be essential for the function of YqjA and YghB (Figure 7.1) (Kumar and 
Doerrler 2014; Kumar and Doerrler 2015). Moreover, membrane-embedded basic amino 
acids like arginine are also critical for the function of YqjA and YghB (Figure 7.1) (Kumar, 
Bradley et al. 2016). Arginines have been shown to be important for membrane proteins 
involved in various biological processes like regulation of redox potential (Cutler, Davies 
et al. 1989), voltage detection (Tao, Xie et al. 2010) and proton transport (Hellmer, Teubner 
et al. 2003; Sigal, Vardy et al. 2005). 
 AlignMe, a novel program, showed the evolutionary similarity of DedA proteins to 
LeuT family of transporters based on hydropathy profile (Khafizov, Staritzbichler et al. 
2010). The LeuT family transporters exist as a dimer of two 5-TM helices with a pseudo 
2-fold axis symmetry and it was hypothesized that DedA proteins may adopt dual topology 
and form dimers as shown in Figure 7.2 (Faham, Watanabe et al. 2008; Khafizov, 
Staritzbichler et al. 2010). It was recently confirmed that YqjA actually forms dimers in 
the membrane (Keller, Schleppi et al. 2015). A model of the structure of YqjA based on 
the LeuT structure is shown in Figure 7.1. 
 The DedA homolog plays a role in selenite uptake in Ralstonia metallidurans 
(Ledgham, Quest et al. 2005) and  likely iron uptake in Clostridium (Zhang, Ma et al. 
2011). Apart from these, DedA domains appear in secondary transporters of the Tripartite 
ATP- independent periplasmic transporter (TRAP- T) superfamily. 
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Figure 7.1 Structural model of DedA/Tvp38 family member YqjA of Escherichia coli 
showing locations of cytoplasmic N- and C-termini and critical amino acids E39, D51, 
R130 and R136 performed using the (PS) 2 -v2 Protein Structure Prediction Server and the 
structure of the repeat domain of LeuT (PDB: 2a65_A) as a template. The Figure was 
reproduced with permission from FEMS Microbiology Letters journal (Kumar, Bradley et 
al. 2016) 
 
Figure 7.2 Proposed mechanistic model of YqjA and YghB representing the likely 
transporter function of YqjA and YghB. A model suggesting the role of YqjA and YghB 
in the PMF maintenance as a proton transporter. Previously, DedA proteins were 
hypothesized to form dimers in the membrane based on fold similarity to LeuT transporters 
(Khafizov, Staritzbichler et al. 2010) and take part in proton transport into the cytoplasm, 
in exchange of symport or antiport of yet to be identified substrate. Using a crosslinking 
approach it is now confirmed that YqjA forms homodimers (Keller, Schleppi et al. 2015). 
Moreover, we propose YqjA and YghB likely act as Na+-K+/H+ antiporter similarly to 
MdfA during PMF homeostasis (Lewinson, Padan et al. 2004) . 
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 Based on these observations, we proposed that YqjA and YghB form homodimers 
and act as proton transporters similarly to MdfA as shown in Figure 7.2. However, unless 
proved through biochemical assay, both symport or antiport of yet unknown substrate is a 
possibility and is something for future consideration. Therefore, potential future 
experiments are required to answer our hypothesis that YqjA and YghB are actually proton 
dependent transporters. 
 7.3  Additional interesting observations 
 Previously, our lab had shown that BC202 has impaired motility and produces outer 
membrane vesicles with increased amounts of flagellin subunit FliC (unpublished 
observation). These phenotypes suggest inefficient functioning of  type III secretion system 
(T3SS), which might be due to loss of PMF in BC202. Moreover, B202 is unable to form 
biofilms (unpublished observations), a phenotype which might be linked to a motility 
defect (Pratt and Kolter 1998). Quorum sensing is a method in bacteria to control gene 
expression by recognizing the cell density through small signaling molecule such as 
autoinducer 2 (AI-2) that are secreted into the environment (Bassler 1999). AI-2 is known 
to stimulate biofilm formation in E. coli (Gonzalez Barrios, Zuo et al. 2006). DNA 
microarray studies in E. coli showed that AI-2 controls the expression of numerous genes 
including those for chemotaxis, motility, flagellar synthesis and virulence factor (DeLisa, 
Wu et al. 2001; Ren, Bedzyk et al. 2004). It is important to note that expression of yghB is 
induced by AI-2 quorum signaling and might play a role in biofilm formation (DeLisa, Wu 
et al. 2001). The occurrence of  “C- group” DedA homologs- YabI and YohD as a 
multicopy suppressor for BC202 phenotypes make it difficult to analyze the function of 
YqjA and YghB (Thompkins, Chattopadhyay et al. 2008; Boughner and Doerrler 2012). 
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YabI also has the ability to rescue the ∆yqjA mutant growth at alkaline pH when 
overexpressed from a plasmid (unpublished observation). Alternatively, there is also a 
possibility of  different roles for these homologs in contratst to YqjA and YghB, since they 
become important only in the absence of yqjA and yghB in E. coli. Using a transposon-
directed insertion sequencing (TraDIS) screening approach, it was found that an E. coli 
∆yabI mutant has modest IR survival rate as compared to wild-type cells (Byrne, Chen et 
al. 2014) suggesting a link between yabI and IR survival in E. coli. IR causes double-
stranded breaks (DSBs) and other DNA damage. Therefore, genes involved in IR survival 
are suggested to play an essential role in bacteria. 
7.4  Future directions 
 In spite of our genetic and physiological observations, mechanistic and structural 
information of DedA/Tvp38 family remains unclear. However, using LeuT as a template a 
structural model of a DedA homolog, Slr0305 of Synechocystis sp. PCC6803, was recently 
published (Keller, Ziegler et al. 2014). We know E. coli DedA family mutants (∆yqjA and 
BC202) are growth-compromised at alkaline pH . Moreover, overexpression of yqjA can 
correct alkaline pH sensitivity only if adequate extracellular sodium or potassium is 
supplied (> ~100 mM). Additionally, the activity of the yqjA promoter also increases at 
elevated pH, but, again, only if extracellular cations are present. All the evidence points to 
Na+ or K+ as potential substrates and therefore symporter or antiporter assays using 
membrane vesicles are needed to determine the direction of transport. We also need to 
measure cytoplasmic pH under different extracellular pH’s to address the role of YqjA in 
alkaline adaptation and measure ΔΨ to address the energy requirements of transport. We 
think that the cytoplasmic pH of ∆yqjA and BC202 is likely to be more alkaline than 
179 
 
normal. Intracellular pH can be measured in live E. coli cells at several external pH’s by 
ratiometric fluorescence measurements of the pH sensitive, cell permeable fluorescent 
probe 2,7-bis-(2-carboxyethyl)-5-carboxyfluorescein (Holdsworth and Law 2013). 
Alternatively, the use of 14C-methylamine, which gathers in the cell in a ΔpH dependent 
manner is also used in some cases (Lewinson, Padan et al. 2004). Additionally, to know 
the stoichiometry of transport cycle or measure the ΔΨ we need to determine if YqjA-
mediated transport is electrogenic using the ΔΨ-sensitive fluorophore [bis-(3-phenyl-5-
oxoisooxazol-4-yl) pentamethine oxonol] (Holdsworth and Law 2013).  
 Furthermore, our observations show the expression of yqjA is highly induced at 
alkaline pH and with increasing concentration of Na+ or K+ salt. To further support our 
reporter gene assay results of yqjA expression and other DedA genes we will carry out 
quantitative PCR to determine the mRNA levels at the alkaline conditions. 
 Antibiotics are one of the most important discoveries of science, used by the 
healthcare units for reducing mortality and morbidity in severe bacterial infections 
(Leibovici, Paul et al. 2016). However, the extensive use of antibiotics has led to the rise 
of bacterial strains which can survive in the presence of multiple antibiotics (Putman, van 
Veen et al. 2000). The rise in multidrug resistant bacterial pathogens represents a global 
public health concern due to difficulty in finding efficient treatments (Kumar, He et al. 
2016). There are numerous studies that suggest DedA proteins may represent potential drug 
targets and may be important for virulence in some species. A DedA homolog (BCG2664) 
from Mycobacterium bovis confers resistance to the antibiotic halicyclamine A, when 
overexpressed in Mycobacterium smegmatis, suggesting a probable target for this 
antibiotic (Arai, Liu et al. 2011). Additionally, DedA proteins seem to be necessary for 
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resistance to cationic peptides in both Salmonella enterica and Neisseria meningitidis. In 
Salmonella, the ∆yqjA mutant is susceptible to protamine and α-helical cationic peptide, 
including magainin 2 and melittin (Shi, Cromie et al. 2004). Covalent modifications to lipid 
A often provides resistance to cationic peptides (Raetz, Reynolds et al. 2007), however 
Salmonella ∆yqjA exhibits wild-type lipid A profile (Shi, Cromie et al. 2004). Therefore, 
the role of YqjA in providing resistance to cationic peptides in Salmonella is not yet clear. 
Additionally, a Neisseria NMB1052 (dedA) mutant was found hypersensitive to 
polymyxin (Tzeng, Ambrose et al. 2005). A combination of lipopolysaccharide (LPS) 
modification, efflux pumps and type IV pilin secretion is used by Neisseria to get resistance 
against cationic peptides (Tzeng, Ambrose et al. 2005; Lewis, Choudhury et al. 2009). The 
roles of DedA genes in Neisseria is also unclear, however,  the similarity of the Neisseria 
and Salmonella DedA mutants further suggests these genes to be a potential drug targets. 
Many other pathogenic bacteria like Pseudomonas, Burkholderia, Vibrio and Klebsiella 
have either one or multiple DedA family genes in their genomes. Therefore, it will be 
interesting to study the roles of DedA family genes in the drug resistance of these 
pathogenic organisms. In short, studies of the DedA/Tvp38 family promise to 
fundamentally change our understanding of bioenergetics and physiology in bacteria. 
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